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ABSTRACT 
 
Australia has decades of public policy experience attempting to overcome the disparities in 
health  outcomes  facing  Aboriginal  and  Torres  Strait  Islander  (Indigenous)  Australians. 
Significant  resources  have  accompanied  these  policy  initiatives,  however,  Indigenous 
Australians  continue  to bear  a heavier burden of death, disease, disability  and economic 
hardship than other Australians. Despite the policy experience of Australia and widespread 
support for initiatives to overcome Indigenous disadvantage, there is little consensus on the 
best means to actually do so. Working to ensure that available resources are used  in their 
most  effective  way  possible  is  vital  to  improving  the  health  of  Australia’s  Indigenous 
populations.  
 
At its broadest level, health economics is the study of the choices made in the allocation of 
scarce  resources  to  improve  the  health  status  of  populations  and  service  delivery. 
Notwithstanding the political, moral and economic  importance of the  issue, there remains 
limited health economic research in the field of Indigenous health nor is there a developed 
evidence  base  to  provide  guidance  to  policy‐makers  looking  to  invest  in  cost‐effective 
interventions.  Further,  health  economic  methods  have  been  criticised  as  potentially 
inappropriate for the area of  Indigenous health. Current methods for economic evaluation 
tend to adopt a reductionist approach based on a cost per health outcome paradigm and are 
potentially  insensitive to the outcomes and processes that  Indigenous people see to be of 
value  to  their health  and health  care on  three broad  and  related  levels. First,  Indigenous 
conceptions of health have been shown to differ from the biomedical notions which tend to 
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underlie the reductionist approach of health economic evaluations. Second, a central tenet 
of Indigenous health care is community ownership and control of healthcare services. As such 
there is value associated with how well services achieve engagement with communities which 
may  also  be  missed  through  a  reductionist  health  economic  approach.  Third,  social 
determinants of health have  also been demonstrated  to be particularly  important  to  the 
health outcomes of Indigenous Australians but again have tended to lie outside the domain 
of traditional economic evaluation methods.   
 
Potentially because of these and other difficulties, resource allocation decisions in the field of 
Indigenous  health  have  been  made  without  a  strong  economic  evidence‐base  and  have 
instead  seemingly  relied  on  rights‐based  arguments  promoting  investment  based  on  the 
sizeable need that these communities face. While there is no denying the stark disadvantage 
facing  Australia’s  Indigenous  populations,  such  rights‐based  arguments  provide  little 
guidance  on  how  much  to  invest  or  on  trade‐offs  between  different  policy  options  or 
individual service components. Further, the weight attributed to such arguments has tended 
to vary according to the prevailing political climate. Health economic approaches on the other 
hand, can provide evidence based on value that can transcend politics and lay the foundation 
for  rational  priority‐setting  that maximises  the health  of  target  populations.  Ignoring  the 
realities of resource scarcity in the sector will not allow policy interventions to maximise the 
health outcomes for Australia’s Indigenous communities.  
 
Health  economic  methods  such  as  discrete  choice  experiments  (DCEs)  and  contingent 
valuation studies have been used to value factors outside of traditional economic evaluations 
in other  fields  yet have been  largely untested  in Australian  Indigenous populations.  Such 
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techniques potentially  represent a direct means  through which  to  incorporate  Indigenous 
values and preferences into the evaluation and design of health programs and ultimately a 
mechanism  for  the  sector  to  demonstrate  the  value  and  impact  that  properly  designed 
services can have. There  is  limited empirical understanding of the role of culturally‐specific 
healthcare  providers  in  terms  of  the  service  use  patterns  of  these  communities  and 
overcoming  the  barriers  that  face  Indigenous  Australians  attempting  to  access  health 
services.  Examining  these  issues  through  an  economic  lens  is  likely  to  provide  a  level  of 
guidance to policy‐makers that is currently absent from Indigenous health policy in Australia. 
 
This  thesis  explores  these  issues  through  a  mixed‐methods  approach  investigating  the 
application and merits of a variety of health economic methods in these populations. Chapter 
1 introduces the major issues in the field and provides an overview of the published literature 
carried  out  to  date.  Chapter  2  presents  a  more  detailed  investigation  of  the  economic 
evaluation  literature  with  a  systematic  review  of  published  economic  evaluations 
investigating health  interventions  in  Indigenous populations around the world. The review 
finds  relatively  limited  economic  evaluation  of  health  care  interventions  for  Indigenous 
populations  in Australia or globally, however, what has been done has demonstrated  the 
potential  for cost‐effective  interventions  in  these populations. Almost no consideration of 
alternative  conceptions  of  health  or  Indigenous‐specific  values  were  found  through  the 
review. Chapter 3 examines this issue further, investigating the use of health‐related quality 
of  life  (HRQoL)  instruments  in  these  populations,  one  of  the  most  direct  method  to 
incorporate Indigenous conceptions of health into evaluations of health programs, through a 
systematic  review  of  the  use  of  these  instruments  in  Indigenous  populations  around  the 
world. The review found that while HRQoL instruments have been used to elicit the quality of 
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life  of  Indigenous  populations  their  use  was  relatively  limited,  as  was  evidence  of  the 
validation of  these  instruments  in  these population  groups.  The evidence  that does exist 
suggests  that  some  Indigenous  populations  potentially  conceptualise  these  issues 
fundamentally  differently  to  populations  in  which  these  tools  have  been  designed  and 
validated. Chapter 4 discusses the findings of the reviews presented in Chapters 2 and 3 in 
light of  the Australian policy context. The chapter argues  that  the policy environment has 
emphasised rights‐based rather  than economic arguments  in resource allocation decisions 
that has left room for efficiency and equity improvements in the way that resource allocation 
decisions are made in the field of Indigenous health. Given this, the chapter calls for further 
work to investigate the service utilisation of Indigenous populations and the role of culturally‐
specific healthcare providers and incorporate Indigenous values to value programs to improve 
Indigenous health  including  through  contingent  valuation  and discrete  choice experiment 
methodologies.  
 
Chapter 5 takes up the first of these issues with an analysis of the healthcare expenditure of 
a cohort of Indigenous and non‐Indigenous Australians at high‐risk of cardiovascular disease 
to investigate the relative service utilisation of the two groups. The analysis finds that when 
individuals  are  engaged  with  care  providers,  culturally‐specific  providers  were  providing 
equivalent care to mainstream providers in non‐remote areas and factors other than patient 
Aboriginality seem to be more important in determining the healthcare expenditure of these 
high‐risk patients. The chapter also highlights problems with current data collections in the 
field  that acts  to obscure analysis of service utilisation patterns of  Indigenous Australians, 
particularly in remote areas, and comparisons between the relative service use of Indigenous 
and non‐Indigenous Australians. Chapter 6 further investigates the role of culturally‐specific 
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service  providers  through  a  DCE  attempting  to  value  the  cultural  component  of  a  fall‐
prevention service. The chapter presents the findings of a DCE carried out in a cohort of older 
Aboriginal  people  receiving  a  culturally‐specific  fall‐prevention  intervention.  The  chapter 
demonstrates  that  DCEs  provide  a  potential  means  to  incorporate  the  preferences  of 
Indigenous communities  into the design and evaluation of health services. A value  for the 
cultural component of the service was derived through the DCE and the relative importance 
of different barriers  to  care  to  the decision‐making of  the participants were  investigated. 
Chapter 7 presents the findings of a contingent valuation study investigating the value that 
the  Australian  community  places  on  holding  a  driver  licence  as  an  example  of  a  social 
determinant  that  has  been  shown  to  be  associated  with  positive  health  outcomes  in 
Indigenous populations.  The  analysis  finds  contingent  valuation  techniques  can provide  a 
means  to value  social determinants of health  that  lie outside  traditional health economic 
evaluations and to value broader policy interventions to improve living standards. Chapter 8 
puts forward the main findings of this thesis arguing that the health economics field has an 
important  role  to  play  in  improving  the  health  of  Australia’s  Indigenous  populations. 
Appropriate targeting of available resources is essential to close the gap in health outcomes 
between Indigenous and non‐Indigenous Australians.  
 
Economic research  is vital to build an evidence‐base  for policy makers  looking to  invest  in 
cost‐effective  policy  options  and  this  needs  to  be  based  on  factors  that  Indigenous 
communities  consider  important  to  their  health  and  healthcare.  Potential  for  economic 
evaluation of programs needs to be a key consideration in resource allocation decisions in the 
field.  These  need  to  be  robust  enough  to  incorporate  the  factors  that  are  important  to 
Indigenous Australians. The role of culturally‐specific providers needs to be better understood 
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as do  the different  components  that make up  such a  service. Finally,  incorporating  social 
determinants of health  into  the health policy environment  remains  crucial  in  the  field of 
Indigenous health.  
 
Given the political, moral and economic  importance of overcoming the disparities faced by 
Australia’s  Aboriginal  and  Torres  Strait  Islander  communities,  the  relative  lack  of  health 
economic  research  in  the sector  is a  failing of  the  field  in Australia. Building an economic 
evidence  base  will  assist  those  working  in  the  sector  to  demonstrate  the  value  of 
appropriately designed, culturally acceptable healthcare services and decision‐makers in the 
field  to move  beyond  rights‐based  arguments  for  funding  decisions.  Collectively  this will 
enable a system of rational priority‐setting in the sector whereby the health impacts derived 
from scarce resources are maximised. 
 
Keywords:  Aboriginal  and  Torres  Strait  Islander  Australian  health,  health  economics, 
culturally‐appropriate  care,  discrete  choice  experiment,  contingent  valuation,  social 
determinants of health.
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CHAPTER 1: INTRODUCTION 
Chapter Overview 
Overcoming the disparities in health and wellbeing outcomes experienced by Aboriginal and 
Torres Strait Islander (Indigenous) Australians has been the subject of numerous iterations of 
government policy and a significant investment of public resources. In spite of this, the role 
of  health  economic  research  in  the  policy  process  is  unclear.  This  chapter  presents  an 
introduction  to  these  issues  beginning  with  a  brief  summary  of  the  disparities  faced  by 
Indigenous Australians and the policy response to overcome them. An in‐depth overview of 
the  research  to  date  looking  at  these  issues  is  then  presented with  gaps  in  the  existing 
literature highlighted. The gaps in existing research form the basis for further investigation in 
subsequent chapters. The chapter finishes with an outline of the research objectives, specific 
research aims and a description of the overall structure of the thesis. 
  
Health Economics and Indigenous Health 19
Background 
Australian Aboriginal and Torres Strait Islander (Indigenous) communities continue to bear a 
heavier burden of death, disease, disability and economic hardship than other Australians [1, 
2]. Decades of public policy have attempted  to overcome  these disparities, but  they have 
persisted in many areas and grown in others, in particular through an increasing burden of 
chronic disease on Indigenous populations [3]. As a result, shortcomings in the effectiveness 
of  policy  approaches  to  overcoming  Indigenous  disadvantage  in  Australia  have  been 
highlighted both in government reports and the published literature [4‐6]. While Australia has 
decades  of  public  policy  experience  targeting  improvements  in  Indigenous  health  there 
remains limited consensus on the best means to overcome the disparities in health outcomes 
experienced by Indigenous Australians. 
Health economics  is the study of the choices made  in the allocation of scarce resources to 
improve the health status of populations and service delivery [7].  In spite of the sustained 
policy focus and the political, moral and economic importance of overcoming the disparities 
facing  Indigenous Australians,  the  role  that  the health  economics  field has played  in  this 
process  is unclear.  Further,  some have  suggested  that health economic methods may be 
unsuited to Indigenous health [8]. This chapter presents an overview of the previous literature 
examining these issues and highlights areas for further investigation that are taken up in the 
latter chapters of this thesis. Given the policy importance of improving Indigenous health in 
Australia,  it  is an area where the health economics field could have a significant  impact on 
public policy and more  importantly,  lead to a measurable and notable  improvement  in the 
lives of Indigenous people around Australia.   
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The health and wellbeing of Indigenous Australians 
The  poorer  health  outcomes  experienced  by  Indigenous  Australians  relative  to  other 
Australians have been well documented [9]. Indigenous Australians, for example, have higher 
rates of chronic disease, including cardiovascular disease and diabetes, and ultimately lower 
life expectancy [10]. Unfortunately, these disparities extend beyond traditional measures of 
health into broader social‐policy related outcomes such as education, housing, incarceration 
and employment outcomes amongst others [9]. These disparities are stark, long‐lasting and 
have proved resistant to Government attempts to overcome them. 
While the disparities between Indigenous populations and other Australians are clear, they 
result from a complex interaction between historical, social and other factors. The channels 
through which  the health of  these community groups are affected by  these  factors are  in 
many  cases not well understood. A  growing  literature  around  the world has  investigated 
social determinants of health  to  incorporate  these  ideas acknowledging  the  fact  that  the 
health of populations reflects the environments in which they grow, work and live [11]. Given 
the social policy outcomes of Indigenous Australians, many researchers have highlighted the 
particular  importance  of  such  determinants  to  these  populations  [12‐14].  The  lingering 
impacts  of  colonisation,  dispossession  and  forced‐removal  have  been  identified  as  key 
contributors to the health outcomes of Indigenous communities [14]. There is an increased 
recognition of intergenerational trauma, racism and the complex relationships between living 
conditions, health outcomes and health behaviours has also been investigated [15, 16]. The 
importance of social capital to the health outcomes of urban Indigenous Australians has also 
been demonstrated [17]. Finally, Indigenous Australians bear a heavier burden of economic 
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disadvantage which has been shown to be associated with poorer health behaviours in some 
Aboriginal populations, including poorer dietary choices [18].  
Policy Response to Indigenous disadvantage in Australia 
In  recognition  of  the  breadth  of  these  issues,  the  latest Government  policy  initiative  to 
overcoming  these  disparities,  Closing  the Gap,  is  based  on  goals  across  the  social  policy 
spectrum.  Specifically,  the  policy  aims  to:  (1)  close  the  gap  in  life  expectancy  between 
Indigenous and non‐Indigenous Australians within a generation (by 2031); (2) halve the gap 
in mortality rates for Indigenous children under five within a decade (by 2018); (3) halve the 
gap  in  employment  by  2018;  (4)  halve  the  gap  in  reading  and  numeracy  for  Indigenous 
students by 2018; (5) close the gap in school attendance by the end of 2018; (6) enrol 95 per 
cent of all Indigenous four‐year‐olds in early childhood education by 2025; and (7) halve the 
gap in Year 12 attainment by 2020. Unfortunately, Australia remains off‐track from meeting 
most of these targets [5]. 
Closing the Gap has broad support across Australian politics, builds upon decades of public 
policies targeting these inequalities and has been accompanied by a significant investment of 
resources. The health  targets alone have been accompanied by  two Council of Australian 
Governments Agreements  (between all  state,  territory and Commonwealth governments) 
that  collectively  represent  an  investment of over  $2 billion  (AUD)  [19‐21].  This builds on 
previous government policies that have directed significant resources towards overcoming 
Indigenous disadvantage.  
A key component of Closing the Gap is ensuring that Indigenous Australians have access to 
effective,  affordable  and  acceptable  health  services  [19,  20].  There  is  mixed  evidence 
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regarding the healthcare service utilisation of Indigenous Australians. As measured by public 
expenditure on healthcare, without controlling for the relative need of the two groups, the 
average public spend on healthcare  for an  Indigenous Australian  is estimated at $1.47  for 
every $1 spent for the care of a non‐Indigenous Australian [22]. The distribution of this spend 
differs markedly  between  the  two  groups,  however, with  Indigenous Australians  utilising 
significantly less Medicare Benefit Schedule (incorporating general practitioner and specialist 
visits  as well  as diagnostic  tests)  and medication expenditure  (at  a  rate of 0.63  and 0.44 
respectively)  than other Australians but having much higher average hospital expenditure 
(1.76 times higher).  
The results of more  local studies are mixed.  Indigenous  infants were found to have higher 
utilisation of hospital services in Western Australia [23], while Indigenous children under five 
years of age in the same jurisdiction were also found to be more likely than non‐Indigenous 
children to be hospitalised for dental treatment [24]. However, some studies have also found 
lower rates of treatment for Indigenous Australians in hospital settings including Aboriginal 
patients less likely to receive surgeries for some cancers [25]. Other evidence exists of lower 
uptake of health assessments in primary care settings for Indigenous Australians relative to 
other Australians [26] and lower utilisation of eyecare services in areas with a high Indigenous 
population [27]. 
Comparisons between the service utilisation of  Indigenous and non‐Indigenous Australians 
are complicated by two factors in particular. First, in many situations the data recording the 
services received and paid for are different for Indigenous and non‐Indigenous communities. 
This  is a particular problem  in remote communities with both pharmaceutical expenditure 
[28] and other healthcare services not directly comparable to expenditure in other parts of 
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Australia [4, 29]. Second, differences in the clinical risk profiles of the two populations make 
direct comparisons difficult. Limited research has been able to effectively adjust for the risk 
profiles facing these different population groups. Whelan and Wright (2013) attempted to do 
so  by  controlling  for  self‐reported  indicators  of  ill  health  and  found  that  Indigenous 
Australians used more healthcare services than other Australians [30].  
Even  given  this  mixed  evidence,  the  substantial  disparities  in  health  outcomes  facing 
Indigenous Australians have  led many to question whether the expenditure on  Indigenous 
individuals, in particular for primary healthcare, should be higher relative to non‐Indigenous 
Australians [31‐33]. Specifically, the healthcare expenditure patterns leave open the potential 
for  significant efficiency gains and  raise questions as  to whether more  could be  spent  to 
prevent  illness and  the costs  that  follow  through better  investment  in primary health and 
prevention programs.  
Barriers to care and culturally-appropriate services 
There  is widespread agreement  that a number of barriers still  face  Indigenous Australians 
attempting to access healthcare  including financial, geographic, cultural and health  literacy 
impediments to care [4, 34]. Challenges to the universality of the Australian health system 
that  may  particularly  affect  Indigenous  Australians  have  been  noted  in  the  published 
literature  including  increasing  out‐of‐pocket  costs  and  healthcare  service  shortages  in 
particular  communities  [35].  Further,  there  is  a  documented  distrust  of  government 
institutions by Indigenous communities and some have argued that institutional or outright 
racism plays a large part in service utilisation patterns of Indigenous Australians [16, 36]. In 
response  to  these  challenges,  culturally  appropriate  care  services have become  a  central 
component of efforts  to  close  the  gap  in health outcomes between  Indigenous and non‐
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Indigenous Australians  [37, 38]. The benefits of  culturally‐appropriate  services have been 
investigated through a range of literature [21, 37‐46]. Appendix 2 presents an evaluation of a 
culturally‐specific mobile dental service in Australia. We found that the service was able to 
overcome geographic, financial and cultural barriers to care and provide services to residents 
of  a  remote  area  [42].  There  is no  consensus on  the best way  to deliver  and  fund  these 
services,  however,  and  the  complexity  and  inefficiency  inherent  in  the  current  funding 
sources for Indigenous‐specific primary care providers has been highlighted previously [36, 
47]. Similarly, there is limited empirical understanding of the role that these services play in 
the healthcare utilisation patterns of Indigenous Australians. 
Health economics and Indigenous health 
Despite the policy importance of the issue, there is a noted lack of economic evidence in the 
field  of  Indigenous  health  [4,  48].  Several  issues  have  been  raised  in  previous  literature 
suggesting  that  existing  health  economic  techniques  might  be  ill‐suited  to  the  field  of 
Indigenous health which may help  to explain  this  lack of evidence. The positioning of  the 
causes of  (and  solutions  to)  the disparities of  Indigenous disadvantage outside  traditional 
measures of health outcomes presents a challenge to the health economics field [8]. Current 
methods for economic evaluation tend to adopt a reductionist approach based on a cost per 
health outcome paradigm and are potentially insensitive to the outcomes and processes that 
Indigenous people see to be of value in their health care. Social determinants of health that 
have  been  demonstrated  to  be  particularly  important  to  the  health  outcomes  of  these 
populations,  tend  to  lie  outside  traditional  economic  evaluation  methods  [8].  Further, 
Indigenous conceptions of health have been shown to differ  from biomedical notions that 
tend to underlie the reductionist approach of health economic evaluations [2, 8]. Similarly, 
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with the advent of culturally‐specific service providers, a central tenet of Indigenous health 
care is community ownership and control of healthcare services [21]. As such, there is value 
associated with how well services achieve engagement with communities, which may also be 
missed through a reductionist health economic approach. Finally, the stark disparities facing 
Indigenous Australians may have led to economic arguments being relegated behind rights‐
based arguments, justifying  intervention based solely on the disparities these communities 
face. 
While there is no denying the validity of calls for intervention on the basis of the disparities 
faced by Indigenous Australians, such rights‐based arguments alone cannot provide sufficient 
evidence  to maximise  the  health  outcomes  of  Indigenous Australians.  Focusing  solely  on 
rights‐based arguments  for  investment and  ignoring  the  scarcity of  resources available  to 
improve the health of Indigenous people in Australia will not help to close the gap and is likely 
to  create  a  system  in  which  cost‐ineffective  programs  are  able  to  continue,  diverting 
resources  from  potentially  cost‐effective  interventions.  Further,  while  rights‐based 
arguments  have  proven  effective  in  mobilising  public  and  political  support,  the  level  of 
political support for these arguments has tended to vary according to the political climate. On 
the  other  hand,  economic  evidence  tends  to  appeal  to  governments  across  the  political 
spectrum as an objective means to weigh the relative value of different policy options.  
There is a desperate need for economic evidence in the health sector to provide evidence on 
how  to best prioritise  funds  amongst  available  interventions  to maximise  the benefit  for 
Indigenous Australians, which  interventions or policies  to stop  funding and  the amount of 
investment required to achieve the policy goal of overcoming these disparities. There have 
been  numerous  calls  to  better  target  health  system  resources  available  in  the  area,  in 
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particular  through  calls  for  an  increased  focus  on  prevention  and  better  services  for 
Indigenous communities [35, 48]. Rights‐based arguments cannot provide policy‐makers with 
the required guidance on these issues to ensure that the resources available to improve the 
health of Indigenous Australians are used in the most beneficial way possible. 
Progressing health economics in the Indigenous health field 
The difficulties highlighted above suggest that care will need to be taken  in any economic 
work in the field of Indigenous health to ensure that techniques are robust enough to capture 
those factors that are of value to Indigenous communities. The need to incorporate factors 
that lie outside traditional measures of health outcomes, however, is not unique to the field 
of Indigenous health and has been a key focus of the mainstream health economics field over 
recent years [8, 49‐55]. This section highlights the work that has been done  in the field of 
Indigenous  health  and  other  branches  of  the  health  economic  literature  that  could  hold 
lessons  for  the  Indigenous  field.  Chapters  2  and  3  present  a more  in‐depth  look  at  the 
economic  evaluation  literature  and  the  use  of  health‐related  quality  of  life measures  to 
complement the work presented in this chapter. 
Priority setting 
The  desirability  of  explicit  priority‐setting  in  the  case  of  Indigenous  health  has  been 
highlighted  previously  [56].  Incorporating  equity  into  healthcare  provision,  policy  and 
financing  has  been  the  subject  of  much  debate  in  the  literature  though  it  remains  an 
unresolved  issue across the field [57]. Similarly, how to best define and  incorporate equity 
concerns regarding Indigenous health in Australia has been debated in the literature [58‐61]. 
The use of access and output measures to compare the relative service use of Indigenous and 
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non‐Indigenous individuals and concepts of horizontal equity (equal treatment of equals or 
equal access for those of equal need) has been well documented, as have the shortcomings 
with using such an approach in the field of Indigenous health [58, 62, 63]. Simply aiming for 
equity  in services provided or utilised fails to close the gap  in health outcomes nor does  it 
consider  vertical  equity  issues  (differential  treatment  for  ‘unequals’  such  that  particular 
groups receive relatively greater levels of resources to account for the greater health need 
they have) [58, 63]. In moving to funding and priority setting systems to incorporate vertical 
equity there is an immediate concern of whose values to incorporate in any priority setting 
process, an issue that remains debated in the literature [64, 65].  
Previous literature has identified a desire to prioritise health gains to Indigenous communities 
amongst  ‘informed’  citizens  [66].  Similarly, a  sample of  the general Australian population 
were found to prioritise health technologies that resulted in a disproportionately higher share 
of benefits being accrued by Indigenous Australians [67]. These broad preferences have been 
reflected  in  funding  mechanisms  used  to  fund  health  services  to  Indigenous  Australians 
around  the  country.  Examples  of  vertical  equity weightings whereby  health  services  are 
funded more  for  treating an  Indigenous person  than other people have been  seen across 
Australian jurisdictions [33]. In a recently published survey of leading researchers in the global 
priority‐setting field (Appendix 3 [68]), the vertical equity weighting for Aboriginality  in the 
New South Wales health system was identified as an example of successfully incorporating 
an equity concern into a priority‐setting process. This was attributed to a recognised gap on 
the part of policy makers, the advocacy of researchers and ultimately, an alignment of the 
objectives  of  the  two  groups.  This  alignment,  along with  the widespread  public  support 
highlighted above, remains in place and is the driving force behind efforts to Close the Gap. 
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Yet, in spite of the policy experience and goodwill, there remains little consensus on the best 
approach to overcome Indigenous disadvantage in Australia.  
Elicitation of Indigenous values and preferences 
In part, this lack of consensus likely relates to a lack of clarity over what exactly represents a 
‘successful’  program  in  Indigenous  health.  Evaluating  health  interventions  in  Indigenous 
health  is a notoriously complex area [69].  Interventions may need to  improve engagement 
with local communities, overcome barriers to accessing healthcare services and engaging in 
healthy  behaviours  or  achieve  several  other  goals  in  order  to  improve  the  health  of 
Indigenous  Australians.  Incorporating  Indigenous  conceptions  of  health  and measures  of 
community ownership  into evaluation of health programs  is vital  if  it  is deemed these are 
important  to  the  health  of  Indigenous  populations.  The  importance  of  incorporating 
Indigenous  values  into  the  evaluation  and  design  of  health  programs  has  been  widely 
documented in order to use Aboriginal preferences to drive Aboriginal health services, their 
funding and  their performance  indicators  [45, 61, 70]. Yet  the best means of doing  so  in 
practice remains debated. 
The elicitation of preferences and values to  inform health policy decisions and evaluations 
has  been  a  key  focus  of  applied  economics  over  the  past  few  decades  [71].  A  range  of 
potential instruments to do so exist in the published literature. These range from individual 
level health outcome measures [72] to broader consultation and governance arrangements. 
More recently patient experience measures have become more widespread in their use and 
application [70]. Economic techniques including discrete choice experiments and contingent 
valuation studies have been designed to incorporate the values of respondents, including for 
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use  in economic evaluations  [73, 74]. However,  the use of  these measures  in  Indigenous 
populations  remains  limited.  Literature  in  other  populations  does  highlight  the  caution 
needed  in  applying  these measures  to marginalised  populations  to  ensure  that  they  are 
appropriately representing the values and preferences of the populations being studied [75, 
76].  
The need to incorporate the perspectives of patients from culturally diverse backgrounds has 
been raised  in the development of new measures of patient experience (Appendix 4 [77]). 
The lack of understanding of what quality of life measures look like in Indigenous populations 
has also been highlighted in the literature [8]. Chapter 3 investigates the literature utilising 
quality of life measures in Indigenous populations in more detail. Some recent literature has 
focused  on  the  impact  of  measuring  Indigenous  involvement  in  the  development  and 
implementation  of  health  interventions.  Incorporating  Aboriginal  organisations  and 
community members in regional planning was found to be associated with improved access 
to health services  in Victoria and Western Australia  [21]. Appendix 5 presents a review of 
community‐led  interventions  in  Indigenous  communities  [78].  This  review  investigated 
whether  interventions  led  by  Indigenous  communities  themselves  can  be  effective  in 
improving the health of the populations targeted. Using the example of alcohol control, the 
paper demonstrates that such interventions can be effective in improving the health of these 
communities. No published studies in the health literature using techniques such as discrete 
choice experiments or contingent valuation methods to elicit the preferences were found to 
have been used  in Australian  Indigenous populations.  Similarly,  there  is  limited empirical 
understanding of  the value attached  to culturally‐specific services or  the  impact  that such 
services have on the healthcare utilisation patterns of  Indigenous Australians. This type of 
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data and analysis is vital if the health system is to adequately meet the needs of Indigenous 
Australians and provide them with services that they value rather than what others think they 
want or need.  
Closing the gap between the health outcomes of Indigenous and other Australians is a matter 
of utmost policy priority for the Australian health system. In spite of decades of health policy 
aimed at overcoming the disparities, there is limited economic analysis to assist policy‐makers 
looking to invest in cost‐effective interventions. While there are difficulties in conducting such 
research in the field of Indigenous health, expertise and methodologies developed in other 
areas could play a vital role in the field to develop an evidence‐base of effective interventions 
that is built on concepts of community control of health services, Indigenous conceptions of 
health and the preference and values of  Indigenous communities. Through such work, the 
health economics field could play a significant role  in shaping public policy  in the area and 
improving the health of Australia’s Indigenous communities. 
Research objectives 
The aims of this thesis are to: 
1. Investigate the role of health economics in Indigenous populations with particular 
focus on the methods that have been used to value the health of Indigenous 
communities and the healthcare services provided to these groups. 
2. Analyse the role of rights‐based as opposed to economic arguments on Indigenous 
health policy to date in Australia. 
3. Examine the feasibility of using established methods to develop notions of economic 
value in the field of Indigenous health by incorporating the values and preferences of 
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Indigenous populations with regard to their health and healthcare. In particular, the 
work of the thesis will:  
a. Analyse linked administrative data to examine the relative service use and 
healthcare expenditure of Indigenous and non‐Indigenous Australians when 
controlling for clinical risk, potential barriers to care and the provision of 
culturally‐appropriate services to Indigenous communities. 
b. Explore the potential of discrete choice experiments as a method to value 
culturally appropriate care and examine the relative importance of different 
components of services to the communities they serve. 
c. Investigate the role of contingent valuation methods to value social 
determinants of health. 
Structure of this thesis 
This thesis explores these issues through an investigation of the application and merits of a 
variety of health economic methodologies  in  Indigenous populations. Chapter 2 presents a 
detailed investigation of the economic evaluation literature to complement the work of the 
present chapter with a systematic  review of published economic evaluations  investigating 
health interventions in Indigenous populations around the world. The review pays particular 
attention to the methods used in these papers and whether any consideration was given to 
methods to incorporate Indigenous conceptions of health. The review finds relatively limited 
economic evaluation work  in  Indigenous health  in Australia or globally, however, the work 
that has been done has demonstrated the potential for cost‐effective interventions in these 
populations. Almost no  consideration of  alternative  conceptions of health or  Indigenous‐
specific values were found through the review.  
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Chapter 3 examines this issue further through a systematic review of the use of health‐related 
quality  of  life  instruments  (HRQoL).  HRQoL  instruments  represent  a  direct  method  to 
incorporate Indigenous conceptions of health in evaluations of health programs. The review 
found that while HRQoL instruments have been used to elicit the quality of life of Indigenous 
populations,  their  use  was  relatively  limited  as  was  evidence  of  the  validation  of  these 
instruments  in these population groups. The evidence that does exists suggests that some 
Indigenous populations potentially conceptualise  these  issues  in a  fundamentally different 
way to populations for whom these tools have been designed and validated.  
Chapter 4 discusses the findings of the reviews presented in Chapters 2 and 3 in light of the 
Australian policy context. The chapter argues that the policy environment has emphasised 
rights‐based rather than economic arguments  in resource allocation decisions that has  left 
room for efficiency and equity  improvements  in the way that resource allocation decisions 
are made in the field of Indigenous health. Given this, the chapter calls for further work to 
investigate the service utilisation of Indigenous Australians and the role of culturally‐specific 
healthcare providers and incorporate Indigenous preferences to value programs to improve 
Indigenous health  including  through  contingent  valuation  and discrete  choice experiment 
methodologies.  
Chapter 5 takes up the first of these issues with an analysis of the healthcare expenditure of 
a cohort of Indigenous and non‐Indigenous Australians at high‐risk of cardiovascular disease 
to investigate the relative service utilisation of the two groups. The analysis finds that when 
individuals  are  engaged  with  care  providers,  culturally‐specific  providers  were  providing 
equivalent care to mainstream providers in non‐remote areas and factors other than patient 
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Aboriginality seem to be more important in determining the healthcare expenditure of these 
high‐risk patients.  
Chapter 6 investigates the role that discrete choice experiments can play in valuing culturally‐
specific services and presents the findings of a discrete choice experiment (DCE) carried out 
in  a  cohort  of  older  Aboriginal  people  receiving  a  culturally‐specific  fall  prevention 
intervention.  The  chapter  finds  that  DCEs  provide  a  potential  means  to  incorporate  the 
preferences of  Indigenous communities  into  the design and evaluation of health  services. 
Through  the DCE  a  value  for  the  cultural  component of  the  service was derived  and  the 
relative  importance of different barriers to care to the decision‐making of the participants 
were investigated.  
Chapter 7 presents the findings of a contingent valuation study investigating the value that 
the  Australian  community  places  on  holding  a  driver  licence  as  an  example  of  a  social 
determinant  that  has  been  shown  to  be  associated  with  positive  health  outcomes  in 
Indigenous populations.  The  analysis  finds  contingent  valuation  techniques  can provide  a 
means  to value  social determinants of health  that  lie outside  traditional health economic 
evaluations and to value broader policy interventions to improve living standards.  
Chapter 8 puts forward the main findings of this thesis arguing that the health economics field 
has an important role to play in improving the health of Australia’s Indigenous populations. 
Appropriate targeting of available resources is essential to close the gap in health outcomes 
between Indigenous and non‐Indigenous Australians. Economic research is vital to build an 
evidence‐base  for policy‐makers  looking  to  invest  in  cost‐effective policy options and  this 
needs to be based on factors that Indigenous communities consider important to their health 
and  healthcare.  Potential  for  economic  evaluation  of  programs  needs  to  be  a  key 
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consideration  in  resource  allocation  decisions  in  the  field.  The  role  of  culturally‐specific 
providers needs to be better understood, as do the different components that make up such 
a  service.  Finally,  incorporating  social  determinants  of  health  into  the  health  policy 
environment remains crucial in the field of Indigenous health. 
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 CHAPTER 2: HEALTH ECONOMIC EVALUATION IN INDIGENOUS POPULATIONS 
 
CHAPTER OVERVIEW 
This  chapter  reports  the  results  of  systematic  review  of  health  economic  evaluations  in 
Indigenous populations around the world. The chapter consists of a single manuscript titled: 
Global systematic review of the cost‐effectiveness of Indigenous health interventions.  
Despite policy commitments from governments around the world to improve the health and 
wellbeing of Indigenous populations, the level of economic evidence to guide policy makers 
looking to invest in cost‐effective interventions to do so is unknown. In spite of a broad and 
comprehensive  search  strategy,  the  review  identified  a  relatively  small  evidence  base  of 
economic evaluation literature examining the cost‐effectiveness of interventions to improve 
the  health  of  Indigenous  populations  around  the  world.  The  evidence  that  did  exist 
demonstrated the potential for interventions in Indigenous communities to be cost‐effective, 
however,  there was  little  attention  paid  to  Indigenous  conceptions  of  health  in  included 
studies.  The  chapter  calls  for  further  research  into  the  use  of  existing  health  economic 
techniques used to elicit preferences from target populations in Indigenous groups as a means 
to incorporate these values into the evaluation of health programs in a rigorous way. 
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to meet the inclusion criteria before screening the full texts for final inclusion. SJ arbitrated 
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Introduction
There are almost 400 million Indigenous people living in
countries around the world [1]. The World Health Organisation
(WHO) defines Indigenous populations as those that live in distinct
geographical territories, identify themselves as belonging to a
cultural group separate from mainstream society and are
descendent from groups present in the area before modern states
and borders were defined [2]. Indigenous populations have been
repeatedly shown to bear a greater burden of death, disease and
disability than their non-Indigenous counterparts [1,3–6]. Despite
this, little is known about what constitutes cost-effective health
interventions in these unique population groups and there is a lack
of evidence as to the extent and nature of investment in programs
to address the burden of ill-health in these populations [7,8].
Economic evaluation of health care programs has become an
important area of applied economics over the last 30 years [8–10].
The field has had a significant impact on policy-making processes
in countries around the world most prominently through high level
policy initiatives such as the National Institute for Health and Care
Excellence in the UK and the Pharmaceutical Benefits Advisory
Committee in Australia. Economic evaluation analyses whether
the additional benefits of an intervention is worth undertaking
relative to another intervention or normal care [9]. Without a
substantial evidence-base on the cost-effectiveness of policy
options, policy-makers have little economic evidence to make
resource allocation decisions in the field of Indigenous health.
The objective of this review is to systematically search the
literature to pull together existing evaluations that estimate the
cost-effectiveness of health interventions into Indigenous popula-
tions around the world. This review allows for an exploration of
the type of interventions that have been shown to be effective in
these unique population groups, the specific resource requirements
needed to deliver programs to these populations and the aspects of
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these programs that are deemed to be of value by the populations
to whom they are targeted.
Suitability of the traditional health economic paradigm
for the Indigenous health field
There is an increasing recognition of the shortcomings of
traditional methods of measuring health benefits in economic
evaluations of healthcare programs [8,10–12]. Indigenous popu-
lations have been shown to hold different conceptions of health to
mainstream populations [1,8]. Specifically, family, community,
connections to the land and cultural sensitivity have been shown to
be qualitatively valued with regards to health by Indigenous
populations [8]. While this has led some to argue that the
traditional approaches of the health economic paradigm are
inappropriate to measure the impact of interventions in these
communities, it highlights the importance of further economic
research into the field and suggests that valuation of outcomes
within economic studies should ideally incorporate some form of
patient or user-elicited valuation so that they reflect these broader
conceptions of health.
To provide a basis for further evaluating these arguments, this
review also highlights any explicit attempts by included studies to
incorporate these concerns into cost-effectiveness evaluations.
Methods
A systematic review of the literature was conducted to find
articles that provide an economic evaluation of interventions
targeting or reporting on an Indigenous population. No protocol
has been previously published for this review.
Inclusion Criteria
The inclusion criteria for this review specified three character-
istics for studies. First, the studies had to examine interventions
that were primarily aimed at improving the health of target
populations. Second, included papers had to be economic-
evaluations of an intervention that met the definition of one of
the types outlined in Table 1. This depicts a broad spectrum of
economic evaluation methodologies from cost-benefit analysis,
generally considered the form of economic evaluation that is most
comprehensive in scope, to the narrower forms of evaluation
including simple cost-analyses. The search strategy was adapted
from previously published systematic reviews of economic
evaluations [13,14]. Studies were required to report on either
the cost impacts of the intervention of interest or some measure of
cost-benefit to be included in the study. Finally the papers had to
either focus on or separately report on a population that is either
wholly or partially Indigenous. The WHO definition of Indigenous
mentioned above was used as a basis for identifying these
populations in the literature [2]. The specific search strategy was
adapted from a previously published systematic review of this
population group and is designed to encompass Indigenous
populations around the world in line with this definition [15].
Search strategy
A search was conducted of CINAHL, MEDLINE, EMBASE,
PSYCINFO and ECONLIT (from inception to May 2014) using
variations of the search string contained in Table 2. Reference lists
of included studies were also searched for further applicable
studies.
Data Extraction
Study review, selection and data extraction were independently
undertaken by two authors (BA and JM). Abstracts, titles and
keywords of the studies returned from the search were screened for
compatibility with the inclusion criteria. Once studies were
identified for potential inclusion, full texts were reviewed. Data
were extracted from the studies using a form developed for the
review based on standard techniques used in the literature and
included the following items: country of origin, methodology
including type of evaluation, comparators used, outcome mea-
sures, settings and participants, results and evidence of inclusion of
Indigenous conceptions of health [16]. The primary outcome
measures were reported measures of cost-effectiveness.
Results
The search yielded 559 abstracts (see Figure 1). One further
study was identified through a hand search of relevant journals.
Once duplicates were removed, 458 unique abstracts were
reviewed. Three published abstracts were found that appeared
to meet the inclusion criteria. Relevant authors were contacted to
identify if further publications resulted from these abstracts. The
authors of one study did not respond [17], one was published as a
short-report that included no additional information to the
abstract [18] while one was being readied for submission and
not yet available to other researchers [19]. Two of the abstracts
were included as studies as they contained enough information to
meet the data extraction requirements [17,18] while the other was
excluded as there was insufficient information in the abstract to be
included [19]. In total, nineteen studies reporting on 27
interventions met the criteria to be included in this review
[7,11,17,18,20–34]. Tables 3 and 4 summarise the characteristics
of included studies.
Country of Origin
Seven studies were conducted in Australia (covering eleven
interventions) [7,11,20,21,25,27,33], four in Canada [22–24,31]
and three each in New Zealand [26,28,29] and the USA (covering
seven interventions) [30,32,34]. A published abstract was included
from both Thailand [17] and Brazil [18].
Settings and Participants
Two studies evaluated interventions in urban areas, one looking
at a midwifery program [11] and the other at palivizumab
treatment for children [27]. Twelve studies focused solely on rural
or remote locations [17,18,20–25,30–34] while the remaining five
studies were based on wider populations encompassing rural,
remote and urban Indigenous communities [7,26,28,29,31].
The majority of the studies focused on Indigenous populations
with known health conditions including diabetes (six studies all
conducted in rural or remote locations) [20,22–25,32], post-
traumatic stress disorder [30], heart conditions [26], dental
problems [21], drug addiction [29] and pregnancy [11,33]. The
other intervention studies targeted population groups that were
not based on the presence of some particular medical condition
[7,17,18,27,28,31,34].
Of the 27 interventions included in the study, two were carried
out in infants [27,31], one targeted school children [28], another
in children more generally [17], one targeted young adults [34],
two specified older patients [26,32] while the rest were not
targeted at any specific age-groups [7,11,18,20–25,29,30,33,34].
Methodology
Studies were broadly grouped into two groups. The first
included group included studies where authors collected effective-
ness data within the study itself (twelve studies and sixteen
interventions) [11,17,18,20–22,24,25,30,32–34]. The second
Cost-Effectiveness in Indigenous Health
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group included studies that used previous findings in the literature
to model the impact of potential interventions on these populations
(seven studies looking at eleven interventions) [7,23,26–29,31].
The types of economic evaluation are outlined in Table 1. Only
one study met the criteria of a cost-benefit analysis, generally
considered the most comprehensive form of health economic
evaluation [34]. Eight studies met the criteria of cost-analyses, the
least complex of the four categories [11,17,20,22,24,25,30,33].
There were three cost-effectiveness analyses [21,27,29] and seven
cost-utility analyses [7,18,23,28,29,31,32].
Outcome Measures
Costs were the primary outcome measure reported in eight of
the studies [11,17,20,22,24,25,30,33]. One study reported cost-
benefit ratios for five injury-prevention interventions [34]. The
study of a remote dental service in Western Australia attempted to
use published valuations of equivalent government services as an
estimate for the value of services provided and reported on the
cost-benefit ratio in this regard [21]. Five studies reported costs per
quality adjusted life years gained [23,26,31,32] and two reported
on cost per disability life years gained [7,18]. Costs per life years
saved were reported by Sheerin et al. in their study on Hepatitis C
treatment for injecting drug users in New Zealand [29], while cost
per avoided hospitalisation was the focus of the study of Reeve et
al. on palivizumab injections for high risk infants [27].
Each included paper made some judgment as to the cost-
effectiveness or cost-impact of the interventions being studied. In
total, only five of the 27 interventions were deemed to be strictly
not cost-effective or cost-saving [7,11,27,32]. Of the eight cost-
analysis studies, six found interventions would be cost-saving over
time relative to the comparison [17,20,22,24,25,30]. The study of
the group midwifery program in the Top End of Australia found
no significant cost differences between the provided intervention
and usual care [33], while the urban midwifery program was
deemed not cost-saving although qualitative results demonstrated
that patients valued the service [11]. The cost-benefit analyses
carried out all found the injury prevention interventions to be cost-
beneficial in that they had benefit-cost ratios above one [34]. Two
of the three cost-effectiveness studies found their interventions to
be cost-effective [21,29]. Three interventions analysed using cost-
utility analysis were found to cost-ineffective [7,32]. Table 5
depicts included interventions by cost-effectiveness.
Comparators Used
The choice of comparator against which the cost-effectiveness of
the intervention is assessed plays a large part in determining
whether a particular intervention is cost-effective or not. Included
studies could be grouped into two main categories in this regard.
Fourteen of the studies assessed the cost-effectiveness of their
intervention against so-called ‘business as usual’ cases where they
were compared to a situation with no intervention, either through
the use of a control group [11,28,30,32], projecting historical
trends [7,17,20,25,26,29,31,33,34] or in one case actual hospital
records with the impact of the intervention being retrospectively
assessed [27]. The remaining five studies compared the cost-
effectiveness of the intervention to a hypothetical or alternatively
modelled scenario where participants would be forced to obtain
the intervention through alternative service providers [18,21–24].
Wider conceptions of health
Only one study that met the inclusion criteria explicitly set out
to capture wider benefits of culturally appropriate service
provision [11]. This was done through broader qualitative
evaluation of the value of the provided midwifery service and
the use of a cost-consequence approach designed to incorporate
broader values than narrowly defined health outcomes. Another
included study also included qualitative results from patient
interviews to document the appropriateness of the service to the
Indigenous community [22]. The work of the ACE prevention
project in Australia modelled the different impact of delivering
interventions via Aboriginal Medical Services and mainstream
general-practitioners, suggesting that health benefits to Indigenous
communities would be higher from those services delivered
through Aboriginal Medical Services as a result of increased
Table 1. Types of Economic Evaluation.
Cost Analysis A partial form of economic analysis where only the costs of an intervention are compared to another potential
intervention.
Cost-Effectiveness Analysis Provide a measure of the effectiveness of an intervention using natural units such as life-years gained relative to the
cost incurred to obtain that outcome.
Cost-Utility Analysis A particular form of Cost-Effectiveness Analysis that measures effectiveness using a measure of utility such as Quality
Adjusted Life Years or Disability Adjusted Life Years.
Cost-Benefit Analysis An economic evaluation that sees both the costs and benefits of a particular intervention valued in monetary terms.
doi:10.1371/journal.pone.0111249.t001
Table 2. Search Strategy.
Database/s Search terms
Cinahl, Medline, EMBASE and
PsycINFO
(1) The following terms as words within the title, abstracts or texts of papers: aborigin* or american indian* or eskimo* or Ethnic
Group* or first nation* or greenlandic or indigenous or inuit* or inupiat* or inuvialuit* or kalaallit* or maori or maoris or
mapuche* or native american* or native people* or native population* or native siberian* or navaho* or nunangat* or sami* or
skolt* or taiga* or tribe or tribal or yuit or yupik or zuni
(2) ‘‘cost-effectiveness’’ or ‘‘economic evaluation’’ or ‘‘cost impact’’ as words within the title, abstracts or texts of papers or
containing a subject heading under ‘‘cost analysis/’’
Econlit (3) Econlit was also searched with ‘‘Health’’ as a subject
doi:10.1371/journal.pone.0111249.t002
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Figure 1. PRISMA Flowchart.
doi:10.1371/journal.pone.0111249.g001
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engagement of the target population [7]. The remaining studies
did not explicitly attempt to measure any wider or Indigenous-
specific conceptions of health. It is important to note, though, that
of the 27 interventions included in the analyses, only four were not
targeted specifically at Indigenous populations [26–29]. Of the
modelled studies, six of the eleven interventions examined were
based on estimates of intervention effectiveness that had been
obtained from studies carried out in Indigenous populations [7,26–
29,31]. The other five were based on effectiveness estimates
emanating from the general non-Indigenous literature and applied
to Indigenous populations.
Discussion
This systematic review has found that very few cost-effectiveness
studies are available in the published global Indigenous health
literature. This has implications for generating investment into
Indigenous health programs since the lack of such evidence limits
our ability to assess the investment-case of interventions based on
the criteria of cost-effectiveness, rather than solely for equity
reasons or broader policy objectives. This is concerning given the
significant disparities in health and access to health care that exist
between Indigenous and non-Indigenous populations worldwide.
Nonetheless, the evidence-base that does exist in the literature
provides some isolated insights into the potential cost-effectiveness
of specific types of interventions. There is potential for further
work to both increase the use of economic evaluation in this area
and methodological work to ensure that health economic
methodologies are relevant to Indigenous populations.
Limited Economic Research in the Field of Indigenous
Health
A total of nineteen studies met the inclusion criteria for this
review. Given the broad scope of the research question and search
strategy, this depicts a very limited evidence-base from which to
draw insights on the potential cost-effectiveness of interventions
into Indigenous populations. This finding implies that investment
into the area is largely being undertaken blind, based on
assumptions rather than evidence of the cost and effectiveness of
particular policies and interventions.
Three main reasons are offered here as potential factors
explaining the lack of research in the field. First, there is a general
lack of effectiveness studies in the field of Indigenous health, with
the majority of research carried out in the field being observational
rather than interventional in nature [35]. The findings of this
review build upon previous literature that has emphasised the need
to focus further research on finding effective interventions to
improving the health of these unique groups. Second, the lack of
studies could be a reflection on the attitudes of policy-makers and
service providers in the area of Indigenous health that due to the
severe inequalities faced by Indigenous population groups,
interventions are justified purely on equity grounds rather than
cost-effectiveness considerations. Such an argument overlooks the
role that economic research could play in not only highlighting the
relative importance of investing in Indigenous health, but
providing guidance as to the best use of resources within the
sector to maximise their impact. Third, as a result of the unique
conceptions of health held by Indigenous populations, traditional
economic evaluation methodologies may be inappropriate for the
field of Indigenous health [8]. Specifically, it has been argued that
traditional economic evaluation methods have failed to adequately
accommodate the values, knowledge and beliefs of Indigenous
populations such as those set out in the United Nations
Declaration on the Rights of Indigenous People [8,36]. Health
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benefits have generally been measured using individualistic and
Westernised constructs of health, which have been shown, at least
in the Australian context, to be distinctly different from the
communitarian values of Indigenous culture [8]. This has
potentially led to missed opportunities to improve indigenous
health and wellbeing as the full range of benefits, costs and cost-
savings that potentially arise from indigenous health interventions
may not be captured. There is room for further refinement of
economic methodologies to incorporate these concerns and
particularly in the assessment of the applicability of existing health
utility instruments, and potentially the development of new ones
that may be more sensitive to Indigenous conceptions of health.
While the evidence-base identified in this review demonstrates
that traditional health economic approaches can ostensibly be used
to show the cost-effectiveness (or otherwise) of interventions aimed
at improving Indigenous health, there has rarely been much
attempt to incorporate Indigenous valuations of the potential gains
from such programs.
Examples do exist in the literature of attempts to incorporate
these values into economic evaluations of health interventions.
The study of the Daruk-controlled midwifery service included
above attempted to do so by taking a broader cost-consequence
approach rather than restricting the analysis to narrowly defined
health outcomes [11]. This involved a strong qualitative compo-
nent to the study, which is an approach also taken by Jin et al. in
their included study above [22]. Cost-consequences analyses or
‘the basket of goods approach’ has been viewed with some disdain
in the health economic literature because of the potential for data
mining and its inability to generate a clear decision rule [37]. It has
been suggested however that this can be to some extent addressed
by pre-specification of a conceptual framework in which the link
between the multiple outcomes are linked to the intervention [38].
Further research into the suitability to of existing health economic
techniques used to elicit preferences from target populations to
Indigenous groups could provide a means to incorporate these
values in a meaningful and rigorous way.
Characteristics of Included Studies
While there was a limited amount of cost-effectiveness research
of interventions to improve the health of Indigenous population
Table 5. Included Interventions by cost-effectiveness.
Cost-Effective Interventions
Palivizumab in Indigenous infants
Multicomponent physical activity and nutrition program
Genetic testing for CYP2C19 Variants to guide thienopyridine treatment
Low dose diuretics for the prevention of cardiovascular disease
ACE Inhibitors for the prevention of cardiovascular disease
Polypill for the prevention of cardiovascular disease
Screening for diabetic retinopathy
Rapid syphilis testing
Hepatitis C treatment for injecting drug users on methadone maintenance programs
Safety-belt program
Installation of streetlights on remote highways to prevent crashes
Livestock control measures to prevent crashes
Drowning prevention program
Suicide prevention program
Outreach dental services
Cost-Saving Interventions
Screening for diabetic retinopathy
Screening for hepatitis B prior to vaccination
Perindopril for diabetes patients along with other medication as necessary and education
Telehealth for psychiatric interviews
Outreach diabetes services
Better training of local diabetes staff and visiting specialist
Interventions with Non-Significant Cost Savings
Midwifery group practice
Cost-Ineffective Interventions
Palivizumab for high-risk infants
Broadbased healthy living program to prevent cardiovascular disease
Statins to prevent cardiovascular disease
Lower targets for blood pressure and LDL cholesterol in diabetics
Interventions that were not cost-saving
Community-based midwifery service
doi:10.1371/journal.pone.0111249.t005
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groups, a number of conclusions can be drawn from the studies
that were identified.
First, this review highlights that interventions into Indigenous
populations, in particular rural and remote Indigenous commu-
nities, can be cost-effective, a broad but important finding given
the often isolated and small populations of these groups when
compared to non-Indigenous populations. Of the 27 interventions
examined by included studies, 21 were deemed to be cost-effective
or cost-saving while of the twelve interventions targeted solely to
rural and remote populations, ten were found to be cost-effective
or cost-saving by the respective studies. Being able to point to a
body of evidence highlighting the cost-effectiveness of such
interventions is important to justify widespread implementation
of such programs on more than solely equity grounds and ensure
that domestic debates on service provision are informed and based
on the best available evidence.
The evidence-base drawn together by this review provides
insights into particular interventions. Outreach programs were
shown to be consistently cost-effective or cost-saving in all six
interventions studied. These interventions were assessed relative to
populations obtaining the services from alternative service
providers. Thus they were found to be cost-saving or cost-effective
despite often representing relatively high-costs for the health gains
that occurred. They may be prohibitively costly in low-income
environments outside of donor provision and it is also unclear how
sustainable or community appropriate such models of service
provision are. Explicit decisions need to be made by policy-makers
in assessing the appropriateness of these services to local
conditions.
The four injury prevention interventions were all found to be
cost-effective as was the study of telehealth. Conversely, neither of
two midwifery programs studied was found to be strictly cost-
effective (one found non-significant cost-savings). Nor were the two
studies focused solely on interventions in urban areas, highlighting
the need for further work in this area. The majority of the
interventions were targeted specifically at Indigenous groups
(twenty-three interventions) and most were delivered through
culturally specific medical providers, such as Aboriginal Medical
Services in Australia and Canada. This is in line with findings from
the literature that culturally specific services are more effective in
reaching these populations [39].
Limitations of this Review and included studies
While the strength of the review lies in the broad search strategy
and research question, the heterogeneity of included studies
limited the policy implications that could be drawn from the
identified literature. The studies were of varied scope and included
different notions of what constituted a cost-effective intervention.
There are inherent difficulties in comparing the outcome of the
studies when the notion of what constituted a cost-effective
intervention varied so greatly between them.
The studies identified were largely drawn from high-income
nations and focused at a primary-care level in rural or remote
populations. There is a large gap in the literature for Indigenous
populations of low and middle-income nations. Similarly, urban
Indigenous communities have been largely overlooked in the
literature despite these communities often representing the bulk of
Indigenous populations within countries. In Australia, for exam-
ple, it is estimated that the 60% of the ‘gap’ in health outcomes
between the Indigenous and non-Indigenous populations is a result
of the health of urban Indigenous communities [40]. The results of
this review are consistent with previous studies that have pointed
to a lack of studies in the area of urban Indigenous health relative
to remote and rural communities [41]. Indigenous conceptions of
health were rarely explicitly acknowledged in the cost-effectiveness
literature. While the finding that the majority of included
interventions were Indigenous-specific suggests that these factors
may be implicitly be worked into most of the studies (at least to the
extent that interventions are appropriately designed for these
cultural groups), there is room to better include these ideas into
general economic methodologies.
Conclusion
Despite global commitments to reducing Indigenous health
disadvantage, relatively little is known about what constitutes cost-
effective investments into Indigenous populations around the
world. Furthermore, the evidence that exists has often relied on
pivotal evidence extrapolated from non-Indigenous settings and
been based on methods that have not allowed for the values that
such communities place on health to be included. Nevertheless, in
light of the limited available evidence, this review suggests that
interventions into these often hard to reach populations can be
cost-effective. Further economic research has the potential to
provide much needed guidance to policy-makers on resource
allocation decisions and help improve the health of Indigenous
people around the world but it needs to be based on the
development of methods that incorporate values specific to the
communities in question. .
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CHAPTER 3: THE HEALTH-RELATED QUALITY OF LIFE OF INDIGENOUS 
POPULATIONS 
 
CHAPTER OVERVIEW 
This chapter reports the results of systematic review of the use of health-related quality of 
life (HRQoL) instruments in Indigenous populations around the world. The chapter consists of 
a single manuscript titled: The health-related quality of life of Indigenous populations: a global 
systematic review.  
Chapter 2 called for further research into means of incorporating Indigenous conceptions of 
health into the evaluation of health programs. This chapter begins to address this question 
through an investigation of HRQoL instruments which represent a direct means through 
which Indigenous preferences and values can be incorporated into the evaluation and design 
of health programs. Ensuring that the HRQoL of Indigenous populations is being appropriately 
measured is vital to accurately measuring the effectiveness of interventions. Few examples 
of Indigenous-specific instruments were found through the review, however, a number of 
studies were identified that had utilised generic population or disease-specific instruments to 
measure the HRQoL of Indigenous populations. Four studies found specific HRQoL 
instruments to be valid in these populations. The limited examples of Indigenous-specific 
instruments that did exist highlighted the potential importance to the HRQoL of these 
populations of domains that lie outside of traditional measures including social and 
community domains as well as domains relating to culture, diet and land use on top of more 
traditional HRQoL domains. 
60 Health Economics and Indigenous Health
AUTHOR CONTRIBUTIONS 
BA and SJ came up with the concept for the study. BA SJ JR and SE developed the search 
strategy and method of the study. BA and JM reviewed articles for inclusion. SJ resolved any 
disputes in this process. BA extracted data and wrote initial draft of manuscript. All authors 
provided input to revised manuscript and approved the final version. 
PUBLICATION DETAILS 
Angell, B., et al., The health-related quality of life of Indigenous populations: a global 
systematic review. Quality of Life Research, 2016. 25(9): p. 2161-2178. 
 
MANUSCRIPT 
 
Health Economics and Indigenous Health 61
REVIEW
The health-related quality of life of Indigenous populations:
a global systematic review
Blake Angell1,2 • Janani Muhunthan1,3 • Anne-Marie Eades1 • Joan Cunningham4 •
Gail Garvey4 • Alan Cass4 • Kirsten Howard5 • Julie Ratcliffe6 • Sandra Eades5,7 •
Stephen Jan1,2,3
Accepted: 30 April 2016 / Published online: 10 May 2016
 Springer International Publishing Switzerland 2016
Abstract
Purpose Indigenous conceptions of health have been shown
to differ from that of their non-Indigenous counterparts. As a
result, there remains uncertainty over the appropriateness and
value of using existing health-relatedquality-of-life (HRQoL)
instruments in Indigenous communities. The objective of this
reviewwas to identify studies that either measure the HRQoL
of an Indigenous population or validated a measure used to
elicit the HRQoL in an Indigenous population.
Methods A systematic review of the published literature
was conducted to (1) investigate the extent to which
HRQoL instruments are used in Indigenous populations;
(2) to identify which instruments have been validated in
which populations; and (3) to identify which instruments
have been tailored for use with Indigenous populations.
Results Forty-one studies were included in the review.
Only three of the 41 studies utilised Indigenous-specific
instruments. The remainder (38 studies) utilised generic
population or disease-specific instruments. Four studies
found specific HRQoL instruments to be valid in these
populations and 32 estimated the HRQoL of an Indigenous
population. The limited examples of Indigenous-specific
instruments highlighted the potential importance to the
HRQoL of these populations of domains that lie outside of
traditional measures including social and community
domains as well as domains relating to culture, diet and
land use on top of more traditional HRQoL domains.
Conclusion Ensuring that the HRQoL of Indigenous popu-
lations is being appropriatelymeasured is vital to prioritising
available resources to the most effective interventions.
HRQoL instruments present an opportunity to directly elicit
and incorporate Indigenous preferences and conceptions of
health into these decisions. Further work is required in the
field to ensure that this potential is realised.
Keywords Health-related quality of life  Systematic
review  Indigenous populations  Quality-of-life
instruments
Introduction
The world’s 400 million Indigenous people continue to
bear a greater burden of death, disease and disability and
live with substantially higher levels of socioeconomic
disadvantage than their non-Indigenous counterparts [1].
The World Health Organisation (WHO) defines Indigenous
populations as those descendent from groups present in the
area before modern states and borders were defined that
live in distinct geographical territories and identify them-
selves as belonging to a cultural group separate from
mainstream society [2]. As defined, the term ‘Indigenous’
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is used throughout this paper to refer to all those population
groups that come under this definition as a group with
respect to the unique nature of each of these many
populations.
Along with maintaining distinct cultures, Indigenous
conceptions of health and well-being have been shown to
differ from the individualised measures that underlie most
evaluations of healthcare interventions and other research
in health-related fields. Indigenous populations have been
shown to qualitatively value factors that lie outside
Westernised measures of health such as cultural sensitivity,
family and community and connections to the land [3]. At
the same time, the health economic literature has been
criticised for failing to incorporate Indigenous values and
conceptions of health into the valuation of the benefits for
economic evaluations of interventions for Indigenous
populations [3, 4].
Health-related quality of life (HRQoL) is a multifaceted
concept incorporating factors such as physical and mental
health, social functioning and emotional well-being [5].
HRQoL instruments allow for a broader consideration of
health and well-being than narrowly defined, one-dimen-
sional health outcomes. They may be preference based and
used to calculate utility values for the purpose of economic
evaluation or they may be non-preference based.
It has been argued that existing HRQoL instruments
limit the focus of quality-of-life measures to narrowly
defined indicators of disease and associated treatment, to
the detriment of considerations of the broader social
determinants of health important in the context of Indige-
nous populations [6–8]. Previous literature has highlighted
other factors not considered in existing HRQoL measures
such as the impact of experiences of dispossession,
colonisation and assimilation that may have a significant
impact on the quality of life for Indigenous populations [6,
9]. Qualitative evidence has emerged to suggest that
instruments used in other areas of research, such as mea-
suring and classifying disability, may not be compatible
with Indigenous conceptions of health [10].
While a major strength of HRQoL measures is the
ability to provide a platform to compare health outcomes
across interventions, there is evidence to suggest that
HRQoL instruments may elicit different responses for the
same health states across different population groups. This
has been explored in a variety of areas including, for
example, comparisons of different ethnic groups [6, 11–
14], those of different ages [15–17] as well as in patients
compared to general population samples [17]. To obtain
meaningful information from HRQoL instruments, it is
vital that they capture and accurately measure the com-
ponents of HRQoL that are valued by the study population
[18].
There is limited consideration in the literature of whe-
ther the domains of quality of life used in HRQOL
instruments are relevant to Indigenous constructs of health
and well-being. Similarly, there is limited evidence of
appropriate valuation of health states or domains used in
existing HRQoL measures by Indigenous population
groups, casting doubt on the appropriateness of using these
measures in these populations. It is vital that we are able to
encapsulate value the HRQoL of Indigenous populations in
a manner that reflects those aspects of health which are
most important for Indigenous people and to target inter-
ventions most beneficial to these populations. The objec-
tives of this review were to: (1) investigate the extent to
which HRQoL instruments are used in Indigenous popu-
lations; (2) to identify which instruments have been vali-
dated in which populations; and (3) to identify which
instruments have been tailored for use with Indigenous
populations.
Methodology
A systematic review of the published literature was con-
ducted to identify the measures that have been used to
assess quality of life in Indigenous populations and assess
the extent to which Indigenous concepts of health have
been factored into their domains.
Inclusion criteria
The inclusion criteria for this review consisted of two
components. Papers had to:
1. Measure the HRQoL of the target population or
validate a HRQoL instrument in a population. Any
instruments used to measure the HRQoL of a popu-
lation were included in the review including both
preference-based as well as non-preference-based
instruments. Studies were not excluded on the basis
of methodological quality but were included if the
reported outcome was a HRQoL result or if the aim of
the study was to validate such a measure. Any
methodological approach to validation met the criteria
for this review. Studies that only reported on an overall
measure of self-reported health, for example using
categories such as ‘good’ or ‘poor’, were excluded.
Measures that investigated specific components that
may influence a person’s quality of life, such as
measures of psychological distress, pain or discomfort
or social support, for example, but not overall HRQoL,
were excluded. While these factors have an undeniable
2162 Qual Life Res (2016) 25:2161–2178
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impact on the HRQoL of people and communities and
have vital importance to a holistic conception of health
as described above, the focus of this review was
instruments that produced an overall assessment of
HRQoL rather than of specific components of HRQoL.
The search strategy for this part of the inclusion
criteria was adapted from published systematic reviews
of HRQoL instruments in the literature [16, 18].
2. Focus on or separately report on a population that is
Indigenous. The WHO definition of Indigenous men-
tioned above was used as a basis for identifying these
populations [2]. Any study that reported the required
outcome measures for Indigenous participants sepa-
rately was included in the review. The specific search
strategy for this component of the review comprises a
list of specific Indigenous populations as well as
general terms to identify studies on these population
groups. The search string was adapted from a previ-
ously published systematic review of this population
group and is designed to encompass Indigenous
populations around the world in line with the WHO
definition [19].
The review was limited to published studies. Included
papers were not restricted to specific types of interventions,
the comparator used in the studies, health conditions being
studied, the country or setting of the paper as long as the
above two conditions were met. No limits were placed on
the search with regard to the language of the paper.
Search
A search was conducted in November 2014 of CINAHL,
MEDLINE, EMBASE, PsycINFO and ECONLIT (from
inception to November 2014) using variations of the search
string contained in Table 1. Reference lists of included
studies were also searched for further applicable studies
using the same criteria as above.
Study selection and data extraction
Study review and selection were independently undertaken
by two authors (BA and JM). Abstracts, titles and key-
words of the studies returned from the search were
screened for compatibility with the inclusion criteria. Once
studies were identified for potential inclusion, full texts
were reviewed. Disagreement was overcome with consen-
sus between the two reviewing authors or by consulting a
third author (SJ) when needed. Data were extracted from
the studies using a form developed by the authors for the
review that included the following items: country of origin,
HRQoL instrument used, sample size, gender and age of
sample, comparator, the setting of the study, whether the
HRQoL instrument used was Indigenous specific or adap-
ted for Indigenous populations (and if so how it was
adapted), the results of the study, whether the HRQoL
instrument used was preference based and whether a utility
was calculated in the study and if so the methods used.
Data on whether the HRQoL results were used for the
purpose of economic evaluation were also collected. The
rationale behind the selection of these fields was to identify
how specific studies attempted to address Indigenous-
specific conceptions health, the domains they used and the
values attached to them. The primary outcome measures
were reported measures of HRQoL. Given the breadth of
the inclusion criteria and the research question, conducting
a meta-analysis of results was not considered appropriate
or meaningful in this case.
Results
The search yielded 2857 abstracts (see Fig. 1). Once
duplicates were removed, 1820 unique abstracts were
reviewed. Seventy-seven abstracts were considered poten-
tially suitable for inclusion, and full texts were reviewed.
Fifteen of these had been published only as abstracts and
Table 1 Search strategy
Databases Search terms (MEDLINE search shown below)
CINAHL, MEDLINE, EMBASE
and PsycINFO
(1) The following terms in the titles, abstracts or full texts of articles: (aborigin* or American Indian* or
eskimo* or Ethnic Group* or first nation* or greenlandic or Indigenous or inuit* or inupiat* or
inuvialuit* or kalaallit* or maori or maoris or mapuche* or native American* or native people* or native
population* or native siberian* or navaho* or nunangat* or sami* or skolt* or taiga* or torres strait
islander or tribe or tribal or yuit or yupik or zuni).tw
(2) ‘Quality of life’ in the title, abstract or full text of articles or containing a subject heading under
‘quality of life,’ that is: (quality of life).tw. OR ‘quality of life’/
Econlit (3) Econlit was also searched with ‘Health’ as a subject
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were excluded from this review. A further 22 were exclu-
ded from the review for either not reporting separately on
an Indigenous population (ten studies) or for not reporting
on HRQoL results (12 studies). The reference lists of
remaining papers were examined for further studies
potentially meeting the inclusion criteria for the review.
This led to a further fifteen full text articles being examined
and one further article included in the review. In total, 41
studies were included in the review [20–60]: 32 that
reported estimates of HRQoL in Indigenous populations
[20, 21, 23, 24, 26–32, 36–41, 44–49, 51, 52, 54–56, 58–
60] and nine additional studies that validated particular
measures in Indigenous populations [22, 33–35, 41–43, 53,
57]. One study both reported an estimate of HRQoL in a
Native American population and validated the measure
[41]. These groups of studies are analysed separately here
and summarised in Tables 2 and 3.
Studies examining HRQoL in Indigenous
populations
In total, 32 studies were included that reported on a
HRQoL outcome in an Indigenous population [20, 21, 23,
24, 26–32, 36–41, 44–49, 51, 52, 54–56, 58–60]. On
average, these studies had a sample size of 480 Indigenous
individuals, an average age of participants of just under
40 years of age and were 38 % male.
Of these studies, the vast majority (26) were cross-sec-
tional [20, 23–29, 31, 32, 36, 37, 39–41, 46, 48, 49, 51, 52,
55, 56, 58–60] and four were cohort studies, which all
emanated from the USA [38, 44, 46, 47]. HRQoL was the
primary outcome measured for all but three studies where a
HRQoL measure was used as a secondary outcome. Thir-
teen studies compared the HRQoL of Indigenous popula-
tions to a non-Indigenous population group. Comparator
groups differed based on the study and country and
included general populations, non-Indigenous population
groups as well as other ethnic minority populations. Of
these studies, eight found worse outcomes for Indigenous
peoples [21, 28–30, 44, 45, 56, 58], while the other five
found no statistically significant difference between the
Indigenous group and the comparator [25, 32, 40, 49, 51].
Country of origin
Nineteen studies came from the USA [23, 25, 28–30, 32,
36, 38, 39, 44, 46–49, 51, 52, 54, 59], including one from
Hawaii [40], followed by Canada (five studies) [20, 21, 41,
45, 56], while New Zealand [24, 31, 58] and Australia both
had three studies each [26, 27, 60]. There was one study
included in the review from each of Mexico [37] and
Malaysia [55]. Studies from the USA tended to be larger
than those from other countries (average sample size of 680
relative to 189 for studies based in other nations).
Topics and groups studied
The most common area studied was oral health with six
studies investigating the oral HRQoL of Indigenous pop-
ulations [23, 24, 30, 58–60]. Each of these used an oral
health-specific HRQoL instrument predominantly the
OHIP-14 (four studies). Seven studies were specific to
children or adolescents [20, 23, 24, 27, 29, 49, 58], while
four were specific to older populations [31, 36, 46, 48].
Five studies investigated HRQoL in groups of Indigenous
women: one looking at a group of female low-income
carers [30], while others focused on women with particular
conditions: HIV [37], arthritis or diabetes [52], rheumatoid
arthritis [51] and menopause [55]. Only one study exam-
ined a male population, looking at diversionary programs
Papers idenﬁed through 
database search 
n = 2857 
EMBASE = 609 
CIHNAL = 737 
MEDLINE =   769 
PSYCHINFO = 342 
ECONLIT = 400 
Papers idenﬁed through 
reference list search  
n = 15 
Records aer duplicates removed = 1835 
Records Screened  
n = 1835 
Records excluded  
n = 1758 
Full Records Assessed for 
Eligibility  n= 77 
Records excluded   
n = 15 full texts not available 
 = 12 didn’t report on HRQoL 
 = 10 Indigenous not reported 
separately 
Records included in review  
n = 41 
Fig. 1 PRISMA flowchart of search strategy
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for a group of at-risk young men [27]. There was a mix of
studies looking at Indigenous populations in urban and
rural areas.
Instruments used
Across the 32 studies that measured the HRQoL in an
Indigenouspopulation, 20 different instrumentswere used (see
Table 4). The most commonly used were the SF-36 in five
studies [36, 38–40, 56] and theOHIP-14 in four studies [24, 30,
59, 60]. Just over half (18) of the studies used generic instru-
ments that were not disease or condition specific [20, 21, 26–
28, 32, 36, 38–41, 48, 49, 51, 52, 54, 56],while 15useddisease-
specific instruments for oral health [23, 24, 30, 58–60], vision
[46, 47], diabetes [20, 44], HIV [37, 45] and one each for
scoliosis [29], cancer survivors [25] and menopause [55].
Economic evaluation and utilities
Given that the majority of studies were cross-sectional,
there is limited evidence relating to the sensitivity of
included HRQoL instruments to change over time. This is
an important omission as sensitivity to change over time is
a critically important criterion for evaluations, economic or
otherwise. Similarly, none of the included studies used
HRQoL measures to calculate utilities or QALYs for the
studied population.
Incorporating Indigenous conceptions of health
Of the included studies, only one used an Indigenous-
specific tool to explore the domains most important to the
Canadian Aboriginal population being studied [41]. Their
findings are discussed in more detail in the next section.
Five studies adapted generic HRQoL tools for use in
Indigenous populations through either language translation
or adaptation [31, 51, 55], modifying the options available
to respondents within the questionnaire [25] or in the case
of Jiang et al. [38] removing a question that was deemed
inappropriate for a Native American population—‘I expect
my health to get worse’. The vast majority of studies that
measured HRQoL in these populations did not attempt to
alter instruments in the light of alternative conceptions of
health. Included studies that examined the validity of
existing instruments provided greater insight into these
issues which are described below.
Validation and new measure studies
Ten studies were included that either attempted to validate
HRQoL instruments in Indigenous populations or the
scoring systems that are commonly used to produceT
a
b
le
2
co
n
ti
n
u
ed
R
ef
er
en
ce
s
C
o
u
n
tr
y
In
d
ig
en
o
u
s
sa
m
p
le
si
ze
A
v
er
ag
e
ag
e
G
en
d
er
(%
M
)
P
o
p
u
la
ti
o
n
L
o
ca
ti
o
n
H
R
Q
o
L
to
o
l
C
o
m
p
ar
is
o
n
g
ro
u
p
R
el
at
iv
e
H
R
Q
o
L
o
f
In
d
ig
en
o
u
s
g
ro
u
p
H
R
Q
o
L
re
su
lt
W
el
ls
et
al
.
[5
9
]
U
S
A
1
1
8
N
o
t re
p
o
rt
ed
4
5
G
en
er
al
ad
u
lt
p
o
p
u
la
ti
o
n
R
u
ra
l
O
H
IP
-1
4
N
/A
N
/A
O
ra
l
H
ea
lt
h
-r
el
at
ed
q
u
al
it
y
o
f
li
fe
w
as
af
fe
ct
ed
b
y
lo
w
o
ra
l
h
ea
lt
h
k
n
o
w
le
d
g
e
an
d
sy
st
em
ic
h
ea
lt
h
.
T
h
er
e
w
as
an
as
so
ci
at
io
n
b
et
w
ee
n
p
o
o
r
ac
ce
ss
to
d
en
ta
l
ca
re
an
d
p
o
o
r
o
ra
l
h
ea
lt
h
-r
el
at
ed
q
u
al
it
y
o
f
li
fe
W
il
li
am
s
et
al
.
[6
0
]
A
u
st
ra
li
a
4
6
8
3
8
3
7
G
en
er
al
ab
o
ri
g
in
al
p
o
p
u
la
ti
o
n
R
u
ra
l
O
H
IP
-1
4
N
/A
N
/A
T
h
e
p
re
v
al
en
ce
o
f
h
av
in
g
ex
p
er
ie
n
ce
d
o
n
e
o
r
m
o
re
o
f
O
H
IP
-
1
4
it
em
s
‘f
ai
rl
y
o
ft
en
’
o
r
‘v
er
y
o
ft
en
’
w
as
3
4
.8
%
.
R
is
k
in
d
ic
at
o
rs
fo
r
th
is
in
cl
u
d
ed
p
ro
b
le
m
-b
as
ed
d
en
ta
l
at
te
n
d
an
ce
,
av
o
id
in
g
d
en
ta
l
ca
re
b
ec
au
se
o
f
co
st
,
d
if
fi
cu
lt
y
p
ay
in
g
a
$
1
0
0
d
en
ta
l
b
il
l
an
d
n
o
t
o
w
n
in
g
a
to
o
th
b
ru
sh
.
T
h
e
ex
te
n
t
o
f
O
H
IP
-1
4
sc
o
re
s
w
as
1
.8
8
,
w
h
il
e
th
e
se
v
er
it
y
w
as
1
5
.0
Qual Life Res (2016) 25:2161–2178 2171
123
72 Health Economics and Indigenous Health
T
a
b
le
3
H
R
Q
o
L
in
st
ru
m
en
ts
v
al
id
at
ed
in
In
d
ig
en
o
u
s
p
o
p
u
la
ti
o
n
s
R
ef
er
en
ce
s
C
o
u
n
tr
y
In
st
ru
m
en
t
u
se
d
In
st
ru
m
en
t
o
r
sc
o
ri
n
g
sy
st
em
v
al
id
at
ed
V
al
id
S
am
p
le
si
ze
A
v
er
ag
e
ag
e
o
f
p
o
p
u
la
ti
o
n
G
en
d
er
o
f
sa
m
p
le
(%
M
)
P
o
p
u
la
ti
o
n
o
f
st
u
d
y
L
o
ca
ti
o
n
G
u
p
ch
u
p
et
al
.
[3
4
]
U
S
A
A
Q
L
Q
-N
A
A
In
st
ru
m
en
t
Y
es
5
1
3
8
3
3
A
st
h
m
at
ic
s
U
rb
an
h
o
sp
it
al
b
u
t
in
cl
u
d
ed
n
o
n
-u
rb
an
p
ar
ti
ci
p
an
ts
in
st
u
d
y
H
ar
w
o
o
d
et
al
.
[3
5
]
N
ew Z
ea
la
n
d
H
u
a
o
ra
n
g
a
o
u
tc
o
m
e
in
st
ru
m
en
t
In
st
ru
m
en
t
Y
es
9
4
N
o
t
re
p
o
rt
ed
in
st
u
d
y
N
o
t
re
p
o
rt
ed
in
st
u
d
y
S
tr
o
k
e
p
at
ie
n
ts
N
o
t
re
p
o
rt
ed
in
st
u
d
y
K
it
et
al
.
[4
2
]
A
u
st
ra
li
a
S
F
-1
2
In
st
ru
m
en
t
N
o
6
0
4
6
(m
ed
ia
n
ag
e
re
p
o
rt
ed
in
st
u
d
y
)
4
7
T
y
p
e
2
d
ia
b
et
ic
s
R
u
ra
l
P
er
k
in
s
et
al
.
[5
0
]
N
ew Z
ea
la
n
d
E
q
u
at
io
n
5
D
In
st
ru
m
en
t
Y
es
6
6
4
1
5
0
G
en
er
al
M
ao
ri
p
o
p
u
la
ti
o
n
N
o
t
re
p
o
rt
ed
in
st
u
d
y
E
d
w
ar
d
s
et
al
.
[3
3
]
U
S
A
S
F
-1
2
(s
co
ri
n
g
m
et
h
o
d
s)
S
co
ri
n
g
Y
es
1
1
,1
2
7
N
o
t
re
p
o
rt
ed
in
st
u
d
y
3
8
G
en
er
al
N
at
iv
e
A
m
er
ic
an
p
o
p
u
la
ti
o
n
s
N
o
t
re
p
o
rt
ed
in
st
u
d
y
T
ra
eb
er
t
et
al
.
[5
7
]
N
ew Z
ea
la
n
d
C
P
Q
1
1
–
1
4
In
st
ru
m
en
t
N
o
8
8
1
3
5
3
1
2
-
an
d
1
3
-y
ea
r-
o
ld
sc
h
o
o
lc
h
il
d
re
n
N
o
t
re
p
o
rt
ed
L
ix
et
al
.
[4
3
]
C
an
ad
a
S
F
-3
6
an
d
M
in
i-
O
Q
L
Q
In
st
ru
m
en
t
Y
es
(S
F
-3
6
)
an
d
N
o
(M
in
i-
O
Q
L
Q
)
2
5
8
4
4
0
W
o
m
en
8
4
%
U
rb
an
B
ea
ls
et
al
.
[2
2
]
U
S
A
S
F
-3
6
S
co
ri
n
g
N
o
3
4
8
8
N
o
t
re
p
o
rt
ed
in
st
u
d
y
N
o
t
re
p
o
rt
ed
in
st
u
d
y
4
8
-
to
8
1
-y
ea
r-
o
ld
s
M
ix
ed
S
co
tt
et
al
.
[5
3
]
N
ew Z
ea
la
n
d
S
F
-3
6
S
co
ri
n
g
Y
es
fo
r
th
o
se
ag
ed
\
4
5
n
o
fo
r
th
o
se
ab
o
v
e
4
5
y
ea
rs
o
ld
1
3
2
1
N
o
t
re
p
o
rt
ed
in
st
u
d
y
N
o
t
re
p
o
rt
ed
in
st
u
d
y
G
en
er
al
N
ew
Z
ea
la
n
d
p
o
p
u
la
ti
o
n
N
o
t
re
p
o
rt
ed
in
st
u
d
y
2172 Qual Life Res (2016) 25:2161–2178
123
Health Economics and Indigenous Health 73
summary scores and calculate utility of HRQoL [22, 33–
35, 41–43, 53, 57]. Validating HRQoL measures in dif-
ferent populations demonstrates that the instrument is
measuring what it claims to measure, while validating the
scoring systems used to produce overall HRQoL results
ensures that the information provided by populations via
Table 4 HRQoL instruments used in Indigenous populations
Studies Country Population
Instruments used in Indigenous populations
HAT-QOL Holtz et al. [37] Mexico Rural women with HIV
SF-8 Dyrbye et al. [32] USA Medical students
SRS-22 Daubs et al. [29] USA Urban 10- to 19-year-old health adolescents
BRFSS health survey Chowdhury et al. [28] USA General Indigenous population,
SEIQOL-DW Chenhall and Senior [26, 27] and Chenhall et al.
[27]
Australia Alcohol and drug addiction, at-risk youths
NACES QOL survey Burhansstipanov et al. [25] USA Cancer survivors
Huntington
POHRQoL
Braun et al. [23] USA Young rural children
Determinants of
health and quality-
of-life survey
Barton et al. [21] Canada Rural and remote
SF-36 Henderson et al. [36], Jiang et al. [38] Johnson
et al. [39], Kaholokula et al. [40] and
Thommasen et al. [56]
USA Older people on multiple medications, diabetics,
diabetics with hypertension, rural diabetics,
rural diabetics
Structured
questionnaire and
Likert scale
Kant et al. [41] Canada Remote and older people living in reservations
KDQOL-SF Lopes et al. [44] USA Diabetics
NEI VFQ-25 McClure et al. [46, 47] USA Uncorrected refractive error, older people (over
40)
MOS-HIV Martin et al. [45] Canada Injecting drug users on HAART
Dartmouth COOP
CHARTS
McFall et al. [48] and Poole et al. [51] USA Older people at primary care, rheumatoid arthritis
PedsQL Allan et al. [20] and Naughton et al. [49] Canada, USA Diabetic children
Cantril’s [67] self-
anchoring ladder
Poole et al. [51] USA Rheumatoid arthritis
SF-12 Spencer et al. [54] USA Rural and remote carers
MEN-QOL Syed Alwi et al. [55] Malaysia Menopausal women
CPQ 11–14 Ukra et al. [58] New Zealand Adolescents
OHIP-14 Broughton et al. [24], Dyall et al. [31], Wells et al.
[59] and Williams et al. [60]
New
Zealand,
USA,
Australia
Teenagers, 80- to 90-year-olds, general
population
Instruments validated in Indigenous populations
AQLQ-NAA Gupchup et al. [34] USA Asthmatics
Hua Oranga outcome
instrument
Harwood et al. [35] New Zealand Stroke patients
Equation 5D Perkins et al. [50] New Zealand General Indigenous population
SF-36 Lix et al. [43] Canada Women
Instruments found to be invalid
Mini-OQLQ Lix et al. [43] Canada Women
SF-12 Kit et al. [42] Australia Rural diabetics
CPQ 11–14 Traebert et al. [57] New Zealand 12- and 13-year-old school children
Instrument scoring systems validated
SF-12 Edwards et al. [33] USA General Indigenous population
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HRQoL instruments is appropriately interpreted. There was
substantial variation between included studies with regard
to the validation process used. Two included studies
developed new measures to measure HRQoL: one in a
Native American population and the other in a Canadian
Aboriginal population [34, 41].
New Indigenous HRQoL measures
Gupchup et al. [34] used focus groups to modify an existing
quality-of-life instrument for an asthmatic Native American
population. The original instrument (the AQLQ-M) was
selected following consultation with clinicians treating the
Native American population based on the tool’s ease to
complete and score. Focus groups were conducted with
Native American asthmatics to determine the domains of the
existing measure that were applicable to these individuals,
and comments were sought on the options presented to par-
ticipants as potential responses. Through this process, the
instrument was adapted to be based on three domains
(community and social restrictions, psychological impact
and symptoms) and 19 items that were identified in the focus
groups to be important considerations among Indigenous
Americans. Language adjustments were made across all
items as a result of the focus groups. The study found that the
new tool (AQLQ-NAA) was valid and internally consistent
in a sample of 51 Native American Asthmatics. The instru-
ment created was not designed to generate utility values that
could be used to calculate QALYs.
Kant et al. [41] investigated the most important domains
of health and well-being in a sample of 316 Canadian
Aboriginal people living in two distinct reserves. They
found that social, cultural and land use factors were most
important to the health and well-being of the sample. The
most important contributors to these were the proportion of
meals that came from a traditional Canadian Aboriginal
diet and the impact that government regulation had on land
use. Important health domain factors that were found to
impact on the well-being of this population were the
prevalence of mental and psychological problems and the
quality of health services available. The authors note that
their work was exploratory and not designed to create a
measure that could be used across different Indigenous
populations. The work does highlight though, the impor-
tance of factors outside traditional measures to the HRQoL
for this population.
Validation studies in Indigenous populations
Nine studies attempting to either validate HRQoL instru-
ments or the underlying scoring systems for calculating
utilities using these instruments were included in the
review [22, 33–35, 42, 43, 50, 53, 57].
Four HRQoL measures were found to be valid in
Indigenous populations: AQLQ-NAA, EQ-5D, the Hua
Oranga outcome instrument and the SF-36 (see Table 4).
The methods used to determine that measures were valid
varied substantially between studies. Gupchup et al. [34]
tested the internal consistency and convergent validity of
the AQLQ-NAA and found that it displayed good evidence
of both. The instrument divided HRQoL into three
domains: community and social restrictions, psychological
impact and symptoms.
Perkins et al. [50] found 76 % of their small Maori
sample agreed that the EQ-5D adequately represented their
concept of health. This proportion was consistent with a
previous study of a general New Zealander population
which the authors interpreted as evidence of content
validity [61]. The authors attempted to derive valuations
for the underlying health states of the instrument and found
a number of inconsistencies that they suggested may have
resulted from differing conceptions of health. However, a
number of shortcomings with their approach were noted
and the authors suggested that these results needed to be
explored further in future studies.
Lix et al. [43] investigated the measurement equivalence of
the SF-36 and the Mini-OQLQ, an osteoporosis-specific
measure ofHRQoL, to examinedifferences between responses
to the instruments between Aboriginal people and other
Canadians. The technique was used to assess whether the
conceptual interpretationsof thequestions beingasked through
each instrument were being interpreted in the same way in
Aboriginal and non-Aboriginal Canadian women. They found
that this is the case in the SF-36 but not with theMini-OQLQ.
As such, the authors argue that ethnicity does appear to influ-
ence responses about the effects of osteoporosis on HRQoL.
Similarly, differential item functioning across some
measures were found by Traebert et al. [57], looking at the
use of the CPQ11-14 instrument, suggesting that the
measure is potentially not capturing the same measure of
health in the New Zealand Maori population as in other,
Westernised populations.
A number of the other studies that examined instruments
concluded that they were also unsuitable for use in the
studied Indigenous populations. The SF-12 was found by
Kit et al. [42] to not be valid for use in a small rural
Australian Aboriginal population with type 2 diabetes. The
authors argued that while the instrument provided useful
insight about social functioning that was not otherwise
evident, the tool was cumbersome to use in the population
studied requiring Aboriginal health workers to complete
the tool and was unable to differentiate patients most in
need of treatment. Workers administering the questionnaire
felt that participants were providing answers that they
wanted to hear. No formal validation study of the instru-
ment was undertaken.
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Three studies examined the use of factor component
scores to derive HRQoL, two using the SF-36 [22, 53] and
one the SF-12 [33]. Beals et al. [22] found that while the
use of the SF-36 instrument in an Native American Indian
population was valid, the assumption of equivalent factor
loadings across cultural groups was not. They found evi-
dence that the use of differentiated physical and mental
functioning was likely to be improper in at least some
groups of these population groups. Adopting the method-
ology of Ware et al. [62], the authors found that a model
with a single-factor structure was more appropriate in
explaining HRQoL in this population than the two-factor
structure (with physical and mental component summary
scores) found by Ware et al. and in a number of other
countries around the world [63]. Specifically, the authors
found that there was no distinct differentiation from
respondents between their mental and physical health.
This is also consistent with the findings of Scott et al.
[53] who found that for New Zealand Maori aged over
45 years, the construct validity of differentiation between
mental and physical components was not supported or
appropriate in explaining HRQoL. This was in contrast to
results for younger Maori, where the differentiation
between mental and physical components was found to be
appropriate in explaining HRQoL. The authors suggested
that this may be a result of the increasing urbanisation and
reduced cultural affinity in younger Maori. The results for
non-Maori New Zealanders were also consistent with those
found in Western Europe, suggesting differences between
the ethnic groups and reported HRQoL. The validity of the
mental and physical component scores was also affirmed in
other populations including a large American Indian and
Native Alaskan population using the SF-12 instrument
[33].
Discussion
Accurate measurement of the HRQoL of populations is
important to evaluate and prioritise interventions to max-
imise the impact on health and well-being. To do so, the
domains used in HRQoL instruments must be applicable to
the population in question and, in the case of preference-
based instruments, the underlying health states need to be
appropriately valued for the population being studied.
Given conceptions of health that have been shown to differ
from mainstream definitions and the persistent health dis-
parities faced by the world’s Indigenous populations, it is
particularly important to ensure that this is done for these
groups. The findings of this review provide some important
foundations for future work in HRQoL measurement in
Indigenous populations around the world.
The majority of HRQoL work in Indigenous populations
is building off narrow, individualised conceptions of health
that may not align with alternative conceptions of health
such as those held by particular Indigenous populations.
The findings of some studies included in this review sug-
gest that there may be fundamental shortcomings in using
existing instruments to measure the HRQoL in some of
these Indigenous populations with many finding existing
instruments were not valid in the Indigenous group studied
and others highlighting the importance of factors not gen-
erally considered in existing HRQoL measures.
Some included studies attempted to adapt existing
measures to be more applicable to Indigenous populations.
The vast majority of these, however, attempted to do so
through minor language adjustments. The results of some
studies included in the review suggest that more funda-
mental reform may be needed to ensure applicability of
HRQoL instruments to Indigenous populations. Of the two
studies that investigated the domains used in these instru-
ments, both highlighted the importance of community or
social factors to the HRQoL of the studied populations as
well as other domains that lie outside traditional measures
such as diet or land use. At the same time, a number of
studies suggested that two-factor models of HRQoL com-
monly used in many measures of HRQoL (based on dis-
tinct domains of mental and physical health) may not be
adequately capturing Indigenous conceptions of health in
some population groups. A number of studies found evi-
dence that HRQoL instruments were being interpreted in
different ways between Indigenous and other ethnic groups
or that there were fundamental differences in the ways that
different health conditions were reported through these
instruments. Future work in the area of the HRQoL of
Indigenous groups must begin with a careful consideration
of factors that are considered the most important determi-
nants of HRQoL for these populations.
The work of Gupchup et al. [34] used focus groups and
professional opinions to determine domains most important
to an American Indian population and modify an existing
instrument to create an Indigenous-specific measure [28].
Kant et al. [41] explored the factors most important in
determining the HRQoL of the Indigenous population of
the study, finding that social, cultural and land use factors
were the most import to the HRQoL of this population [35].
These factors tend to lie outside traditional measures of
HRQoL. Few other studies attempted to change the
domains or components of measures to be applicable to
Indigenous populations. No included studies attempted to
use adapted scoring systems to score the responses from
Indigenous populations. Similarly, no studies estimated
utilities for these populations or investigated the methods
used in the literature to calculate such values.
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Previous work has suggested that the current health
economic evaluation paradigm may be unsuited to the field
of Indigenous health [3, 4]. Other studies have proposed
alternative methodologies for use in these populations such
as broader cost-consequence analysis [64, 65]. However,
these techniques have been criticised as a result of uncer-
tainty over the relative weightings attached to different
outcomes and the fact that such methods do not allow for
easy comparison across different interventions [66].
Further work is required in the field to determine the
role of HRQoL techniques in Indigenous health research
and investment. If HRQoL instruments and cost–utility
analysis are to be used in these populations, researchers
must ensure that the tools are relevant to Indigenous pop-
ulations, based on domains that are important to the
HRQoL of these groups and their conceptions of health,
and are informed by the values and preferences of
Indigenous people themselves. This may involve the
development of Indigenous-specific HRQoL instruments or
further validation or adaptation of existing instruments to
ensure applicability to these populations. In order to do so,
it is imperative that broader indicators of health and well-
being impacting on the lives of Indigenous populations are
considered and investigated. Limited evidence was found
through this review of studies attempting to empirically test
or challenge empirically the biomedically orientated con-
ceptions quality of life dominant in the literature. That said,
it is important to note a number of studies were found that
successfully used existing HRQoL measures in Indigenous
populations. Four instruments were deemed to be valid in
these populations and 32 others made practical use of these
instruments reinforcing the argument that there is a role for
these instruments in measuring the HRQoL in Indigenous
populations.
There were a number of limitations with regard to this
review. First, the populations of included studies were
heterogeneous as they came from diverse cultures and
countries and had experienced different health conditions.
This limits the generalisability of the findings that were
drawn from the analysis. This was compounded by the
breadth of instruments used to elicit HRQoL values from
these populations. Nonetheless, certain findings of this
review emerged across different populations and instru-
ments and would have been missed if the analysis was
limited to more specific populations, instruments or con-
ditions. Second, the paucity of studies found may also
reflect that work that is highly relevant to quality of life for
Indigenous people may not actually be referred to in those
terms. While there is a wealth of important work exploring
issues that may contribute to HRQoL, this paper specifi-
cally focussed on the use of formal instruments. As such,
measures that investigated only specific components that
may influence a person’s quality of life such as measures of
psychological distress, pain or discomfort or social support
were excluded from this study. Further work to develop
HRQoL instruments to incorporate Indigenous or more
holistic conceptions of health more generally would need
to investigate these issues more generally. Another poten-
tial factor to the relatively low numbers of studies found is
that much of the work in these populations may be found in
the grey literature that was not included in this review.
Finally, no critical appraisal of included studies was carried
out.
Conclusion
HRQoL measures potentially enable the inclusion of
Indigenous preferences and conceptions of health into the
evaluation of healthcare programs. Such work can play an
essential role in optimising the design and investment in
programs aimed at improving the health of the world’s
Indigenous populations. To fulfil this potential, it is vital
that HRQoL instruments are based on the domains that are
most important to the HRQoL of these groups and any
valuation of health states comes from the Indigenous
groups themselves. This review has found relatively lim-
ited attempts to do this but provides important findings for
future work in the field to build on.
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CHAPTER 4: HEALTH ECONOMICS AND CLOSING THE GAP 
 
CHAPTER OVERVIEW 
This chapter presents a discussion of the findings of the reviews presented in Chapters 2 and 
3 in light of the Australian policy context. The chapter consists of a single manuscript titled: 
to Close the Gap we need to identify the best (and worst) buys in Indigenous health.  
The chapter argues that the Indigenous health policy environment has emphasised rights-
based rather than economic arguments in resource allocation decisions that has left room for 
efficiency and equity improvements in the way that resource allocation decisions are made. 
Given this, the chapter calls for further work to investigate the service utilisation of 
Indigenous Australians and the role that culturally-specific healthcare providers play in these 
patterns and methods to incorporate Indigenous preferences to value programs to improve 
Indigenous health including through discrete choice experiments and contingent valuation 
methods. These issues form the basis for the next three chapters respectively. 
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Closing the Gap is the overarching national strategy to overcome the persistent disadvantage faced 
by Aboriginal and Torres Strait Islander 
Australians. The policy has six key goals 
across the health and social policy spectrum 
with the Commonwealth Government held 
accountable for progress via publicly released 
annual reports, the latest of which was 
published in February. While there have been 
significant gains in some areas as a result of 
concerted efforts to overcome the disparities 
facing these communities, there has been 
limited or no progress in other areas, such as 
closing the gap in life expectancy between 
Aboriginal and Torres Strait Islander and 
other Australians (Table 1).1,2 As a result, the 
effectiveness of the policy has been widely 
questioned in the academic literature,3-5 
mainstream media6,7 and Government 
reports.8 The resources available to improve 
the health of Australia’s Indigenous 
communities are finite and ensuring that 
they are used for their most effective purpose 
is vital to closing the gap in health and 
living standards between Aboriginal and 
Torres Strait Islanders and other Australians. 
Resource-allocation decisions in the sector 
need to be based on evidence and there 
needs to be the potentially uncomfortable 
recognition of the imperative to disinvest 
in programs that are ineffective or simply 
represent poor value for money.
Closing the Gap as an 
investment in overcoming 
Indigenous disadvantage
In line with community expectations, there 
have been significant resources invested 
under Closing the Gap and previous policies 
to improve the health outcomes of Australia’s 
Aboriginal and Torres Strait Islander 
communities.8 This targeted investment 
has led to substantial gains, e.g. the gap in 
child mortality rates between Aboriginal and 
Torres Strait Islander and non-Indigenous 
Australians decreased 34% between 1998 and 
2014.2 Yet on many other indicators there has 
been limited progress, perhaps most notably, 
we remain off-track for the goal of closing the 
gap in life expectancy by 2031.2
While many have suggested that overcoming 
this disadvantage will require an increase 
in the level of resources devoted to doing 
so,3-5,8 others have highlighted the lack of 
evidence behind current expenditure in 
the field.6,8 A recent review of the economic 
evaluation literature in Indigenous health 
programs around the world found very few 
examples of economic evaluations of the 
cost-effectiveness of interventions to improve 
the health of these populations.9 Economic 
evaluations allow a judgement to be made 
on the relative costs and benefits of particular 
programs and interventions to assist decision-
makers prioritise those of most benefit to the 
targeted communities. The review findings 
suggest there is limited evidence upon 
which decision-makers can confidently base 
resource-allocation decisions in Indigenous 
health. At the same time, ‘cutting waste’ was 
used to justify large funding cuts to the sector 
in the 2014 Commonwealth Budget which 
saw $160 million cut from the budget of 
Indigenous health programs).10 Without an 
economic evidence-base demonstrating the 
value of the services provided, it is difficult 
for the sector or affected communities to 
effectively counter such arguments.
One potential reason for the lack of economic 
evidence in this area may be the perception 
that economics is a second-order issue and 
that in the face of the stark disadvantage 
facing Indigenous Australians investment is 
justified based on a rights-based approach. 
While such an argument holds appeal in 
highlighting the urgency of the problem 
and may be a powerful tool in mobilising 
statutory measures to address disadvantage, 
it poses a danger when it is invoked exclusive 
of economic considerations. The reality is that 
every dollar spent on a failed program is a 
dollar that could have been used on a more 
effective program and makes it harder for a 
case to be mounted for further investment 
in programs to overcome this disadvantage. 
Ignoring the politics and realities of resource 
scarcity does little to help overcome the 
disparities within the Australian population. 
The starting point to incorporate these 
considerations into public policy needs to 
be an evidence-base to provide direction for 
decision-makers responsible for investment 
in this area. In any case, the limited economic 
evidence that is available has highlighted 
the strong economic case for investing 
in interventions targeting Indigenous 
communities, in particular rural communities. 
Economic evaluation or cost-effectiveness 
studies are also able to identify low-value 
programs. Disinvestment is nearly always 
a politically fraught process as it tends to 
create losers. There is rarely ever universal 
consensus of what constitutes a ‘bad 
buy’, particularly when there is a lack of 
evidence. Often the easy option in the 
face of potential stakeholder resistance is 
to continue to fund failing programs. This 
problem is perhaps more acute in this area 
due to: 1) the scale and urgency of health 
disadvantage in Aboriginal and Torres Strait 
Islander populations combined with the 
historical neglect of this problem add weight 
to political arguments against any individual 
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Table 1: Closing the Gap goals and progress.
Area Target Progress 
Health close the gap in life expectancy within a generation (by 2031) Not on track to achieve 
Health halve the gap in mortality rates for Indigenous children under five by 2018 On track to achieve
Education ensure access to early childhood education for all Indigenous 4-year-olds in remote 
communities by 2013
Not on track to achieve
Education halve the gap in reading, writing and numeracy achievements for children by 2018 Not on track to achieve
Education halve the gap for Indigenous students in Year 12 (or equivalent) attainment rates by 2020 On track to achieve
Employment halve the gap in employment outcomes between Indigenous and other Australians by 2018 Not on track to achieve
Source: Department of Prime Minister and Cabinet, Closing the Gap Prime Minister’s Report 2016, Commonwealth of Australia, Editor. 2016: Canberra.
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disinvestment decision; and 2) as indicated 
above, the dearth of economic evidence 
means that decision makers face investment 
and disinvestment decisions without a high 
degree of confidence due to imperfect 
information. This combination of factors can 
generate the conditions for institutionalised 
inertia in funding patterns, discourage 
creative destruction and ultimately stifle 
the development of innovative and 
potentially effective interventions. There is 
an urgent need for further work to identify 
both successful programs for scaling up 
and further investment and unsuccessful 
programs for disinvestment. 
Challenges in ensuring evidence is fit 
for purpose
On top of the difficulties inherent in 
evaluating the effectiveness of interventions 
in a policy area as complex as Indigenous 
health which have been described 
extensively,11 health economic evaluations 
have particularly been criticised as potentially 
unsuited to Indigenous populations as they 
are based on a biomedical notion of health 
that may be inconsistent with the way that 
these populations may view their health.12 
Nonetheless, health economic techniques 
used to measure health outcomes, such as 
health-related quality of life measures, have 
been used and validated in Indigenous 
populations around the world.13 They 
allow for patient preferences for health 
to be incorporated into the design and 
evaluation of services and present a clear 
mechanism through which the values and 
preferences of Aboriginal and Torres Strait 
Islander Australians can be used to identify 
the services most effective in improving the 
health of these communities. A number of 
other techniques are commonly used in the 
health economic field to directly incorporate 
population preferences for different 
aspects of health and healthcare such as 
discrete choice experiments or contingent 
valuation studies. These techniques, if used 
in Aboriginal and Torres Strait Islander 
communities, could potentially serve as 
a means to value interventions aimed at 
improving the health of these populations 
from the point of view of the communities 
themselves and highlight components of 
services that are most important to the health 
of these groups. Such methods, however, 
remain virtually untested in these population 
groups in the published literature. 
Barriers that prevent Aboriginal and 
Torres Strait Islander Australians accessing 
appropriate health services include financial, 
cultural, geographic and health-literacy 
impediments to care. Policy interventions to 
improve the health of Aboriginal and Torres 
Strait Islander Australians need to recognise 
these barriers and assist in overcoming 
them. A key component of Closing the Gap 
are attempts to overcome these barriers to 
accessing services to ensure that appropriate 
healthcare is provided to these communities. 
Without adjusting for the differences in 
need between the two population groups, 
Australia spends more per capita on the 
health care of Indigenous Australians than 
on non-Indigenous Australians (at a ratio of 
$1.47 to every $1 spent on a non-Indigenous 
Australian).14 However, the makeup of this 
spend differs markedly between the two 
groups with Aboriginal and Torres Strait 
Islander Australians utilising significantly 
less primary healthcare and pharmaceutical 
services.14 Given the elevated risk facing 
Australia’s Indigenous communities this 
discrepancy is particularly concerning. We 
know that improving access to primary health 
care reduces hospital expenditure through 
improved health outcomes and this has 
been shown to be the case in an Australian 
Indigenous setting.15 These patterns highlight 
the significant scope for efficiency gains to 
our current spending patterns in Indigenous 
health and suggest there is more we can 
be doing to overcome the barriers to care 
facing these communities. Paradoxically, 
recent cuts to Aboriginal health expenditure 
have targeted primary health care funding. 
New programs in Indigenous primary health 
care and population health are required and 
capacity for economic evaluation needs to be 
a key component considered. 
There are some examples of programs being 
trialled in the sector on the basis of economic 
evidence developed in different jurisdictions 
and populations. The David Olds nurse home 
visiting partnership program developed in 
the United States was tested in randomised 
control trial settings and had economic 
evaluation of short, medium and long-term 
outcomes.16,17 This program has been licensed 
for implementation in Australia over several 
years and the Commonwealth Government 
has funded a more extensive national roll-out 
of the program in the 2016 budget.18 Such 
evidence-based decision-making is promising 
yet it is vital that effectiveness and cost-
effectiveness results from other jurisdictions 
are backed up in local settings.
Next steps and conclusions
The moral and political imperatives to 
overcome Indigenous disadvantage reflect 
the history of neglect and social and health 
disadvantage of Aboriginal and Torres Strait 
Islander Australians. The policy response to 
this disadvantage has often been based on 
a rights-based argument for investment in 
Indigenous health. Whilst acknowledging 
these fundamental imperatives and the 
importance of a rights-based approach to 
mobilise political and public action and 
support, we submit that there is a major flaw 
in this approach as it can lead to a neglect 
of considerations of cost-effectiveness and 
value for money. This does not enable us to 
distinguish between good and bad buys in 
Indigenous health and potentially entrenches 
patterns of funding in which failure can be 
perpetuated. 
Determining the most cost-effective means 
of delivering health services to Aboriginal and 
Torres Strait Islander Australians needs to be a 
priority for government to strengthen current 
efforts to Close the Gap with a targeted 
effective system of prevention with primary 
and population health care expenditure 
in particular. Leaving aside the question 
as to whether enough resources are being 
devoted to the sector, if Australia is to finally 
overcome the persistent disparities facing our 
Indigenous communities, there needs to be a 
focus on ensuring that appropriate evidence 
is used to support investment in programs 
to improve the health of these groups and 
that resources are prioritised to interventions 
that demonstrate the greatest return. This is 
not to say that rights-based arguments do 
not have value in highlighting the disparities 
faced by these communities and the moral 
and political case for overcoming them, 
but they need to be augmented by, rather 
than supercede, economic evidence. While 
recognition of rights-based arguments have 
differed according to political affiliation, 
economic arguments have appeal across the 
political spectrum and therefore help ‘future-
proof’ effective programs from the vagaries 
of the short-term political cycle. Health 
economic evaluations built on Indigenous 
values and preferences will provide a means 
to prioritise interventions and policies to 
ensure that the resources that are available 
to improve Indigenous health are used in the 
most effective ways possible. 
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CHAPTER 5: HEALTHCARE EXPENDITURE OF INDIGENOUS AND NON-
INDIGENOUS INDIVIDUALS AT HIGH RISK OF CARDIOVASCULAR DISEASE 
 
CHAPTER OVERVIEW 
This chapter presents an analysis of data collected through the Kanyini Guidelines Adherence 
with the Polypill (GAP) pragmatic randomised controlled trial. The chapter consists of a single 
manuscript titled: Healthcare expenditure on Indigenous and non-Indigenous Australians at 
high risk of cardiovascular disease.  
In spite of the disparities faced by Australia’s Indigenous populations and policy commitments 
to ensure access to affordable, acceptable and effective health services, there is mixed 
evidence as to whether Indigenous Australians utilise more or less healthcare services than 
other Australians given their elevated risk level. Further there is limited empirical 
understanding of the role of culturally-specific care providers in providing care to these 
communities. This study analyses the Medicare expenditure and its predictors in a cohort of 
Indigenous and non-Indigenous Australians at high risk of cardiovascular disease. Almost all 
the Indigenous participants in the trial received care at a culturally-specific provider allowing 
us to assess the level of care being providers at these centres. There was no significant 
difference in the expenditure of Indigenous and non-Indigenous participants in non-remote 
areas following adjustment for individual characteristics. Indigenous individuals living in 
remote areas had significantly lower Medicare expenditure than other individuals. The 
findings suggest that for the majority of participants, once individuals are engaged with a 
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primary care provider, factors other than whether they are Indigenous determine the level of 
Medicare expenditure on services for each person.  
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Abstract
Background: In spite of bearing a heavier burden of death, disease and disability, there is mixed evidence as to
whether Indigenous Australians utilise more or less healthcare services than other Australians given their
elevated risk level. This study analyses the Medicare expenditure and its predictors in a cohort of Indigenous
and non-Indigenous Australians at high risk of cardiovascular disease.
Methods: The healthcare expenditure of participants of the Kanyini Guidelines Adherence with the Polypill (GAP)
pragmatic randomised controlled trial was modelled using linear regression methods. 535 adult (48% Indigenous)
participants at high risk of cardiovascular disease (CVD) were recruited through 33 primary healthcare services
(including 12 Aboriginal Medical Services) across Australia.
Results: There was no significant difference in the expenditure of Indigenous and non-Indigenous participants in
non-remote areas following adjustment for individual characteristics. Indigenous individuals living in remote
areas had lower MBS expenditure ($932 per year P < 0.001) than other individuals. MBS expenditure was found to
increase with being aged over 65 years ($128, p = 0.013), being female ($472, p = 0.003), lower baseline reported
quality of life ($102 per 0.1 decrement of utility p = 0.004) and a history of diabetes ($324, p = 0.001), gout ($631,
p = 0.022), chronic obstructive pulmonary disease ($469, p = 0.019) and established CVD whether receiving
guideline-recommended treatment prior to the trial ($452, p = 0.005) or not ($483, p = 0.04). When controlling for all
other characteristics, morbidly obese patients had lower MBS expenditure than other individuals (−$887, p = 0.002).
Conclusion: The findings suggest that for the majority of participants, once individuals are engaged with a primary
care provider, factors other than whether they are Indigenous determine the level of Medicare expenditure for each
person.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN 126080005833347.
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Background
The burden of chronic diseases facing Australians has
grown significantly over recent decades making providing
appropriate care for these patients increasingly complex
[1, 2]. Studies have shown a growing burden on health sys-
tem expenditure in Australia as a result of the increased
prevalence of obesity and diabetes for example [3], while
other chronic diseases such as chronic obstructive pul-
monary disease (COPD), gout and cardiovascular diseases
(CVD) are likely to place significant demands on health
system resources.
Greater chronic disease multi-morbidity is an import-
ant contributor to the health gap between Aboriginal
and Torres Strait Islander (Indigenous) Australians and
non-Indigenous Australians [4]. Ensuring that Indigen-
ous Australians have access to effective healthcare ser-
vices is a central component of government attempts to
eradicate these inequalities [5]. Nonetheless, a number
of barriers prevent Indigenous Australians from accessing
appropriate health services including financial, cultural,
geographic and health-literacy impediments [6, 7].
Healthcare service use of indigenous Australians
Without controlling for the relative need of the two
groups, the average public spend on healthcare for an
Indigenous Australian is estimated at $1.47 for every $1
spent for the care of a non-Indigenous Australian [8].
The distribution of this spend differs markedly between
the two groups, however, with Indigenous Australians
utilising significantly less Medicare Benefit Schedule
(MBS) and medication expenditure (at a rate of 0.63 and
0.44 respectively) than other Australians but having
much higher average hospital expenditure (1.76 times
higher than non-Indigenous Australians). MBS expend-
iture incorporates general practitioner and specialist
visits and diagnostic tests. Given the substantial dispar-
ities in health outcomes facing Indigenous Australians,
many have questioned whether the expenditure on Indi-
genous individuals, in particular for primary healthcare,
should be higher relative to non-Indigenous Australians
[6, 9]. Limited research has been able to effectively ad-
just for the different clinical risk profiles of the two pop-
ulations. One study that was able to do so (through
controlling for self-reported indicators of ill health)
found that Indigenous Australians used more healthcare
services than other Australians [10].
This study investigates these issues using patient-level
clinical data to examine the relative patterns of health-
care expenditure of Indigenous and non-Indigenous
individuals at high-risk of CVD and investigate the
predictors of expenditure across the two groups. Un-
derstanding the healthcare utilisation patterns of these
populations is important to ensure that the health system
is providing the level of care required to close the gap in
health outcomes between Indigenous and non-Indigenous
Australians and appropriate levels of care to those living
with chronic diseases.
Methods
Participants
Data were collected during the Kanyini Guidelines Ad-
herence with the Polypill (GAP) randomised controlled
trial testing the effectiveness of a cardiovascular combin-
ation polypill (containing aspirin, simvastatin and two
low dose blood pressure lowering agents) in Indigenous
and non-Indigenous adults over 18 years at high-risk of
CVD. High-risk of CVD was defined as either an estab-
lished diagnosis of CVD or an estimated five-year risk of
CVD greater than 15 percent based on the Framingham
risk equation (with an additional five percent increment
for Indigenous participants) [11]. Participants were ex-
cluded if it was deemed clinically inappropriate to alter
their medications. Participants had a median follow-up
of 19 months (maximum follow up of 36 months). Fur-
ther details of the trial design and randomisation
process are presented elsewhere [11]. The trial was ap-
proved by human research ethics committees in all
relevant jurisdictions.
Service expenditure
Data collected included data from the Medicare Benefits
Schedule (MBS), which records government and patient
out of pocket expenditure (government legislated co-
payments) on general practitioner and specialist visits
and diagnostic tests, linked with data from the clinical
trial [12]. MBS data are automatically collected at the
point of service when the healthcare provider bills the
government or patient for the service rendered and par-
ticipants consent for these data to be linked to the data
collected through the trial. Pharmaceutical Benefit
Schedule (PBS) data were also collected for the trial,
however, this did not include: (1) the polypill treatment
used in the trial (as it was not PBS-approved); (2)
pharmaceutical treatments falling under the general co-
payment threshold; and (3) those medicines accessed by
people of remote Aboriginal Health Services under the
provisions of section 100 of the National Health Act
(1953) [13]. As such, the average MBS expenditure per
patient per follow-up year was used as the outcome vari-
able for the analysis.
Geographic setting
The trial was conducted within Indigenous-specific (12
centres) and other primary-care providers (21 centres) in
urban, rural and remote settings around Australia.
Urban, regional or remote areas were classified based on
definitions of the Australian Bureau of Statistics [14]. For
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this analysis, ‘remote’ is used to refer to those living in ei-
ther remote or very remote areas under these definitions.
Statistical analysis
The average annual MBS benefit of the two groups was
modelled using linear regression methods using Stata
13.1 (StataCorp). To account for the skewness of the
data, the outcome variable was log-transformed and
then estimated using linear regression models [15]. The
adjusted log means were then transformed back to a
dollar scale using a smearing estimate in order to de-
rive unbiased estimates of mean costs [16]. Medicare
benefit expenditure was estimated within key socioeco-
nomic and demographic variables collected from study
participants at the baseline visit including gender, income,
whether they received the polypill or usual care, Indigen-
ous status, remoteness, highest education level attained,
the presence of certain chronic diseases (diabetes, COPD,
gout and morbid obesity defined as having a body mass
index (BMI) greater than 40), whether a person was a pri-
mary or secondary prevention patient and whether they
were on appropriate medication prior to entering the trial
with and without covariate adjustments. The quality of life
of the patient measured at baseline using the EQ-5D and
converted to a summary score using Australian based
estimates was included as an explanatory variable in
the analysis [17]. Non-significant baseline covariates
(P > 0.1) were removed via backwards stepwise elimin-
ation. Age of participants and morbid obesity were in-
cluded as dummy variables in the analysis due to an
observed differential impact for those aged 65 years
and over and those with a BMI over 40. Indigenous sta-
tus was captured through two dummy variables, one in-
dicating if they lived in a remote area and another if
they lived in an urban or regional setting. This was ne-
cessary as the impact of living in a rural area could not
be isolated for non-Indigenous Australians as there
were too few non-Indigenous people in the sample liv-
ing in rural or remote locations. All costs are presented
in 2012 Australian dollars.
Results
General characteristics
Complete data were available for 535 participants in the
Kanyini GAP study which represented 88% of the total
trial population1. Table 1 summarises the general charac-
teristics of participants and shows the average MBS ex-
penditure by each category shown. It is important to
highlight that the individual characteristics vary across
the urban and regional Indigenous, Remote Indigenous
and non-Indigenous groups and as such, this average
expenditure should be interpreted with caution. The
sample included 48% Indigenous people, had an average
age of 63 years and 36% were female. Overall, 67% of
participants were from urban areas, 12% from regional
areas and 21% were from remote areas. Thirty-eight per-
cent of the patient cohort were receiving treatment for the
primary prevention of CVD and 62% had an established
diagnosis of CVD prior to entering the study. The average
BMI of participants was 31 with 9.7% (52 participants) of
the cohort classified as morbidly obese. The average five
-year cardiovascular risk score of primary prevention pa-
tients was 18.7%, and this was similar for Indigenous
(18.7%) and non-Indigenous (18.6%) individuals. On aver-
age, Indigenous participants were younger, more likely to
be receiving primary rather than secondary prevention
care and more likely to live in rural or remote locations
than their non-Indigenous counterparts.
There were no major differences between Kanyini
GAP participants who were included and excluded from
this analysis (88 subjects) in terms of age, primary pre-
vention risk score, average age or regional classification.
A higher proportion of trial participants who did not
provide consent for linkage to their MBS records were
Indigenous (64%).
Service utilisation
On average, participants accessed a total of 34 MBS ser-
vices per year during the trial. The average MBS benefit
paid per year for care of the patient cohort was $1,699.
Indigenous participants had lower MBS service utilisa-
tion across the trial (see Table 2). Remote Indigenous
participants had accessed almost 27 MBS services as
opposed to 36 for other participants (Indigenous and
non-Indigenous) and had an average MBS Benefit ex-
penditure of $1,161 compared to $1,843.
Predictors of service expenditure
Table 3 outlines the predicted variation in MBS benefits
based on the model developed. Indigenous patients (liv-
ing in non-remote areas) were estimated to have an
average annual MBS benefit expenditure $108 higher
than non-Indigenous participants, however, this differ-
ence was not statistically significant (p = 0.33). Indigen-
ous people living in remote locations, however, had an
average annual MBS benefit expenditure $932 less than
other participants (p < 0.001). Baseline self-reported
quality of life was significantly associated with the MBS
benefit expenditure of the patients with expenditure in-
creasing on average $102 for each 0.1 decrement of util-
ity. Morbidly obese patients (BMI > 40) had significantly
lower MBS expenditure per year ($887 lower per year,
p = 0.002). Medicare expenditure was significantly associ-
ated with whether a person was a primary or secondary
prevention patient and whether they were on appropriate
medications before they started the trial: secondary
prevention patients who were not on all evidence-based
medications prior to the start of the trial were estimated
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to have service use $483 higher on average than primary
prevention patients who were similarly not on appropriate
medications (p = 0.04). Other socio-demographic variables
including the education level and income of the partici-
pants were not statistically significant predictors of service
use once the other variables were included in the model.
The MBS expenditure of participants was not different
between the randomisation groups, that is, whether they
received the polypill intervention or usual care in the trial.
Discussion
Cardiovascular diseases are estimated to affect 5.2% of
Australians [18], 12% of Indigenous Australians [19] and
have been estimated to be responsible for approximately
Table 1 General Characteristics of Cohort
Total Urban and Regional
Indigenous
Remote Indigenous Non-Indigenous
n(%) Average MBS
Expenditure
n(%) Average MBS
Expenditure
n(%) Average MBS
Expenditure
n(%) Average MBS
Expenditure
Participants 535a $1,699 146 (27%) $1,863 113 (21%) $1,161 276 (52%) $1,833
Age, mean (SD) 63 (12.5) NA 57 (8.8) NA 55 (13.6) NA 70 (9.5) NA
Morbidly Obese 52 (10%) $1,310 27 (18%) $1,519 9 (8%) $637 16 (7%) $1,336
Female 193 (36.1%) $1,833 56 (39%) $1,932 49 (43%) $1,284 88 (32%) $2,075
Primary Healthcare Provider
Aboriginal Medical Service (AMS) 266 (50%) $1,580 136 (93%) $1,901 113 (100%) $1,161 17 (6%) $1,805
Non-AMS 269 (50%) $1,816 10 (7%) $1,346 0 (0%) NA 259 (94%) $1,834
Geographical Classification
Urban 356 (67%) $1,878 102 (70%) $1,979 0 (0%) NA 254 (92%) $1,837
Regional 64 (12%) $1,625 44 (30%) $1,594 0 (0%) NA 20 (7%) $1,693
Remote and very Remote 115 (21%) $1,185 0 (0%) NA 113 (100%) $1,161 2 (1%) $2,565
CVD Risk Group
Primary Prevention, not on optimal
therapy before the trial
94 (18%) $1,421 41 (28%) $1,623 20 (18%) $789 33 (12%) $1,421
Primary Prevention, on optimal therapy
before the trial
108 (20%) $1,601 22 (15%) $1,980 39 (35%) $959 47 (17%) $1,957
Secondary Prevention, not on optimal
therapy before the trial
42 (8%) $1,941 12 (8%) $1,819 4 (4%) $1,346 26 (9%) $2,089
Secondary Prevention, on optimal
therapy before the trial
291 (54%) $1,790 71 (49%) $1,973 50 (44%) $1,452 170 (62%) $1,813
Highest Educational Attainment
Primary education or lower 142 (27%) $1,513 51 (35%) $1,703 49 (43%) $1,041 42 (15%) $1,834
Secondary level 247 (46%) $1,742 56 (38%) $1,844 44 (39%) $1,236 147 (53%) $1,855
Post-secondary 146 (27%) $1,807 39 (27%) $2,099 20 (18%) $1,288 87 (32%) $1,795
Risk Score of primary prevention patients,
mean (SD)
18.7 (5.9) NA 19.2 (5.8) NA 18.3 (6.8) NA 18.6 (5.2) NA
Presence of COPD at baseline of trial 45 (8%) $2,130 23 (16%) $2,146 5 (4%) $2,405 17 (6%) $2,027
Presence of diabetes at baseline of trial 289 (54%) $1,741 98 (67%) $1,961 83 (73%) $1,083 108 (39%) $2,047
Presence of gout at baseline of trial 109 (20%) $2,054 30 (21%) $2,139 14 (12%) $1,340 65 (24%) $2,169
Received polypill intervention 272 (51%) $1,708 69 (47%) $2,052 59 (52%) $1,161 144 (52%) $1,766
a88% of Kanyini GAP trial participants
Table 2 Average Selected services per follow-up year
Total Urban and Regional Indigenous Remote Indigenous Non-Indigenous
Number of MBS Services 34 36 27 36
Average Total MBS Benefit Expenditure per year $1,699 $1,863 $1,161 $1,833
Average MBS Out of Pocket Expenditure $67 $16 $4 $121
Angell et al. International Journal for Equity in Health  (2017) 16:108 Page 4 of 7
Health Economics and Indigenous Health 89
a quarter of the gap in health outcomes between Indi-
genous and non-Indigenous Australians [4, 20]. CVD
hospitalisations and death rates in remote and very re-
mote areas of Australia are estimated to be 30% higher
than in major cities [21]. Ensuring that Indigenous and
remote communities experiencing or at risk of CVD can
access appropriate care is vital to closing this gap. This
study provides a unique insight into the service use pat-
terns of this high-risk cohort. Average MBS expenditure
was lower per capita for Indigenous Australians relative
to other participants, in line with national estimates [8].
Most of this difference, however, resulted from remote
Indigenous participants receiving significantly lower levels
of Medicare-funded care. While this finding is consistent
with previous literature highlighting service-gaps and diffi-
culties in providing healthcare services to remote commu-
nities, Medicare services are also an incomplete picture of
healthcare being received as many services may be funded
by other sources including government grants, which pre-
vious estimates have suggested could represent up to
$1,300 per person per year of services in these areas [22].
This would account for a large part of the difference in
Medicare expenditure between remote Indigenous and
other participants found in this study. It is worth noting
though the potential equity implications resulting from a
two-tiered funding system. Most notably, the additional
burden on AMS providers who need to apply for and meet
other requirements of these grants has been well docu-
mented [23, 24].
On the other hand, once demographic and risk-related
factors were controlled for there was no significant dif-
ference in the MBS expenditure of Indigenous and
non-Indigenous participants. For Indigenous individ-
uals living in non-remote locations, other factors were
more important in determining their care than their
Indigeneity. This suggests that this cohort of high-risk
individuals were receiving care equivalent to their non-
Indigenous counterparts with similar risk levels. While
it could be argued that these individuals should be re-
ceiving a greater level of care to ‘close the gap’, this is a
promising result particularly given that almost all Indi-
genous individuals in this cohort received care at an
Aboriginal-specific primary healthcare centre. The im-
portance of Aboriginal-specific services and culturally
appropriate care has been highlighted repeatedly in the
qualitative literature as an essential component in en-
suring that appropriate care is received by these com-
munities [25–28]. The findings of this study suggest
that in urban areas at least, culturally-specific services
can help to overcome the underutilisation of primary
care services by Australia’s Indigenous communities.
Further it suggests that urban Indigenous specific pro-
viders may be overcoming a historical underutilisation
of Medicare as a funding source.
We were unable to separate the MBS expenditure into
that relating to cardiovascular as opposed to other spe-
cialties as the majority of costs were for services such
as pathology tests and general consultations which may
result from a number of conditions. While a patient
history of gout, diabetes and COPD were all associated
with significantly higher Medicare expenditure as would
be expected, morbidly obese patients were found to be re-
ceiving significantly lower levels of care receiving almost
$900 less care per year than other participants and an
average of under 29 services per year as opposed to 34 for
other participants. This goes against findings in the litera-
ture that have found increased levels of obesity to be asso-
ciated with higher expenditure [3] as well as national data
Table 3 Average increases in estimated annual MBS benefit associated with patient characteristics
Increase in estimated annual MBS Benefita p-Value**
Urban Indigenous $108 0.326
Baseline quality of life $102 per 0.1 decrement in utility 0.004
Aged 65 and over $128 0.013
Female $472 0.003
Remote Indigenous -$932 <0.001
Primary prevention and on optimal medications prior to trial $285 0.193
Secondary prevention and not on optimal medications prior to trial $483 0.04
Secondary prevention and on optimal medications prior to trial $452 0.005
Patient history of gout $631 0.022
Patient history of diabetes $324 0.001
Patient history of COPD $469 0.019
BMI > 40 -$887 0.002
Constant $2,379 <0.001
aexpenditure increases based on differences in smeared means
**p-values based on natural log-transformed data adjusted for all variables included above
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indicating that obese people were more likely to see a GP
than non-obese individuals [29]. While the reasons under-
lying this finding are not immediately apparent there are
several potential explanations. First, we did not have data
on the hospital service use of patients so that the differ-
ence in Medicare expenditure may be compensated by
hospital expenditure if these morbidly obese individuals
used more hospital services. Second, previous studies have
not controlled for the presence of multi-morbidities as we
have suggesting that perhaps the higher expenditure found
in those studies may reflect the presence of other chronic
diseases. Third, it may be the case that the morbidly obese
patients are either less proactive in seeking out health
services or the primary healthcare services may not be
meeting the needs of this cohort. Given the increasing
prevalence of obesity in Australia, it is vital to ensure
that primary care providers effectively meet the health-
care needs of this population to maximise patient out-
comes and minimise downstream cost impacts. In any
case, this relationship between service use and obesity
warrants further investigation.
There were several limitations to this analysis. First,
the sample is not representative of the general Austra-
lian Indigenous population. Participants were recruited
from primary care services such that they were already
receiving care and many of the impediments to care dis-
cussed in the literature had already been overcome. This
might lead to our estimates of expenditure being an
overestimate for these communities. Further our focus
on Indigenous communities likely means our cohort is
not generalizable to the broader Australian population
at high-risk of CVD. Second, there were too few non-
Indigenous Australians living in remote locations to sep-
arate the impact of living in a remote area and that of
being Indigenous. While one of the strengths of the
paper was our ability to exploit patient-level data to con-
trol for risk and other socio-demographic variables there
are limitations to the dataset. We did not have access to
hospital data and the lack of clarity around potential al-
ternative services being provided particularly in remote
areas means that we cannot ascertain the exact level of
services being accessed by these communities. Similarly,
other characteristics that we could not control for may
influence the healthcare spend of these individuals. Fi-
nally, our data may be affected by the higher rate of
Indigenous participants who did not consent to link
their trial and Medicare data.
Conclusion
Understanding the healthcare utilisation patterns of In-
digenous Australians is important to ensure that the
health system is providing the level of care required to
close the gap in health outcomes between Indigenous
and non-Indigenous Australians. This analysis suggests
that in an urban setting, once individuals are engaged
with a service, culturally-specific care providers can be
effective in providing care to this high-risk patient
group. Indigenous individuals living in remote areas had
significantly lower levels of Medicare funded care, how-
ever, we were unable to determine if this was a result of
fewer services being received or limitations with our
data. Policy efforts to improve access to primary care for
Indigenous Australians should focus on getting these
communities engaged with care providers and overcom-
ing barriers facing those in remote areas.
Endnotes
1Six hundred twenty-three completed the trial, 555
provided consent for Medicare, complete health related
quality of life data for 535.
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CHAPTER 6: VALUING CULTURALLY-SPECIFIC CARE 
 
CHAPTER OVERVIEW 
This chapter presents the findings of a discrete choice experiment (DCE) examining the value 
the relative importance of known barriers to care to a cohort of older Aboriginal Australians. 
The chapter consists of a single manuscript titled: Participant preferences for an Aboriginal-
specific falls prevention program: measuring the value of culturally-appropriate care.  
This chapter builds on the work of Chapter 5 through a more specific examination of 
culturally-specific care providers and addresses calls from the work in Chapters 2 and 4 for 
further research into techniques to elicit Indigenous values and preferences. The chapter 
presents a DCE of participants of a culturally-specific fall-prevention service to determine 
participant preferences for different components of the service. This represents the first 
known DCE in the health field examining preferences amongst an Aboriginal population and 
we were able to empirically demonstrate the value of the culturally-specific element of a 
program has to this cohort. The chapter demonstrates the potential that DCEs and stated-
preference methods can have in incorporating the preferences of Aboriginal Australians and 
valuing cultural components of health services. 
The questionnaire used in this study is reproduced in Appendix 6. 
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Summary 
Culturally-specific services are central to efforts to improve the health of Aboriginal 
Australians. Few empirical studies have demonstrated the value of such services relative to 
mainstream alternatives. To investigate, a discrete choice experiment (DCE) was conducted 
alongside a study of a culturally-specific fall-prevention service to determine participant 
preferences for components of the service. Attributes that were assessed were out-of-pocket 
costs, whether transport was provided and whether the class was Aboriginal-specific. Choices 
of participants were modelled using mixed logit methods. 60 patients completed the DCE. 
Attending a service was strongly preferred over no service (selected 99% of the time). 
Assuming equivalent efficacy of fall-prevention programs, participants indicated a preference 
for services that were culturally-specific (OR 1.25 95% CI: 1.04-1.46) and incurred lower out-
of-pocket participant costs (OR 1.19 95% CI 1.13-1.25). The provision of transport did not have 
a statistically significant influence on service choice (p=0.55). This represents the first 
published DCE in the health field examining preferences amongst an Aboriginal population. 
The results empirically demonstrate the value of the culturally-specific element of a program 
has to this cohort and the potential that stated-preference methods can have in incorporating 
the preferences of Aboriginal Australians and valuing cultural components of health services. 
Note on terminology: As the majority of the NSW Aboriginal and Torres Strait Islander 
population is Aboriginal (97.2%), this population will be referred to as ‘Aboriginal’ in this 
manuscript (The Australian Bureau of Statistics, 2009). 
Key words: Aboriginal health, discrete choice experiment, falls prevention, culturally specific 
services 
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1. Introduction  
Falls are a leading cause of injury amongst older Aboriginal Australians as they are in 
Indigenous and non-Indigenous communities around the world (Lukaszyk, Harvey, et al., 
2016). Fall-prevention programs are an evidence-based means of reducing the risk of older 
people experiencing a fall or to improve outcomes following a fall (World Health Organiation 
Ageing & Life Course Unit, 2008). The effectiveness of such services has been shown 
repeatedly in the literature (Chang et al., 2004), however, the effectiveness of mainstream 
programs in reaching Aboriginal populations is unknown (Lukaszyk, Coombes, et al., 2016). 
More broadly, there is a documented underutilisation of primary care services by Aboriginal 
communities attributable to barriers to services including financial, cultural and geographic 
impediments to care (Alford, 2015; Hayman, White, & Spurling, 2009).  
Largely qualitative evidence has highlighted the importance of culturally-appropriate 
healthcare to Aboriginal Australians. Aboriginal-specific services have thus become a central 
component of efforts to overcome these barriers and improve the health of Australian 
Aboriginal people (Hayman et al., 2009). There have, however, been limited attempts to 
demonstrate the value of these components empirically through an economics lens which 
poses questions about the value of such services (Angell, Muhunthan, Irving, Eades, & Jan, 
2014; Jan, 1998; Mooney, 2009). 
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This paper examines these issues through a discrete choice experiment (DCE) of participants 
of a culturally-specific fall prevention program. We assess the preferences and willingness to 
pay (WTP) of participants for attending a class and the relative importance of transport, cost 
and cultural-appropriateness in the choices made by participants. An understanding of the 
value placed on the components of health services is vital to ensure that resources aimed at 
improving the health of Australia’s Aboriginal populations are used in their most effective way 
possible and to develop services that meet the healthcare needs of Aboriginal Australians. 
1.1 Discrete Choice Experiments 
DCEs are based on stated-preference surveys where respondents are asked to make a series 
of choices between hypothetical alternatives that differ on several key attributes. DCEs are 
able to provide valuations of specific attributes based on individuals’ WTP, the trade-offs 
respondents are willing to make between attributes and overall WTP for the program in 
question (Mangham, Hanson, & McPake, 2009). No DCEs were found in the published health 
literature carried out specifically in Australian Aboriginal populations or valuing the cultural 
aspects of a program. Studies have attempted to value the importance of cultural factors  in 
other sectors, for example in environmental and agricultural economics to value traditional 
connections to the land in Australian and Canadian Aboriginal populations (Haener, Dosman, 
Adamowicz, & Boxall, 2001; Zander & Straton, 2010). These studies have found differences in 
the preferences of Aboriginal populations to those of the non-Indigenous population, 
however, have emphasised the importance of extensive work in the development stages of 
DCE studies to ensure that the DCE is capturing the true preferences of respondents. Similarly, 
DCEs have been used to value components of care linked to traditional practices in other 
health systems around the world (Mangham et al., 2009). 
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2. Methods 
A face-to-face DCE survey was administered to assess the preferences for a fall-prevention 
service following published guidelines for the conduct of DCEs in health (de Bekker‐Grob, 
Ryan, & Gerard, 2012; Lancsar & Louviere, 2008). The study was approved by the Aboriginal 
Health and Medical Research Council ethics committee (1084/15). 
2.1 Participants  
The DCE was administered to participants of the Ironbark program, an evidence-based, 
culturally-appropriate fall-prevention intervention. The intervention is a weekly group-based, 
balance and strength exercise class with an education component held within ‘yarning circles’ 
which facilitate discussion. Participants were Aboriginal adults over the age of 40 years 
recruited through six urban Aboriginal-specific services across New South Wales, Australia.  
2.2 Questionnaire 
Each participant completed one questionnaire of 6 questions. Each question comprised 2 
unlabelled class alternatives, A and B. For each question, respondents were asked to indicate 
their preference to take class A or B or no class. They were asked to assume that both classes 
were equally effective in preventing falls and that the classes did not differ apart from in the 
ways specified. The consequence of selecting no class compared with one of the classes was 
explained by highlighting that the patient would not receive the benefits of the class if they 
did not attend. A trained Aboriginal research assistant explained the questionnaire to 
participants, asked the questions and recorded the choices of participants. 
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2.3 Attributes and Levels presented 
As recommended in the DCE literature (de Bekker‐Grob et al., 2012), attributes were 
developed based on qualitative work carried out in this population which identified the 
important factors of care to participants, literature looking at the barriers facing Aboriginal 
people from accessing healthcare services and discussion between the authors and the 
Aboriginal research assistants. Following this process, the survey was extensively piloted at 
Ironbark sites among participants to refine the number and levels of the attributes and assess 
the readability and interpretation of the questions. Through this iterative process the survey 
was simplified by reducing the number of attributes and levels presented to participants. Each 
class was defined by the attributes and levels outlined in Table 1. This included attributes 
representing the cost of the class, whether transport was provided and whether the class was 
Aboriginal-specific.  
2.4 Experimental Survey Design and Theoretical Sample Size 
The final survey used a d-efficient design (d-error = 0.403) based on Bayesian prior 
probabilities using Ngene software. From the design generated, a theoretical minimum 
sample size of 6 participants answering 12 questions each was required. In line with feedback 
from participants and the Aboriginal research assistants during the piloting phase that the 
initial questionnaire was too burdensome for participants, the survey was blocked into 2 
versions of 6 questions, which increased the theoretical required minimum sample size to 12. 
2.5 Econometric and Statistical Analysis 
DCEs are theoretically based on random utility theory where independent rational actors act 
to maximise their individual utility (Hensher, Rose, & Greene, 2005). We assume that 
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individuals choose the alternative that maximises their individual benefit or utility which 
depends on the attributes such that: 
U(A or B) = 𝛽1 Cost + 𝛽2 Culture + 𝛽3 Transport + ε 
U(no class) = 0 
Where: Cost = out-of-pocket cost associated the class in Australian dollars  
  Culture = whether the class is Aboriginal-specific or a mainstream class   
Transport = whether transport is provided   
The model was estimated using panel mixed multinomial logit methods using NLOGIT 4.0. The 
dependent variable was the choice of the participants with a higher utility indicating a 
preference to attend a class compared with no class and choose one class over another. 
Limited sociodemographic information was able to be collected about participants including 
their age, body mass index (BMI), gender and who they lived with. The model was based on 
the attributes presented and interaction terms between all attributes with sociodemographic 
information collected. The model complexity was reduced based on the likelihood ratio test 
while retaining significant predictors of choice (P<0.10). Odds ratios (ORs) for choosing 
treatment or no treatment were derived as were participants WTP for different attributes. 
Internal validity was tested by examining the signs and significance of parameter estimates 
relative to a priori expectations. 
3. Results 
3.1 General Characteristics 
In total 60 participants completed the DCE questionnaire across the six sites. The average age 
of participants was 64 years. The participants had an average body mass index (BMI) of 31 
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and 62% of participants were female. Thirty percent of the cohort lived alone, 35% lived only 
with a spouse and 30% lived with either their spouse and children (13%) or just their child or 
children (17%).  
3.2 Predictors of choice and Willingness to Pay 
The results of the mixed logit model are presented in Table 2. The model exhibited a good fit 
to the data (pseudo-R2 of 0.379). There was a strong underlying preference to attend a class 
compared to not attend as demonstrated by the significant constant term. Across the 1,080 
choice observations where participants had the option to opt-out of attending a class, they 
chose attending a class rather than no class 1,065 (99%) of the time. Out-of-pocket costs and 
whether a class was Aboriginal-specific were statistically significant predictors of choice 
between class options with higher odds of preferring a service compared to no service with 
every dollar decrease in out-of-pocket cost (OR 1.19 95%CI: 1.13-1.25) and when Aboriginal-
specific classes were provided (OR 1.25 95%CI: 1.04-1.46). Participants had a willingness to 
pay of $1.76 (95% CI: $0.68-$2.83) for an Aboriginal-specific service relative to a mainstream 
population session. The provision of transport did not statistically influence the choice of 
service (p=0.55). None of the interaction terms were significant predictors of the choices of 
participants nor improved model fit. The directions of the parameter estimates for the class 
characteristics regarding costs and cultural-specific care were in line with a priori expectations 
lending support to the internal validity of the model.  
4. Discussion 
Since the 1970s with the introduction of the first Aboriginal Medical Service, there has been 
a growing recognition of the importance of culturally-specific care to the health and wellbeing 
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of Aboriginal communities (Liaw et al., 2011). In spite of this, the value of funding a separate 
stream of Aboriginal-specific services when mainstream services already exist remains largely 
empirically untested (Angell et al., 2014; Mooney, 2009). This study has empirically 
demonstrated the preference of this Aboriginal cohort for a culturally-specific component of 
a fall-prevention program. In doing so, we have demonstrated the potential of these 
methodologies to incorporate Aboriginal preferences and value components of services 
important to target populations that lie outside traditional measures of health outcomes. 
Out-of-pocket costs and whether the class was Aboriginal specific were found to be significant 
predictors of the choices of participants. The results suggest that there was heterogeneity 
across the cohort preferences with significant deviations around the mean estimated 
coefficients. This is an important finding that needs to be further investigated and highlights 
the importance of community involvement and consultation in the provision of culturally-
specific services to ensure that they are meeting the needs of communities. While we were 
not able to collect information on the income of respondents, the relatively low WTP value 
for a culturally-specific class ($1.76) despite the significant preference for the cultural 
attribute likely reflects the constrained budgets of many in the cohort. The result reinforces 
the importance of cost as a major barrier to care facing this group.  
This study reflects difficulties encountered in previous work that have attempted to elicit 
preferences from older and otherwise marginalised populations (Haener et al., 2001; 
Mangham et al., 2009). The survey was developed utilising qualitative work, literature reviews 
and consultation with experts, Aboriginal researchers, community members and service 
providers but still required significant alteration following the piloting phase. The process 
highlight the need for caution in the design of DCEs to ensure that data collected reflects the 
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true preferences of respondents. Studies in different Aboriginal populations may be able to 
investigate the components of a culturally-appropriate service in more detail to derive 
important points for service design, delivery and evaluation. 
The specific nature of our cohort limits the generalisability of these findings to other 
Aboriginal communities. Participants were recruited from urban centres around NSW and it 
is likely that findings and importance of the attributes, particularly the transport attribute, 
would be different in other populations. We were limited by the amount of sociodemographic 
information that we could collect on respondents which could potentially provide greater 
insight into the preferences of respondents.  
5. Conclusion 
This represents the first published DCE in the health field of an Aboriginal-only cohort. 
Assuming equivalent efficacy of fall-prevention programs, this study demonstrates the 
relative importance of overcoming two major barriers to care known to face Aboriginal 
Australians: out-of-pocket costs and whether the class was culturally-specific. DCEs provide a 
tool that can aid in valuing culturally-specific healthcare, however, care is needed in the 
design and use of these methods to ensure the validity of the results. Evidence demonstrating 
the value of such factors lying outside the traditional health-outcome framework is vital for 
resource-allocation decisions and to inform the design of services for Aboriginal communities. 
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6. Tables 
Table 1 - attributes and levels used in final questionnaire 
Attribute  Level 
Cost 0 
 
5 
 
10 
Transport Yes 
 
No 
Culture Aboriginal-specific group 
 
Mainstream group 
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Table 2 - Discrete Choice 
Experiment Modeling 
Results 
Coefficient Odds 
Ratio 
p-value 
Mixed Logit Model    
Fixed Parameters   
 
Constant (preference for 
attending class as opposed 
to no class) 
3.18 
 
<0.001 
Transport Provided -0.06 0.94 0.55 
Random Parameters 
   
Cost of Class 0.17 1.19 <0.001 
Aboriginal Specific Class 0.22 1.25 0.04 
Pseudo-R2 0.379   
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CHAPTER 7: VALUING SOCIAL DETERMINANTS OF HEALTH 
 
CHAPTER OVERVIEW 
This chapter presents the findings of a contingent valuation study examining the value that 
Australians place on holding a driver licence. The chapter consists of a single manuscript titled: 
What is the value of a driver licence? A contingent valuation study of Australian adults.  
Incorporating social determinants of health into economic evaluations remains a debated 
issue in the health economics literature and has been highlighted as a key issue for the field 
of Indigenous health. This chapter addresses the final suggestion of Chapter 4 to investigate 
the potential of contingent valuation methodologies to value factors important to the health 
outcomes of Indigenous communities. Holding a driver licence is a vital part of life for many 
Australians and has been shown to be associated with positive health and other social policy 
outcomes in an Indigenous Australian population. This study investigates the monetary value 
that a cohort of Australian adults place on holding a driver licence and how such valuations 
vary on the basis of individual characteristics. This was done as a means of investigating the 
potential use of contingent valuation methods as a means of valuing services beyond health 
outcomes. The study was carried out to inform an ongoing evaluation of the driving change 
program which aims to overcome disparities in licencing rates across Indigenous communities 
around New South Wales. 
Holding a driver licence was found to be of substantial value to participants of this study (the 
mean value to avoid losing a licence for one year was $2,290). Given the link between 
licencing and wider social and economic opportunities, such programs can potentially play a 
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broad role in addressing social disadvantage and exclusion. Incorporating social determinants 
of health into the economic paradigm is essential for a holistic approach to overcoming 
Indigenous disadvantage in Australia. 
The questionnaire used in this study is reproduced in Appendix 7. 
AUTHOR CONTRIBUTIONS 
BA SJ RI conceived the idea for this analysis, BA designed the initial questionnaire with input 
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1. Abstract 
Background - Holding a driver licence is a vital part of life for many Australians, enabling 
access to employment, education and health services, as well as facilitating social 
connections. However, there is a lack of evidence about the value the community attaches to 
driver licences. This study investigates the monetary value that a cohort of Australian adults 
place on holding a driver licence and how such valuations vary on the basis of individual 
characteristics. 
Methodology – a contingent valuation study of 1,054 Australian adult licence holders (with 
an oversampling of Indigenous Australians) was carried out to derive the cohort’s willingness 
to pay (WTP) to avoid losing their driver licence for a period of one year. Interval regression 
analyses were undertaken to determine the association between a range of demographic and 
driving-related characteristics of respondents and their WTP valuations. 
Results – the cohort was representative of the Australian population in terms of state of 
residence and gender. Mean WTP based on the base model was $2,290 to avoid losing a driver 
licence for a year (95% CI $2,156 - $2,431). Indigenous participants had a mean WTP higher 
than other respondents ($2,789 as opposed to $2,240, p<0.001). Once individual 
characteristics were controlled for, however, there was no significant difference in the WTP 
results between Indigenous and non-Indigenous participants. WTP was significantly higher for 
respondents who drove multiple times a week ($396 higher WTP, p=0.012) than those who 
did not and who required a car for work compared to those who did not ($520 p=0.002). WTP 
increased with higher incomes and was greatest for those earning over $120,000 annually 
($1,352 higher than those earning under $40,000 per year, p<0.001). Those living in urban 
areas had a significantly lower WTP compared to non-urban residents ($407 lower than other 
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respondents, p=0.012) and WTP decreased with age ($14 lower per additional year of age, 
p=0.03). Those who had incurred a licence suspension in the past 5 years had significantly 
higher WTP ($1,686 p<0.001), than those who had not, and those who had incurred a traffic 
fine in the past 5 years reported a higher WTP than those who had not ($358 p= 0.032).  
Conclusions – holding a driver licence was found to be of substantial value to participants. 
This suggests that there are major opportunities to implement programs to promote 
licensing, its retention and address known disparities in licencing status across population 
groups, such as those faced by Australia’s Indigenous communities. Given the link between 
licencing and wider social and economic opportunities, such programs can potentially play a 
broad role in addressing social disadvantage and exclusion. 
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2. Introduction 
Significant variations in driver licensing rates exist across the Australian population with 
culturally and linguistically diverse populations experiencing lower rates of licencing than 
other groups in the Australian population. Aboriginal and Torres Strait Islander (Indigenous) 
Australians, for example, are far less likely than other Australians to hold a valid driver licence 
[1-5]. A range of barriers have been identified facing Indigenous Australians from obtaining a 
driver licence [6] and a growing literature has investigated the impacts that licencing rate 
differentials have on these communities. 
On top of the transport benefits to the licence holder, holding a driver licence has been shown 
to be associated with a range of positive social indicators including better employment, health 
and education outcomes for the licence holder [7]. Licencing-related offences play a major 
role in the involvement of disadvantaged populations in the criminal-justice system [6, 8, 9]. 
Indigenous Australians are over-represented in prison, and are incarcerated at a higher rate 
than non-Indigenous people for licensing and regulatory offences [10]. In 2011 the 
imprisonment rate for Indigenous people in New South Wales found guilty of a licensing 
offence was 12% compared to 5% for non-Indigenous people [11].  In response to these 
inequities and the importance placed on holding a licence, a number of interventions to 
improve licensing rates among marginalised groups have emerged [12, 13]. There is limited 
economic evidence demonstrating the value of such programs, however, casting doubt over 
the appropriate level of investment that should be directed to these interventions.  
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2.1 Contingent valuation 
Unlike market-based goods, there are no readily available market-prices for driver licences 
that can be used to assess the value that a community places on holding a licence. This is a 
common issue across many fields of applied economics including in the areas of 
environmental protection, health and transportation. Contingent valuation methodologies 
have been refined over recent decades as a method to value such non-market goods [14] and 
are typically used in cost-benefit analyses. Contingent valuation studies are based on stated-
preferences elicited through surveys in which respondents provide values that individuals are 
willing to pay for a certain good or service. While they are subject to a number of limitations, 
in particular regarding how accurately respondents represent their true WTP value with 
regards to a hypothetical situation, formal guidelines have been developed to minimise these 
shortcomings and a literature has developed demonstrating the validity of contingent 
valuation methodologies [15].  
2.2 Existing valuations  
There have been few published attempts to derive a value associated with holding a driver 
licence. Jörgensen and Wentzel-Larsen (2002) conducted a study of 1,287 Norwegian adult 
respondents who had access to a car to estimate what Norwegian drivers would be willing to 
pay in order to avoid losing their licence for six, twelve or twenty-four months [16]. The 
authors found that a driver’s WTP to avoid losing their driver licence increased significantly 
with income, dependence on the car for employment, the amount of driving experience, 
being male, younger and living in rural areas. To avoid losing their licence for two years, 
respondents were willing to pay the equivalent of approximately the average Norwegian 
monthly wage [17]. The authors elicited this value with a single open-ended question. The 
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validity of such a method has been challenged in the contingent valuation literature due to 
concerns over a number of biases and the reliability of the valuations elicited with referendum 
style questions believed to elicit more accurate values [14, 18]. No Australian-based estimates 
of the value of a licence were found in the literature.  
This paper investigates these issues through two major research questions. First, the study 
derives a value that a cohort of Australian adults place on holding a licence in the form of how 
much people are willing to pay to avoid losing their driver licence for a period of one year. 
Second, we examine how the WTP varies based on the individual characteristics of our cohort 
including Indigenous identity. 
3. Methods 
A contingent valuation study was carried out among a representative sample of Australian 
driver licence holders to estimate the WTP to avoid losing their licence for a period of twelve 
months. The study was approved by the Aboriginal Health and Medical Research Council 
ethics committee (964/13). 
3.1 Participants 
Adults (over the age of 18) holding a valid Australian driver licence for at least one year were 
eligible for inclusion in the study. Participants were recruited by a panel provider via email 
and completed the questionnaire through an online interface. The sample was purposively 
recruited to be representative of the general Australian population regarding their state of 
residence and age group. Indigenous Australians were deliberately oversampled to ensure 
adequate representation in the analysis and allow examination of differences between the 
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cultural groups given previous literature highlighting differential licensing rates between the 
two groups. All participants provided informed consent to participate in the study.  
3.2 Scenario and Questionnaire 
A questionnaire was developed based on standard techniques in the contingent valuation 
literature and adhering to National Oceanic and Atmospheric Administration (NOAA) 
guidelines [18] with the exception that the survey was conducted online rather than in 
person. While in-person interviews have traditionally been the recommended means through 
which data should be gathered in this type of study, more recent work in the CV literature has 
demonstrated the validity of using an online interface to conduct CV studies [19]. Participants 
were asked a series of demographic questions and then presented with a short description of 
the role that a driver licence plays in Australia. Respondents were asked to consider a 
hypothetical situation where they were facing the choice of a fine or a suspension of their 
driver licence (reproduced in Figure 1).  
Respondents were presented with a potential fine of either $700 or $7,000 and asked 
whether they would pay the fine, accept the licence suspension or if they were not sure which 
they would prefer. This range was selected based on actual potential fines that a person may 
incur in Australian justice systems, to ensure believability and acceptability of the 
hypothetical situation being presented. To minimise anchoring effects, where valuations are 
biased by the first value that participants see, respondents were split such that approximately 
half saw the $700 fine first and the other half saw $7,000 first. Participants who saw the 
lowest option first continued to see incrementally higher (with increments of $700) potential 
fines until they responded that they would not be willing to pay a fine of that level. For the 
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other group, they continued to see lower hypothetical fines (also $700 increments) until they 
responded that they would be willing to pay such a fine to avoid the licence suspension.  
After the final value was elicited, the respondents were asked the main reason for their 
valuation to identify protest responses and hypothetical bias where an erroneous value is 
provided in a hypothetical choice context. These responses were coded into six general 
categories (the relative size of the fine and the respondent’s budget, the value derived from 
the convenience that a licence represents, the relative access to other transport options, the 
need for the licence to get to work, protest responses and no response) highlighting the 
factors provided by respondents as underlying their valuations. The complete CV survey was 
piloted to ensure that the questions were understandable through an initial sample of 100 
respondents. No changes were made to the survey following this pilot and all responses were 
included in the final analysis. A sample size of 1,000 respondents was targeted to ensure the 
robustness of the results under CV guidelines and as we were advised that such a sample size 
was required to gain generalisable results across the Australian population. Respondents who 
responded ‘Not sure’ to all bids presented and did not accept or reject any bids were removed 
from the analysis as per standard guidelines. 
3.3 Econometric Model and Statistical Analysis   
Contingent valuation methodologies are based on theoretical underpinnings of utility 
maximisation where rational actors maximise their expected utility given their income 
constraints. We assume that each person, i, has a non-negative WTP to avoid losing their 
driver licence for a period of a year Yi* that depends on individual characteristics, Xi, such that 
Yi* =Xi β + εi where εi is assumed to be normally distributed with a mean of zero. While we do 
not observe the exact willingness to pay of each respondent, each valuation is known to lie in 
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a specified interval between the highest bid that they accepted and the lowest bid that they 
rejected (or zero for those who do not accept any bids). For participants who accepted the 
highest bid offered ($7,000) the likelihood WTP of the individual is given by Pr($7,000 ≤ Xi β + 
εi).  
The interval regression method has been used for similar WTP data in the contingent 
valuation literature [20]. The maximum likelihood function was estimated using interval 
regression methods in STATA 13.1 controlling for observed individual characteristics of 
participants including their age, income, employment, race, gender, age, income group, 
dependence on their car for work, self-reported access to other transport options, occasions 
of driving per week and previous traffic infringements of the respondent. Bootstrapped 
standard error (500 replications) was used to calculate the 95% CI on mean WTP. Responses 
from Indigenous participants were compared to non-Indigenous using student’s t-test to 
examine differences in responses. The baseline model presented is based on all variables 
significantly associated with the outcome variable in univariate analysis (p<0.25). The second 
model presented was derived from the initial model using backwards stepwise regression 
techniques to remove all variables not significantly associated with the outcome using the 
more restrictive level of significance p<0.1.  
3.4 Sensitivity analysis 
To test the robustness of the results, protest responses, for example where respondents 
asked why they would pay to hold a licence when they never have before or criticising the 
exercise as government revenue raising, were identified and removed to test the impact on 
our estimates.  
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4. Results 
4.1 General Characteristics  
Table 1 provides an overview of participants in the study. In total 1,054 individuals completed 
the contingent valuation questionnaire of which 97 (9.2%) identified as an Indigenous person 
and 52% were female. Fifty-eight percent (611 respondents) were presented with a starting 
bid of $7,000 with the remainder seeing a first bid of $700. The average age of respondents 
was 45 years and on average respondents reported that they had held a driver licence for 25 
years. Ninety-two percent of respondents owned their own car and 38% responded that they 
needed their car for work. Almost 30% of participants had been issued a traffic-related fine in 
the previous five years (just under 97% of these respondents reported that they had paid the 
fine) and over 5% had had their licences disqualified over the same period. The sample was 
consistent with the general Australian population proportions in terms of state of residence 
and gender. Our sample had a higher proportion of Indigenous Australians than the general 
population (9% as opposed to 3%). Twenty-seven respondents (2.6%) did not reject or accept 
any bids shown (answered ‘not sure’ to every bid) and were removed from the analysis. 
4.2 Willingness to Pay  
Almost half of the respondents (49.6%) had a lowest rejected bid (upper bound WTP) of 
$1,400 or less while 17.3% did not reject any value such that they had a WTP of $7,000 or 
greater. Table 2 shows the results of the interval regression analysis. Mean WTP for this 
cohort from the baseline model was $2,290 to avoid losing a driver licence for a year (95% CI 
$2,156 - $2,431). Indigenous participants had a mean WTP higher than other respondents 
($2,789 as opposed to $2,240, p<0.001). Once the variables included in the baseline model 
were controlled for, there was no significant difference in the WTP results between 
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Indigenous and non-Indigenous participants. WTP was significantly higher for respondents 
who drove multiple times a week ($396 higher WTP than others, p=0.012) than those who did 
not and who required a car for work compared to those who did not ($520 p=0.002). WTP 
increased with higher incomes and was greatest for those earning over $120,000 annually 
($1,352 higher than those earning under $40,000 per year, p<0.001). Those living in urban 
areas had a significantly lower WTP compared to non-urban residents ($407 lower than other 
respondents, p=0.012) and WTP decreased with age ($14 lower per additional year of age, 
p=0.03). Those who had incurred a licence suspension in the past 5 years had significantly 
higher WTP ($1,686 p<0.001), than those who had not, and those who had incurred a traffic 
fine in the past 5 year reported a higher WTP than those who had not ($358 p= 0.032). 
Respondents who were presented with the high bid first of $7,000 had a WTP $640 higher 
than other respondents (p<0.01). The gender of the respondent, whether they had a 
university degree or were a full-time student, if they were unemployed or retired, if they had 
access to other forms of transport and if they were Indigenous were all insignificant predictors 
of WTP and were not included in the second model presented in Table 2. The reasons 
provided behind the valuations of respondents are summarised in Table 3.   
4.3 Indigenous Status 
As shown in Table 4, without controlling for other characteristics, Indigenous participants had 
a mean WTP higher than other respondents ($2,789 as opposed to $2,240, p<0.001). Once 
the variables included in the baseline model were controlled for, there was no significant 
difference in the WTP results between Indigenous and non-Indigenous participants. 
Indigenous participants were significantly more likely to report a licence suspension in the 
past five years (24% as opposed to 4%, p<0.001), less likely to live in urban areas (57% to 77%, 
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p<0.001), less likely to have an annual income of over $80,000 (30% to 43%, p=0.01) and were 
younger on average (39 compared to 46, P<0.01) than other participants. 
4.4 Sensitivity Analysis 
Fifty-eight respondents were identified as protest responses and removed from the analysis 
to test the robustness of the findings. With these respondents removed the mean WTP was 
higher at $2,365. This did not have a major impact on the significance of specific variables 
(results included in appendix). 
5. Discussion 
This study has derived a value that a cohort of Australian adults place on holding a driver 
licence for a period of 12 months. Our cohort was found to have an average WTP valuation of 
$2,290 (95% CI $2,156 - $2,431) which equates to approximately 150% of the Australian 
fulltime average pre-tax weekly earnings [21]. Valuations varied across individual level 
characteristics in ways that would be expected. Variables that were associated with a person’s 
dependence on driving including: i) driving multiple times a week; ii) living in non-urban areas 
where transport may be less accessible; iii) requiring their car to work; and iv) whether the 
respondent lived alone or with dependent children were associated with a higher WTP. 
Individuals with higher incomes had a higher WTP than other individuals while older, retired 
and unemployed individuals had a lower WTP on average.  
Those previously exposed to a licence suspension or traffic fine had significantly higher WTP 
than those who had not. Previous literature has found that those who experience a fine or 
other such sanction exhibit safer behaviours afterwards which could be interpreted as an 
increase in the value they attach to holding their licence [22]. Such a result is also consistent 
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with findings of contingent valuation studies in other fields, in particular environmental 
economics where WTP valuations have been shown to be consistently higher for individuals 
who have experienced the environment they are attempting to value [23]. In this case, it may 
be that those who have experienced a licence suspension are better able to appreciate the 
impacts that it has on their life or are more open to the hypothetical situation presented. This 
was highlighted by one respondent to the open-ended question asking for the reasons behind 
their valuation: ‘I lost my licence for 3 months before and it was really difficult. $7000 is a lot 
of money but for a period of 1 year it would probably be beneficial.’ It may also suggest that 
respondents who had not been exposed to these outcomes were potentially less informed of 
the flow-on consequences of disqualification. 
As a driver licence has not traditionally been valued in this way, it is important to understand 
what people were considering when they provided their valuations. The WTP to hold onto 
their driver licence will reflect a variety of factors including attitudes towards the law and 
potential acceptance of driving without a licence. Responses to the open-ended question at 
the end of the survey suggest that people were primarily weighing up the benefits of being 
able to legally drive relative to the size of the potential fine and their budget constraints. 
Many highlighted the relative ease of access (or otherwise) to other transport options. Others 
noted the administrative hassle and lost convenience associated with losing a licence. No 
participants mentioned the possibility of driving while unlicensed suggesting that this was 
perhaps either not a key consideration for many of the cohort in determining their value or 
they did not feel comfortable declaring this in the questionnaire. 
Incorporating social determinants of health into health economic research has been 
highlighted as a priority repeatedly in the literature [24-26] as have the difficulties in doing so 
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[26]. In particular, the importance of factors lying outside the remit of traditional health 
interventions or health economic evaluations to the health of Indigenous populations in 
Australia is widely accepted [24]. Holding a driver licence is an example of such a factor with 
recent literature highlighting the importance of a licence to an individual and associations 
with a range of positive social, health and wellbeing outcomes in Indigenous populations [7]. 
The methodology used in this study provides an example of how to value such social 
outcomes for use in economic evaluation. Through the use of contingent valuation 
techniques, we have been able to demonstrate the value of a social outcome that has 
traditionally lain outside the remit of health economic evaluation. 
The results of this study have provided a basis for the valuation of programs aimed at 
overcoming licensing disparities across populations. Indigenous participants in our cohort had 
a higher WTP value than other respondents on average. This predominantly reflects a higher 
level of licence suspensions and respondents residing in non-urban areas in this group, both 
of which factors were significantly associated with higher WTP in this study. Once these and 
other individual characteristics were controlled for the difference in WTP of Indigenous and 
non-Indigenous participants was not significant. Our results, however, still demonstrate the 
substantial value associated with holding a licence for these Indigenous individuals and the 
cohort of our study more generally. Structural issues that have led to persistent disparities in 
the rate of driver licensing, such as those seen between Indigenous and non-Indigenous 
Australians, are likely to be having significant impacts on individuals within communities 
experiencing lower rates of licensing. The WTP value found in this study suggests that, on 
average, individuals were associating almost $2,300 worth of benefits with holding a driver 
licence for one year. Programs designed to overcome barriers to licensing for affected 
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communities, for example Indigenous communities in Australia, are likely to be particularly 
valuable when these results are considered. The results also highlight the potential 
effectiveness that the threat of a licence suspension might have as a deterrent against driving 
related offences. Variation in the effectiveness of such a deterrent across the population is 
likely, with those more dependent on their car and those who have previously experienced a 
licence suspension or traffic fine more likely to be deterred (and subsequently impacted) by 
the threat of a licence suspension. 
There are several limitations to this analysis. There are known downsides to contingent 
valuation studies generally and this study is not immune to these, though attempts were 
made to minimise many of the likely biases. There was clear anchor or starting point bias in 
the valuations provided, with those who saw the higher potential bid first having a WTP $640 
higher than others. While we could control for this in our analysis, the starting bids that 
people saw evidently played a role in the final value elicited suggesting that the WTP values 
elicited were possibly biased by the range of fines presented ($700 - $7,000). Our sample, 
though reflective of the Australian population in terms of state of residence and gender may 
not be reflective of the broader Australian population nor of the Australian Indigenous 
population in other ways and this might affect the generalisability of our findings. Further, 
there are always concerns over the accuracy of responses in stated preference studies and 
this study is no exception. The fact that most respondents highlighted the considerations they 
were using to obtain a WTP value suggests that they were weighing up the costs and benefits 
of a driver licence to them. Finally, the WTP question in this study was framed in terms of 
respondents facing a loss of their licence rather than the gain of a licence for non-holders. 
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Previous research suggests that this is might lead to higher valuations due to the premium 
attached to loss aversion [27].  
6. Conclusion 
Through contingent valuation methods, we have been able to quantify the value that this 
cohort of Australian adult drivers attached to holding a driver licence. The high values given 
by respondents suggest that there is strong recognition within the community of the major 
flow-on effects of licencing in terms of economic and social empowerment. The findings of 
the study provide support for licencing programs and the potential role they play in 
addressing the cycles of disadvantage experienced by many communities. 
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7. Tables and Figures  
  
Please read the following and then answer the questions that follow 
Holding a valid driver’s licence is necessary to legally drive on Australian roads. It 
is estimated that approximately 7 in 10 Australians aged 18 years and over travel 
to work or full-time study primarily in private cars.1  
Given the importance that holding a licence and driving more generally holds for 
many people in Australian society, it is important that the value of holding a 
licence is fully recognised. The aim of this survey is to obtain a dollar value of 
having a licence from members of the general public. This will help us guide 
policies and programs that will help people attain and ultimately keep their 
licences.    
For the following questions, please consider yourself in a hypothetical situation 
where you face suspension of your licence for a period of 12 months. Over this 
time you will not be able to legally drive on Australian roads using any vehicle. 
Figure 1 - Hypothetical situation presented to respondents 
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Table 1 - General characteristics of study 
participants 
n % 
Total Participants 1,054 100% 
Female 544 52% 
Age Group 
  
18-24 137 13% 
25-34 196 19% 
35-44 210 20% 
45-54 186 18% 
55-64 142 14% 
65 plus 183 17% 
Aboriginal and Torres Strait Islander  97 9% 
Full time Student 97 9% 
Income 
  
<$40,000 254 24% 
$40,001 - $60,000 184 18% 
$60,001 - $80,000 173 16% 
$80,001 - $100,000 168 16% 
$100,001 - $120,000 99 9% 
>$120,000 176 17% 
Education 
  
Left school before year 12 154 15% 
Year 12 or equivalent 196 19% 
Trade Certificate or diploma 321 31% 
Holding a university degree 383 36% 
Employment Status 
  
Yes - fulltime 413 39% 
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Yes – Part-time or casual 210 20% 
Yes – self-employed 55 5% 
Retired 205 19% 
Unemployed 171 16% 
Require a licence to work 404 38% 
Previous Licence suspension (past 5 years) 57 5% 
Previous traffic-related fine (past 5 years) 314 30% 
Own their own car 972 92% 
State of residence   
Australian Capital Territory 20 2% 
New South Wales 346 33% 
Northern Territory 10 1% 
Queensland 205 19% 
South Australia 83 8% 
Tasmania 29 3% 
Victoria 267 25% 
Western Australia 94 9% 
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Table 2 - Interval regression results for WTP to avoid losing driver licence for 12 months 
 
Full Model (everything significantly 
associated with outcome in univariate 
analysis) 
Significant variables only (p<0.1) 
Variable Coefficient P 
value  
Lower 
95% CI 
Upper 
95% CI 
Coefficient P 
value  
Lower 
95% 
CI 
Upper 
95% CI 
Age -14.94 0.017 -27.22 -2.66 -12.95 0.006 -22.13 -3.76 
Male 129.94 0.381 -160.70 420.58 
    
University Degree 29.96 0.855 -290.87 350.80 
    
Unemployed -277.51 0.227 -727.55 172.53 
    
Retired 134.15 0.622 -399.68 667.99 
    
Living with dependent 
Children 
183.64 0.274 -145.64 512.92 
    
Living alone 484.66 0.025 59.77 909.55 409.83 0.043 763.95 1,622.30 
Full time student 74.54 0.782 -454.11 603.18 
    
Require a licence to work 558.80 0.001 234.75 882.85 605.40 0.000 358.43 931.75 
Traffic Fine in the last 5 
years 
389.16 0.017 70.23 708.10 401.25 0.014 106.81 940.65 
Licence suspension in past 
five years 
1,583.18 <0.001 888.19 2,278.18 1,533.01 <0.001 129.96 735.17 
Owning their own car 477.69 0.090 -74.21 1,029.59 532.06 0.057 -4.06 1,051.38 
Income         
    
Under $40,000 p.a. Reference 
group 
      
    
$40-60,000 p.a. 323.36 0.162 -130.28 777.00 
    
$60-80,000 p.a. 652.24 0.007 175.34 1,129.14 523.73 0.014 12.02 807.65 
$80-100,000 p.a. 775.42 0.003 261.78 1,289.07 675.44 0.002 -
689.12 
-24.75 
$100-1200,000 p.a. 599.15 0.055 -13.72 1,212.03 523.66 0.052 294.82 915.98 
Over $1200,000 p.a. 1,277.30 <0.001 745.39 1,809.22 1,193.12 0.000 82.03 720.47 
Drove multiple times a 
week 
395.71 0.012 87.40 704.02 432.56 0.005 854.30 2,211.71 
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 Table 3 - factors raised by respondents 
affecting their valuations 
Number of 
respondents 
% 
The size of the fine and impact on their budget 637 60.4% 
Convenience of having a licence 43 4.1% 
Relative access to other transport options 18 1.7% 
Need a licence to get to work 34 3.2% 
Protest Response 58 5.5% 
No answer or unclear answer 264 25.0% 
 
 
 
 
 
 
 
 
 
Access to any transport -5.52 0.988 -748.87 737.83 
    
Saw the high bid first 640.04 <0.001 352.94 927.13 645.09 <0.001 -15.50 1,079.62 
Urban -397.55 0.021 -734.74 -60.36 -356.93 0.035 242.14 1,108.74 
Indigenous -15.46 0.952 -522.40 491.48 
    
Constant 1,068.14 0.064 -62.38 2,198.65 1,115.37 0.002 396.71 1,834.03 
Table 4 - WTP and selected 
demographic information by 
Indigenous status for respondents 
in analysis 
Aboriginal and 
Torres Strait Islander 
Respondents 
Non-
Indigenous 
p-value for 
difference 
Participants 97 931 NA 
Mean WTP $2,789 $2,240 <0.001 
Licence Suspension 24% 4% <0.001 
Traffic Fine 39% 29% 0.06 
Gender 43% 49% 0.22 
Average age 39 46 <0.001 
Urban 57% 77% <0.001 
Income over $80,000 30% 43% 0.01 
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8. Appendix – Sensitivity Analysis Results 
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Interval regression results for WTP to avoid losing driver licence for 12 months with protest responses removed 
 
Full Model (everything significantly associated 
with outcome in univariate analysis) 
Significant variables only (p<0.1) 
Variable Coefficient P 
value  
Lower 
95% CI 
Upper 
95% CI 
Coefficient P 
value  
Lower 
95% CI 
Upper 
95% CI 
Age -14.06 0.030 -26.73 -1.38 -9.38 0.048 -18.66 -0.09 
Male 157.74 0.303 -142.65 458.12     
University Degree 8.88 0.958 -321.36 339.12     
Unemployed -310.13 0.188 -771.67 151.40     
Retired 71.55 0.801 -485.42 628.52     
Living with dependent 
Children 205.79 0.237 -135.12 546.69 
    
Living alone 569.05 0.011 129.05 1,009.06 510.40 0.016 95.45 925.36 
Full time student -29.47 0.914 -566.74 507.81     
Require a licence to work 520.47 0.002 186.02 854.91 600.31 <0.001 281.74 918.87 
Traffic Fine in the last 5 
years 358.36 0.032 31.14 685.58 382.99 0.022 56.09 709.89 
Licence suspension in 
past five years 1,686.13 <0.001 959.33 2,412.94 1,635.46 0.000 928.22 2,342.70 
Owning their own car 403.93 0.171 -174.33 982.19     
Income         
Under $40,000 p.a.         
$40-60,000 p.a. 379.94 0.112 -88.40 848.28 423.83 0.071 -35.72 883.39 
$60-80,000 p.a. 736.35 0.003 244.43 1,228.27 797.22 0.001 318.61 1,275.83 
$80-100,000 p.a. 809.07 0.003 279.14 1,339.00 936.09 <0.001 441.05 1,431.13 
$100-1200,000 p.a. 648.24 0.046 12.48 1,284.01 780.19 0.009 190.67 1,369.71 
Over $1200,000 p.a. 1,351.86 <0.001 801.28 1,902.44 1,492.02 0.000 997.17 1,986.87 
Heavy car user 406.92 0.012 90.14 723.71 477.68 0.002 169.25 786.11 
Access to any transport -85.25 0.827 -851.98 681.49     
Saw the high bid first 785.71 <0.001 491.14 1,080.28 794.10 <0.001 500.10 1,088.11 
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Urban -406.88 0.022 -754.71 -59.04 -406.21 0.020 -748.64 -63.79 
Indigenous -73.82 0.782 -597.24 449.59     
Constant 1,154.56 0.051 -2.80 2,311.92 1,212.97 <0.001 550.93 1,875.00 
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CHAPTER 8: DISCUSSION AND CONCLUSIONS 
Chapter Overview 
Building on the findings of each study, this chapter provides a summary of the findings of 
the thesis as a whole. The important contributions of the work are discussed as are the 
strengths and limitations of the thesis. Finally, this chapter concludes with the implications 
for future research and primary conclusions of the thesis. 
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Main findings of thesis 
Considerable policy attention has focused on efforts to overcome the disparities in health 
outcomes experienced by Indigenous Australians. Both sides of politics have committed to 
overcoming these disparities and a succession of public policies have seen significant 
resources devoted to doing so. Nonetheless overcoming Indigenous disadvantage in 
Australia has, to date, proven to be an elusive aim and Australia’s Indigenous communities 
continue to face poorer outcomes across the health and social policy spectrum [1]. In spite 
of the policy importance of the issue, there has been relatively limited economic research in 
the field of Indigenous health making it difficult to ascertain the cost-effectiveness of 
existing or potential policy interventions. This poses difficulties for decision makers looking 
to maximise the health of Indigenous populations with available resources. While this is 
disappointing given the impact of economic research and evidence in other policy areas and 
the concerted policy effort to overcome Indigenous disadvantage in Australia, the work of 
this thesis has demonstrated that there is clear potential for health economic methods 
refined in other areas to be used in the field of Indigenous health. In doing so there is the 
potential for the health economics field to have a dramatic impact on public policy and, 
more importantly, help achieve a significant improvement in the health and wellbeing of 
Australia’s Indigenous communities. 
This chapter draws together the main findings from the studies that make up this thesis. The 
chapter begins with an analysis of the important contributions of this thesis under the sub-
headings of the objectives of this work laid out in Chapter 1 before examining some of the 
difficulties encountered in this research as a means of putting the results of the studies in 
this context and analyse some of the reasons behind the relatively limited economic 
evidence base in the sector. The strengths and limitations of the work as a whole are 
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outlined before the chapter puts forwards suggestions for future research and policy and 
the main conclusions of the thesis. 
Primary contributions of this thesis 
This thesis has made significant contributions to the existing health economics and 
Indigenous health literature. The major contribution of the work has been in building a 
comprehensive case for economic research in the field of Indigenous health and 
consideration of the concept of value in Indigenous health policy. While there have been 
calls in the existing literature to better target health system resources available to improve 
the health of Indigenous communities [2, 3], this thesis has furthered and developed these 
arguments through a comprehensive analysis of the existing literature. The thesis has also 
demonstrated, in some cases for the first time, that a number of health economic methods 
can be validly used in Indigenous populations or to incorporate Indigenous preferences to 
value factors that are important to the health or healthcare of these communities.  
Objective one: Investigate the role of health economics in Indigenous populations with 
particular focus on the methods that have been used to value the health of Indigenous 
communities and the healthcare services provided to these groups. 
Given the importance of economic evidence for the field of Indigenous health, it is vital that 
an accessible evidence base exists containing all the available evidence. To this end, this 
thesis represents an attempt to substantially expand the nature of the economic evidence 
available in the field of Indigenous health. Chapter 2 presented the result of a systematic 
review of the published health economic evaluation literature of interventions to improve 
the health of Indigenous populations around the world [5]. Chapter 3 presents a systematic 
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review of the use of health-related quality of life (HRQoL) instruments in global Indigenous 
populations [6]. Both represent the first time these studies have been collated in the 
published literature and are complemented in this thesis by the narrative review of relevant 
health economics literature of Chapter 1.  
Unfortunately, given the importance of economic evidence to rational policy making, a 
recurring theme to emerge from the work of this thesis has been the finding that there has 
been limited economic research carried out in Indigenous populations to date. All three of 
these chapters highlighted limited economic work in the field of Indigenous health. Chapter 
5 represented one of the few examples in the published literature using linked data to 
analyse the healthcare resource utilisation of a high-risk cohort of Indigenous and non-
Indigenous individuals. The analysis presented in Chapter 6 represents the first discrete 
choice experiment (DCE) in the health field conducted in an Australian Indigenous 
population. Similarly, the best way to value social determinants of health which have been 
demonstrated as particularly important to the health of Indigenous Australians as 
demonstrated in Chapter 7, remains debated in the literature [7]. 
Difficulties in conducting economic work in Indigenous health 
While a developed economic evidence base to inform policy decisions in the sector would 
be ideal there are a range of clear difficulties associated with developing such a base ranging 
from logistical challenges to more fundamental issues around health economic theory. At a 
practical level, there are logistical challenges facing those wishing to carry out economic 
research in Australian Indigenous communities. These overlap with many of the difficulties 
faced by those carrying out research in Indigenous populations generally [8]. Recruitment 
difficulties, under-identification and thus small sample sizes are common in Indigenous 
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populations given that Indigenous Australians account for three percent of the total 
Australian population [9]. This poses challenges for empirical studies including those using 
economic methods. This is confounded by the fact that there is a larger proportion of 
Indigenous Australians living in remote areas relative to other Australians, further 
marginalising these groups who are harder to contact and living in small communities [9]. 
Combined, these issues can have a crippling effect on empirical studies in Indigenous health.  
Data linkage of routinely collected datasets is one potential solution to these issues. To gain 
a comprehensive view of the healthcare system experienced by Indigenous Australians 
studies need to account for hospitalisations and other state-based and Commonwealth 
healthcare expenditure. Comprehensive data linkage, however, is not always possible and 
often expensive and time consuming when it is. While this is common to research being 
carried out in other Australian population groups there are challenges relating to Indigenous 
populations specifically. There are particular concerns associated with identifying the 
services being provided and received in remote Indigenous communities as Pharmaceutical 
Benefit Scheme (PBS) and Medicare Benefits Schedule (MBS) data do not cover all relevant 
services being provided to and accessed by these communities [10-12]. Services provided by 
culturally-specific providers in particular may be funded through different streams of 
revenue and are thus hard to compare across population groups and available data may not 
be granular enough to identify services being received by particular communities or 
individuals. These issues were encountered in the analysis presented in Chapter 5 where, 
despite data linkage between trial, MBS and PBS datasets, we were not able to ascertain the 
level of services being received (or paid for) in remote Indigenous communities. Further 
complicating these issues there are noted concerns about under identification of Indigenous 
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patients in hospital data collections in particular [13-16], presenting further difficulties for 
those conducting empirical research in this area.  
The acceptability of health economics techniques to Indigenous populations is another 
challenge facing researchers in the field. These challenges were most evident in the work 
presented in Chapter 6 from the process of developing and running a DCE in an older 
Indigenous group receiving a fall-prevention intervention. Extensive work was required to 
develop, refine and pilot the questionnaires to ensure they were adequately capturing the 
values and preferences of the cohort being surveyed. Ultimately, after extensive testing and 
feedback, the experiment came down to a choice between two classes that differed only on 
the basis of three attributes with a maximum of three levels, a very basic design. This is 
consistent with international literature which has highlighted the importance of expansive 
DCE development and piloting to ensure understanding and accurate elicitation of 
preferences in marginalised populations [17].  
At a theoretical level, the health economic evidence that was found in the existing literature 
has generally not incorporated Indigenous-specific conceptions of health nor factors that 
have been highlighted as important to the health and healthcare of Indigenous communities 
including community ownership and engagement as well as broader social determinants of 
health [4, 5]. This has led to health economic methods being criticised as potentially 
unsuitable for use in Indigenous populations [18].  
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Objective two – Analyse the role of rights-based as opposed to economic arguments on 
Indigenous health policy to date in Australia. 
While it has tended to be an emotive area of public policy, the shortcomings of relying on 
non-economic evidence for policy decisions relating to Indigenous health have been 
highlighted throughout this thesis. Specifically, the thesis has posited that rights-based 
arguments – in which the funding for programs is justified on the basis of human rights 
arguments – alone provide little guidance for policy makers on how to prioritise funds 
amongst available interventions to maximise the benefit for Indigenous Australians. Such 
arguments tell us little for instance about  which interventions or policies to stop funding or 
the amount of investment required to overcome these disparities [4].  
Economic evidence is vital in this regard as it demonstrates the relative costs and 
effectiveness of different policy options and can thus provide guidance on the most 
effective means of using the scarce resources available to improve Indigenous health in 
Australia. The health of Australia’s Indigenous populations can only be maximised through 
the appropriate targeting of resources to policies and interventions that represent the most 
effective use of those resources. Further, at a pragmatic level, the political debate over 
funding for Indigenous health services will only be won with evidence that the resources 
allocated to it represent good value to the community. It is likely that this may require 
disinvestment in certain programs that do not represent value for money investments to 
improve the health of these population [4]. It will require an understanding of what does 
constitute cost-effective interventions in Indigenous communities, an understanding of the 
services being received by these populations, where the gaps are and what is valued by 
Indigenous Australians with regard to their health and health care. Importantly the 
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techniques examined through this thesis allow for the incorporation of the preferences and 
values of Indigenous Australians into the design and evaluation of programs and 
interventions designed to overcome Indigenous disadvantage in Australia. 
Objective 3 – Examine the feasibility of using established methods to develop notions of 
economic value in the field of Indigenous health by incorporating the values and 
preferences of Indigenous populations with regard to their health and healthcare. 
These difficulties, however, mirror those which have been encountered and overcome in 
other populations and are not necessarily a valid argument to not use economic tools which 
can provide insights and guidance that has, to date, been missing from Indigenous health 
policy in Australia. In the face of these challenges and the relatively limited health 
economics work in the published literature to date, another major contribution of this thesis 
lies in demonstrating that a range of health economic methods can be robustly used in 
Indigenous populations or to value factors outside of traditional health outcomes that have 
been shown to matter to Indigenous people with regard to their health.  
Chapter 2 demonstrated that health economic evaluations can be used to ostensibly 
demonstrate the relative cost-effectiveness of interventions into Indigenous populations [5]. 
This is a vital finding demonstrating the potential for these techniques to allow policy-
makers greater insight into resource allocation decisions to improve Indigenous health. 
Economic evaluations were successfully found to be used to demonstrate the cost-
effectiveness (or otherwise) of interventions to improve Indigenous health, however, there 
was limited evidence that studies were incorporating Indigenous conceptions of health or 
other factors important to the health of Indigenous communities lying outside traditional 
measures of health outcomes. The chapter calls for further work to identify the 
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appropriateness and potential of health economic techniques used to elicit patient values 
and preferences for potential use in Indigenous populations. 
This was taken up in the subsequent chapters of the thesis. Chapter 3 demonstrated the 
extent of use of HRQoL instruments in Indigenous populations around the world [6]. 
Chapter 5 empirically investigated the service use of a cohort of Australians at high-risk of 
cardiovascular disease [19]. We were able to control for the risk profile of the individual 
participants to a much greater degree than has previously been done in the published 
literature in order to compare the relative utilisation of the cohort of Indigenous and non-
Indigenous Australians to gain an insight into the performance of the health system in 
working to close the gap in outcomes between the two groups.  
Chapter 6 represents the first known DCE in the health field conducted in an Australian 
Aboriginal population. While the work encountered many of the challenges described 
above, we were able to derive a value for the culturally-specific component of a fall-
prevention program. The work of the chapter suggests that the provision of culturally-
specific services could have a large impact on the engagement of Indigenous communities 
with health services. Despite the small sample size, the work has been accepted for 
presentation at both the 6th Meeting of the International Academy for Health Preference 
Research and the International Health Economics World Congress highlighting the interest 
in the area, acceptability of the research and importance of this finding. Appendix 5 
represents another means of incorporating Indigenous values [20]. The paper demonstrated 
that Indigenous-led programs can be effective in in improving the health of Indigenous 
populations. Similarly, the study included in Appendix 2 demonstrated that a community-led 
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mobile dental service can be effective in overcoming barriers known to face Indigenous 
communities attempting to access health care services [21]. 
Finally, Chapter 7 successfully utilised contingent valuation methods to robustly derive a 
value for a social determinant that has been demonstrated to be associated with the health 
outcomes of Indigenous Australians. The work of the thesis is in line with respective 
guidelines for best practice analysis using each of the different methods employed. The 
studies presented in Chapters 2-7 (as well as the studies included as appendices) have been 
published or are under review at various international journals. The finding that these 
methods can be successfully used in Indigenous populations is an important one for the 
field. On the other hand, the need for caution in the design of these studies and the need to 
prepare for the difficulties associated with research in this area to ensure that they are 
measuring what they are attempting to is also vital.  
Implications for the health economics and Indigenous health fields  
The work of this thesis taps into broader issues facing the health economics field. In 
particular, ongoing debates in the literature on how to best incorporate equity issues into 
health economic research and more generally on developments in the field to move beyond 
narrow outcomes in measures of cost-effectiveness. As discussed in Chapter 1, the best 
means to incorporate equity concerns into resource allocation decisions in health systems 
around the world remains debated in the literature. Many of these issues came up through 
the work of this thesis. While the vertical equity funding mechanisms used in many 
Australian jurisdictions to preferentially fund treatment to Indigenous Australians were 
raised in the study of Appendix 3 as an example of only a few cases of successfully 
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incorporating equity concerns into a priority-setting process around the world [22], it is 
clear that further work is needed before a consistent approach to doing so is realised.  
The studies included in the thesis have contributed to this debate in several ways. Chapter 3 
found few included studies had attempted to incorporate broader measures of benefit than 
narrowly defined outcome measures in the economic evaluation literature investigating 
Indigenous health. One included study, however, had attempted to incorporate broader 
factors of healthcare important to the target population being studied using a cost-
consequence analysis [23]. Another study found through the same review reported 
qualitative findings alongside the review as a means of broadening the focus of the study to 
demonstrate factors outside measures of health outcome that were important to the study 
population [24]. While both these approaches suffer from shortcomings, at least from a 
health economic view of priority setting, as a result of a lack of empirical value or clear 
decision rule to emerge from such studies, qualitative research has been particularly 
important in Indigenous health policy to date. This has been particularly true with regard to 
building the case for culturally-specific care providers, documenting barriers to care facing 
Indigenous Australians and highlighting shortcomings in current policies.  
The depth of this literature as well as the extensive observational literature examining the 
burden of disease in Indigenous Australian communities are a major strength and should 
form the basis for further health economic research in the sector. The health economic 
techniques explored through this thesis can be used to apply notions of relative value, 
importance and benefit of these factors identified in the qualitative literature. Identifying 
the trade-offs that target populations are willing to make for these components and 
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considerations of the relative value for money that they represent are vital considerations 
for the field.  
Through the work of this thesis it has become clear that there are a number of issues facing 
policy makers and researchers looking to ascertain the best means to use available 
resources to improve the health of Indigenous Australians. Given the scarcity of existing 
literature and the heterogenous populations of the empirical studies included in this thesis, 
limited specific policy recommendations can be drawn directly from the work. There were, 
however, a number of findings that repeated themselves through the work. Outreach 
programs were found to be consistently cost-effective in the review presented in Chapter 2 
[5]. Similarly, the importance of culturally-specific providers was demonstrated repeatedly 
throughout the thesis. In spite of a strong qualitative evidence base demonstrating their 
importance, however, there remains limited published understanding of what these 
providers should look like in practice and the empirical value that these services provide 
relative to mainstream healthcare providers. Specifically, the benefits of such providers 
included factors lying outside traditional measures of health outcomes that have not been 
well measured or valued in the existing literature. 
DCEs represent the technique that demonstrate potentially the greatest potential for both 
incorporating the preferences and values of Indigenous populations as well as the relative 
importance of different components of health, healthcare and other factors to these 
populations. There is great potential for these techniques to be used in both a service 
design as well as evaluative capacity with regard to culturally specific service providers in 
particular. Similarly, the work of Chapter 7 has highlighted the potential of contingent 
valuation techniques to value factors that have tended to lie outside economic evaluations 
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but which have been demonstrated as particularly important to Indigenous Individuals. 
Using broader HRQoL measures is another option that has shown some potential to 
incorporate qualitative results and factors lying outside traditional narrowly defined health 
outcome measures into empirical studies as described in Chapter 3 [6]. However, few of the 
included measures found through this review attempted to significantly address arguments 
raised previously in the literature regarding different sociological structures of Indigenous 
populations that suggest Indigenous conceptions of health are significantly different from 
biomedical or Western notions of health that has led others to argue that there needs to be 
a fundamental rethink of the way that quality of life measures are used if they are to be of 
use in these communities [18]. Further research of these issues is needed prior to ensure 
the applicability of these measures in these communities. 
The focus on social determinants of health is crucial to closing the gap in outcomes between 
Indigenous and non-Indigenous Australians. Far higher rates of incarceration, for example, 
remains a major factor affecting the health and wellbeing of Indigenous Australians. Calls for 
national targets for incarceration under the Closing the Gap framework have merit, yet 
Australia’s experience to date suggests that ultimately these outcomes and initiatives to 
affect them need to be measured in a manner that is more instructive than annual 
department reports to ensure that they are effective. Programs to overcome these 
disparities have emerged that are both direct, for example the use of alternative sentencing 
programs such as circle sentencing, or indirect such as the licencing program examined in 
Chapter 7. Holding a driver licence has been shown to be associated with a range of social 
outcomes including better health and the approach of Chapter 7 demonstrated the 
potential for such determinants to be valued using stated preference surveys. The 
application of contingent valuation techniques (and similarly discrete choice experiments as 
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presented in Chapter 6) has potential to provide a level of guidance to policy makers on 
resource-allocation decisions that target social determinants of health.  
New programs funded and implemented to improve the health of Australian Indigenous 
communities need to have capacity for economic evaluation as a key criteria. There may be 
a role for Government agencies to play in developing this evidence, resourcing service 
providers with people with appropriate skills or capacity building. There is a need for better 
data and oversight of the services that these communities are receiving. While the 
development of such data and information may be confronting for some in the sector, it is 
necessary for Australia to finally overcome Indigenous disadvantage.  
Implications for further research 
Several areas for future research flow from these conclusions and some suggested 
directions for this are proposed here. At the most basic level, there is an urgent need for a 
deeper evidence base demonstrating effective and cost-effective interventions into 
Indigenous communities. The lack of intervention studies in these communities has been 
well documented [25, 26] while Chapter 2 outlined the dearth of economic evaluations in 
the field [5].  
This thesis has repeatedly called for economic evidence based on Indigenous preference and 
values. This raises questions over the best means of incorporating these values into the 
design and evaluation of health services which mirror similar questions that continue to be 
debated regarding the best models of Indigenous ownership, participation and 
representation in the development and provision of health services to Indigenous 
communities. Measures of health outcomes have been used in populations around the 
world to directly incorporate patient values in the evaluation of health services and form a 
152 Health Economics and Indigenous Health
central component of health economic evaluations and the policy process in health systems 
around the world. The work presented in Chapter 3 suggests  there is a role for these 
instruments in Indigenous populations, with these instruments having been used in 
Indigenous populations around the world [6]. Importantly though, the limited evidence base 
that does exist suggests that this will require further validation of existing instruments or 
potentially the development of new population-specific measures. Future research to do 
either of these will be of great value in assessing the effectiveness and cost-effectiveness of 
interventions to improve the health of these communities. It is vitally important that these 
instruments are accurately representing the outcomes they are trying to measure in 
Indigenous populations and they accurately incorporate factors that are of value to the 
health of Indigenous Australians. 
More recently Patient Reported Experience Measures (PREMs) have become increasingly 
important to policy development in other sectors and are being rolled out in health systems 
around Australia. Such measures assess the experience of care providers of patients who 
receive care. While PREMs do not provide a measure of health outcome and will not be able 
to directly inform economic evaluations at this stage, the interest and roll out of these 
measures across Australian and other health systems presents the sector with another 
means of assessing the importance of culturally-specific care, in particular the impact of 
these providers on the engagement and utilisation of health services. The importance of 
considering ethnic minorities within communities in the development of these measures has 
been raised previously in the study included in Appendix 4 [27], again suggesting that work 
will be needed to ensure that measures used will be appropriate for eliciting the 
preferences and experiences of Indigenous Australians.  
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The work of this thesis has highlighted the importance of culturally-specific care providers in 
providing health care services to Indigenous Australian communities. These findings reflect 
the findings of a relatively developed qualitative evidence base highlighting the importance 
of these providers to efforts to overcoming disparities facing Indigenous Australians. While 
these findings are promising and important, empirical research in this field remains in its 
infancy and needs to be further developed to better understand the role of culturally 
appropriate care providers. The impact of such providers on engagement, utilisation, health 
outcomes and patient experience needs to be understood. Similarly, there needs to be a 
better understanding about what these providers should look like in practice with a clear 
understanding of what constitutes a cultural-appropriate service and what local 
communities are willing to trade in budget constrained environments is vital for cost-
effective spending and sensible, rational priority setting in the sector.  
More generally, there is a need for more analysis of the service use and expenditure of 
Indigenous Australians. There is a pressing need to understand and better track investment 
into Indigenous health. While there is widespread acknowledgment of the importance of 
various barriers to care facing Indigenous Australians, how these affect the service 
utilisation patterns of these communities and preferences with regard to their health and 
healthcare remains empirically unknown. The work of this thesis has highlighted 
heterogeneous preference around service design suggesting the need to involve 
communities in the design of services. The most effective way to do so needs to be 
established and is another topic for future research. 
If, as is likely based on the findings of this thesis, culturally-specific providers are found to be 
particularly valuable to the communities they are servicing, consideration needs to be given 
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to the best means of funding the providers. While generally lying outside the scope of this 
thesis, the difficulties faced by service providers in this sector with regard to the additional 
burden of applying for funding and uncertainty of funding beyond the immediate short-term 
have been well documented [28-30]. On the other hand, the importance of community 
ownership in the sector has led to the proliferation of small to medium sized service 
providers around the country which presents difficulties for funders in designing a system 
with appropriate incentives, security and that promotes appropriate and sufficient care to 
overcome Indigenous disadvantage. Further research on the design of the health system in 
this regard to create an environment that maximises the health of Indigenous Australians 
with regard to the provision of their health care is vital and could potentially have a 
revolutionary impact on the way that such services are provided and funded in Australia. 
Limitations of this thesis 
There are a number of limitations to this thesis as a whole, many of which reflect the 
difficulties of conducting research in these populations outlined above. First, the empirical 
studies included in this work were, on the whole, relatively small-scale. This is a by-product 
of the issues raised above. The populations investigated were heterogeneous and the 
research questions were different for each study meaning that limited policy implications 
can be drawn from the results on their own. The strength of the thesis was in 
demonstrating, often for the first time, that these techniques are viable and meaningful in 
Indigenous populations. However, in many situations, the novelty of the research means 
that the comparative evidence base is limited. The limitations of the specific studies 
contained in the thesis have been raised in each respective chapter.  
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 Conclusions 
The impact to date of the health economics field on policy initiatives to overcome 
Indigenous disadvantage has been unclear. Given an environment of broad public and 
political support for intervention to close the gap in outcomes between Indigenous and non-
Indigenous Australians and an accompanying investment of significant resources, it is an 
area where economic evidence could and should have a large impact on public policy. While 
there are noted difficulties in developing such evidence, economic methods that have been 
developed and refined in other fields represent tools that could directly translate 
information from Indigenous populations into measures of health outcomes, preferences 
over service design and measures of value that extend beyond traditional biomedical 
measures of health outcomes. Health related quality of life measures, discrete choice 
experiments and contingent valuation studies can all be used to incorporate the values and 
preferences of populations into the design and evaluation of health programs. The work of 
this thesis demonstrates that such tools can both be validly used in Indigenous communities 
and provide valuable insights when they are applied. Fundamentally, the existence of 
resource scarcity needs to be better acknowledged in resource-allocation decisions 
targeting an improvement in Indigenous health in Australia. Investing available resources 
into their most effective uses possible is essential to closing the gap in health outcomes 
between Indigenous and non-Indigenous Australians. This cannot occur without an 
understanding of what constitutes value to the Indigenous populations receiving these 
services.   
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APPENDIX 2: PERSPECTIVES ON AN ABORIGINAL-LED MOBILE DENTAL SERVICE 
 
APPENDIX OVERVIEW 
This appendix presents the findings of a qualitive assessment of a mobile dental service 
providing care to remote Aboriginal communities in New South Wales referenced in the 
Introduction to this thesis. The appendix consists of a single manuscript titled: Client 
perspectives on an Aboriginal community led oral health service in rural Australia. 
While not led by the author of this thesis, the work provides a unique perspective on the 
importance of overcoming barriers to care facing Indigenous Australians living in remote 
areas and is included here to provide context for the work of the thesis.  
PUBLICATION DETAILS 
Irving, M., K. Gwynne, B. Angell et al., Client perspectives on an Aboriginal community led oral health 
service in rural Australia. Australian Journal of Rural Health, 2016. 
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Abstract
Objective: An oral health service was implemented,
using a unique community development approach, for
Northern NSW Australian Aboriginal communities in
2013–14. This study examined the views of children
(and parents) who accessed the service, including: the
extent of reported dental problems, oral health knowl-
edge, attitudes and behaviour, accessibility of oral
health services, satisfaction and cultural sensitivity of
the service.
Methods: A survey of the children who accessed this
service was conducted between October 2014 and
December 2014.
Results: A total of 49 (71%) Aboriginal children aged
4–14 (or parents of), provided responses to the survey.
All agreed that healthy teeth were important (100%),
but many thought oral disease leading to extraction
was normal (68%). High levels of oral pain were
reported (66%), half (53%) reported brushing morn-
ing and night. Access to the new dental health service
was reported as ‘easy’ (92%). Many walked (47%) or
were driven (35%) in <30 min (90%). All respondents
were happy with their dental treatment, and that their
Aboriginal heritage was respected by the oral health
team (100%).
Conclusion: The implementation of a new community
led oral health service to Northern NSW Aboriginal
communities was shown here to be well-utilised,
respected and in an area of high need. The collaborative
approach could be continued to be utilised to implement
targeted, community led health promotion programs to
facilitate and encourage better oral health practices for
the Aboriginal children in these communities.
KEY WORDS: Aboriginal, dental, dental health,
health promotion, rural, survey.
Introduction
The poor oral health of indigenous populations world-
wide is well-documented and Australia is no excep-
tion. Australian Aboriginal communities continue to
bear a disproportionate burden of oral ill-health rela-
tive to other Australians. Aboriginal children have
been found to have nearly twice the rate of decay as
non-Aboriginal Australians.1 At the extreme end, the
rates of transport to a major hospital for general
anaesthesia treatment of significant decay outstrip
non-Aboriginal Australians.2
Against this backdrop ensuring Aboriginal Aus-
tralian’s have access to appropriate primary health
care services is a key part of Government policies
aimed at reducing existing health disparities between
Aboriginal and other Australians.3 In spite of this,
Aboriginal Australians have been found to access pri-
mary-care services including oral-health services at a
lower rate than other Australians despite their elevated
risk.4 The reasons underlying this are complex and
have resulted from a variety of historical, social and
economic factors. Developing services that are able to
engage with rural and remote Aboriginal people and
Correspondence: Dr Michelle Irving, Population Oral Health
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overcoming these barriers is essential to improving the
health access for these people. To overcome some of
these barriers the development of culturally appropri-
ate health services has been found to be an important
part of opening access.5 There is limited evidence of
successful, accepted and sustainable dental health ser-
vices being offered to remote Australian Aboriginal
communities, though findings from Western Australia
suggest that such programs can reach these communi-
ties in a sustainable way.6,7 In this study users of a
series of community lead dental services were sur-
veyed. The aim of the study was to tease out the fac-
tors that lead to their use of the service, to determine
prevalent attitudes and oral health behaviours within
this group to look for opportunities to enhance access
and improved oral health behaviours.
Materials and methods
The study was approved by the Aboriginal Health and
Medical Research Council’s ethics committee as part
of a larger study on the evaluation of the collaborative
oral health service in the northern central New South
Wales. (App no. 1004-14). All participants had a con-
sent form signed, by their parents, and were given a
participant information sheet to keep.
Description of the service
For some 30 years Aboriginal elders living in the remote
Northern Central Tablelands of New South Wales
(NSW), Australia had highlighted their concerns to
State Governments. To address the concerns, a collabo-
rative oral health service model was developed with the
local community, local health service providers, The
Poche Centre for Indigenous Health (University of Syd-
ney) and the Centre for Oral Health Strategy (NSW
Health). The service was developed using the innovative
community development model of ‘collective impact’
and commenced in August 2013.8 The service was fully
established in early 2014 with an oral health team that
lives and works in the community. Oral health services
are provided to each local community within this region
on a rotational basis, approximately 1 week per month
in each community. These services utilise space in the
local Aboriginal Medical Service, community centre or
school and if no appropriate facilities are available a
mobile dental van is provided. Clinicians were trained
in Aboriginal culture and held close ties with Aboriginal
Elders in the community to ensure the continued cul-
tural competence of the service.
Survey design
The questionnaire was an evolved design that rested on
the original work of researchers at the University of
Adelaide (L. Jamieson, pers. comm., 2014). The survey
was developed in conjunction with local community
members (who tested it for understandability and rele-
vance) and experienced researchers in Aboriginal den-
tal health. The core of the questionnaire was a record
previous and current oral health issues, how these
affected respondents’ daily lives, their attitudes to oral
health and oral care practices, how they accessed oral
health services and their overall satisfaction with and
cultural appropriateness of the new service they were
attending. Simple demographic data were collected for
each respondent such as age, gender and Aboriginality.
No respondent identifying data were recorded.
Application of survey
The questionnaire was interviewer assisted, and was
completed at the completion of a clinic visit, preferably
the examination visit. The survey was delivered by a
health team member and scope was given to paraphrase
questions and responses to ensure cultural understand-
ing and age appropriateness of the questionnaires.
What is known on this subject:
● Australian Aboriginal populations have
known poor oral health.
● Culturally appropriate health care for Abo-
riginal populations is not readily accessible.
● Prevalent attitudes and oral health beha-
viours have not been documented for chil-
dren in the Aboriginal Communities in
Northern New South Wales.
What does this study add:
● There is a high degree of reported dental
pain in the community.
● Healthy teeth are considered to be very
important, but many thought dental prob-
lems, including extraction was inevitable for
children.
● Implementation of a new collaborative oral
health service for northern central New
South Wales, Australian Aboriginal commu-
nities using a community development
approach of collective impact has been
shown here to be effective for the children
and their families in these communities. The
service is a well-utilised, respected.
© 2016 National Rural Health Alliance Inc.
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Participant selection and recruitment
The study was undertaken in the Northern Central
Tablelands of NSW, in the towns of Boggabilla,
Toomelah, Mungindi, and Inverell. All Aboriginal chil-
dren aged up to 14 years of age attending the new col-
laborative oral health service in the communities
during October to December 2014 were eligible for
participation in the study. The dental team
approached parents requesting consent for their chil-
dren to be involved. Verbal assent was also requested
from children directly after parental consent was
given, for children over 7. Parents of young children
assisted with the completion of the survey.
Statistical methods and software
Children’s demographic and survey responses were
analysed using descriptive statistics. The chi-square
test was used to examine the differences among
responses from different demographic groups (gender
and age as grouped 4–9 and 10–14). SPSS software,
version 22 (SPSS Inc., Chicago, IL, USA) was used for
this statistical analysis
Results
A total of 49 children aged 4–14 years participated in
the study (with the parents/guardians), all of whom
were Aboriginal which represented 71% children who
received any dental care from the team during this
time. There were more females than males (63% ver-
sus 37%); 16 children aged 4–9 years old and 33 aged
10–14 years.
History of dental problems
A considerable range of dental problems were reported.
Nearly 8 out of every 10 (78%) reported having dental
pain at some stage, and over a third (37%) often found
it uncomfortable to eat food because of problems
with their teeth or mouth, 10% often had trouble
pronouncing words, 20% were self-conscious of their
teeth and 12% indicated that problems with their teeth
made daily life difficult (Table 1). Of those reporting
pain, 21% of these individuals had suffered pain for
more than 2 months (Table 2).
Attitudes and behaviours around oral
health
Everyone (100%) agreed that healthy teeth were
important for children, although having dental prob-
lems was seen as inevitable for some, with three quar-
ters (75%) believing that most children will get
problems with their teeth and may have to get them
‘pulled out’ at some stage. Whilst two-thirds (67%)
indicated it was easy to make sure they had tooth-
brush and toothpaste, nearly a third (30%) did not
have easy access to these basic oral health care imple-
ments. Just under half (47%) did not brush their teeth
morning and night and two-thirds (65%) indicated
that they generally consumed a lot of sugary foods
and drinks (Table 3).
Access to dental services
Almost everyone (92%) thought it was easy to access
the new dental health service, with 90% taking <30 min
TABLE 1: History of dental problems
Painful aching
in mouth
Uncomfortable
to eat foods
Trouble
pronouncing
words
Self-conscious
because of teeth
Difficult doing
usual activities
n (%) n (%) n (%) n (%) n (%)
Never 11 (22) 17 (35) 38 (78) 27 (55) 35 (72)
Hardly ever 6 (12) 4 (8) 4 (8) 6 (12) 4 (8)
Occasionally 18 (37) 10 (20) 2 (4) 6 (12) 4 (8)
Often 14 (29) 18 (37) 5 (10) 10 (21) 6 (12)
TABLE 2: For those in pain, length of time my child has
been in pain with a dental problem
Time n %*
Less than a week 6 12
1–2 weeks 8 16
Less than a month 2 4
A month 6 12
2–6 months 5 10
More than 6 months 5 10
Total (in pain) 40 82
*Percentage of total respondents.
© 2016 National Rural Health Alliance Inc.
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to get to where the service was located; the children
were either driven (35%), walked (47%) or caught the
bus (18%). Nearly a third (30%) indicated that they
would find it difficult to travel to see a ‘dentist in the
next town’ (Table 4), and 42% were not aware of
where they could access dental services outside of the
new service.
Thirty percent of the children reported never having
been to the dentist before coming to the new collabo-
rative oral health service and of those who had been
to a dentist before over half had not seen one in more
than 3 years. The reasons given for ‘not seeing a den-
tist regularly in the past’ varied, but many (54%) did
not attend the dentist as they were ‘not in pain’, 15%
did not know where to go to obtain services and 13%
indicated that waiting lists at other oral health services
were too long (Table 5).
Service satisfaction
All 49 respondents reported that they were happy with
their treatment and felt that they had been treated in a
culturally competent manner with their Aboriginality
respected.
Differences in responses between
demographics
There were no statistically different responses to ques-
tions when evaluated by age in the following age
groups; 4–9 and 10–14 years of age. There were some
differences in responses between the genders. Boys
were much less likely to report a history of dental
problems such as; dental pain (P = 0.02), uncomfort-
able eating (P = 0.03), trouble pronouncing words
(P = 0.009) and difficulties with daily activities
because of problems with teeth (P = 0.003). Even
though boys were less likely to report pain, those who
were in pain had been that way longer than the girls
TABLE 3: Attitudes to oral health and oral health behaviours
Most children
will get
problems
with teeth
Most children
will need to
get teeth
pulled out
Healthy teeth
important
for children
It’s NOT easy
to ensure I have
toothpaste/
toothbrush
I usually
brush morning
and night
I generally
eat a lot of
sweet foods/drinks
n (%) n (%) n (%) n (%) n (%) n (%)
Agree 37 (77) 32 (68) 49 (100) 14 (29) 26 (53) 32 (65)
Neither 5 (10) 5 (11) 0 (0) 2 (4) 7 (14) 5 (10)
Disagree 6 (12) 10 (21) 0 (0) 33 (67) 16 (33) 12 (25)
TABLE 4: Access to services
n (%)
Arrival mode
Driven by another person 17 (35)
Bus 9 (18)
Taxi 0 (0)
Walked 23 (47)
Time taken
<30 min 44 (90)
30–60 min 4 (8)
1–2 hours 1 (2)
>2 hours 0 (0)
Ease of arrival
Extremely easy 17 (35)
Easy 28 (57)
Neither 3 (6)
Difficult 1 (2)
Travel further to see dentist (e.g. next town?)
Extremely easy 3 (6)
Easy 19 (39)
Neither 13 (26)
Difficult 14 (29)
TABLE 5: Reasons given for not regularly attending a den-
tist regularly in the past (could choose multiple reasons)
Reason N (%)
Cost 5 (9)
Not in pain 26 (48)
Did not know where to go 7 (13)
Transport difficulties 1 (2)
Too far away 3 (6)
Not welcoming 1 (2)
Long waiting list 6 (11)
Missed or late for last appointment and not seen 0 (0)
Fear of dental treatment 4 (7)
Fear of discrimination 1 (2)
Other 0 (0)
© 2016 National Rural Health Alliance Inc.
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(P = 0.04). When comparing attitudes to oral health
between the genders, responses were similar except for
boys being less likely to admit to eating and drinking
sugary foods (P = 0.03).
Discussion
This study found high levels of dental pain over long
periods of time, and many thought poor oral health
was normal, even though, having healthy teeth was
ranked as highly important by this group. Many did
not have access to a toothbrush and toothpaste and a
majority consumed a lot of sweet foods and drinks.
Access to the new oral health service was considered
easy. Respondents reported that their aboriginal her-
itage was respected when visiting the service. Many
had never seen a dentist, or if they had, not for a long
time.
A number of barriers face Aboriginal Australian
communities from accessing health services. Geograph-
ical, cultural, financial and health-literacy may all pre-
sent barriers to accessing services for these
populations. The results of this study suggest that the
children in these remote communities have historically
not accessed dental services at the level needed to
maintain good dental health. Fifty percent had not
seen a dentist in the past year, even though their bur-
den of dental problems, as indicated by the large num-
bers with dental pain, is very high.
A number of factors influence a person’s access of
dental care including financial costs, perception of
need and lack of access.9 The importance of culturally
competent health care has also been recognised in the
literature.10 Previous access to culturally competent
dental care had been an ongoing problem for the com-
munity for an extended period of time. The implemen-
tation of this new collaborative oral health service was
designed to overcome many of these barriers. It is built
on cultural competence concepts which have been
shown in other services to improve the reach of service
providers to comparable communities.11 This survey
shows that this service is being delivered in a cultur-
ally competent manner, access barriers have been over-
come through basing the service within each
Community’s health care centres, or local schools
using portable and mobile dental equipment, with
90% of patients travelled less than half an hour to
attend for dental care. Cost as a barrier to accessing
care was also largely overcome with philanthropic and
Government funding ensuring that all the Aboriginal
patients using this service did not incur a charge for
their treatment.
Particularly concerning results have emerged from
this survey relating to preventive health behaviours. A
sizeable proportion (29%) of the children interviewed
did not have ready access to toothbrushes and fluoride
toothpaste. The fact that children were not brushing
with a fluoride toothpaste will be a contributing factor
to the high prevalence of dental caries12 which is fur-
ther compounded by the finding that there was a high
reported consumption of sugary foods and drinks.13,14
Previous lack of appropriate access to dental services
and oral health promotion information, for these fami-
lies will have made a sizeable contribution to this find-
ing. It is clear that there is a role to play in improving
the oral health of these communities through targeted
health promotion programs. Appropriate access to
healthy food options in these communities should also
be explored further and the impact this has on food
choices.
There are a number of potential limitations to this
study that should be noted. While a 71% response
rate is considered appropriate for a survey such as
this, it still leaves the possibility of selection bias. The
majority of the clinical services under evaluation here
were offered within local schools, therefore attendance
rates for care could be higher than a community based
clinic. There may, though, still be a small number of
non-attenders who did not see the service as relevant
that have not been given the opportunity to respond.
Further community engagement will be undertaken to
determine factors for non-engagement in the service to
remove any potential barriers to participation. An
interviewer assisted survey was both a strength and a
weakness, it allowed for varying literacy levels encoun-
tered amongst the children and their parents, however,
there is some evidence that the accuracy of reporting
sensitive items, is reduced in interviewer assisted sur-
veys.15,16 This may have impacted on some of the sur-
vey domains, especially reported behaviours around
oral health and therefore our data may be slightly
skewed towards the positive. For example fewer
respondents may brush their teeth as regularly as they
may have suggested in the survey and they may have
been more likely to give positive feedback on the new
dental service.
Conclusion
Implementation of a new collaborative oral health ser-
vice for northern central New South Wales, Australian
Aboriginal communities using a community develop-
ment approach of collective impact has been shown
here to be effective for the children and their families
in these communities. The service is a well-utilised,
respected and serves communities with high dental
need. Many of the barriers to obtaining dental health
care that these populations face have been overcome.
The collaborative approach could continue to be uti-
lised to develop and implement appropriate, targeted
© 2016 National Rural Health Alliance Inc.
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and community led health promotion programs to
facilitate and encourage better oral health practices for
the Aboriginal children and their families. Further
studies to determine the continued impact of the ser-
vice, on the oral health of these children should be
undertaken.
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APPENDIX 3: IMPLEMENTING PRIORITY SETTING FRAMEWORKS 
 
APPENDIX OVERVIEW 
This appendix presents the findings of a qualitive study of leading researchers in the field of 
priority-setting examining the implementation of priority-setting frameworks in health 
systems around the world. The appendix consists of a single manuscript titled: Implementing 
priority setting frameworks: Insights from leading researchers. 
While outside the scope of this thesis, the work provides a unique perspective on the barriers 
and facilitators to rational priority setting in health systems. The vertical equity weighting for 
Indigenous patients of the New South Wales health system is identified as a successful 
example of incorporating an equity concern into a priority-setting process.  
PUBLICATION DETAILS 
Angell, B., J. Pares, and G. Mooney, Implementing priority setting frameworks: Insights from leading 
researchers. Health Policy, 2016. 120(12): p. 1389-1394.  
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a  b  s  t  r  a  c  t
In spite  of a  substantial  literature  developing  frameworks  for policymakers  to use  in
resource  allocation  decisions  in healthcare,  there  remains  limited  published  work  reporting
on the  implementation  or evaluation  of such  frameworks  in  practice.  This  paper  presents
ﬁndings  of a  targeted  survey  of 18 leading  researchers  around  the  implementation  and
evaluation  of priority-setting  exercises.  Approximately  one  third  of respondents  knew  of
situations  where  recommendations  of priority-setting  exercises  had  been  implemented,
one  third knew  that recommendations  had  not been  implemented  and the  ﬁnal  third
responded  that they  did  not  know  whether  recommendations  had  been  adopted.  The  lack
of  evidence  linking  the  implementation  of priority-setting  recommendations  to equity  and
efﬁciency  outcomes  was  highlighted  by all respondents.  Features  identiﬁed  as facilitating
successful  implementation  of priority-setting  recommendations  included  having  a climate
ready  to  accept  priority-setting,  good  leadership  or  a ‘champion’  for the  priority-setting
process  and  having  a health economist  to guide  the process.  Successful  disinvestment  was
very  uncommon  in  the  experience  of  the researchers  surveyed.  Recommendations  emerg-
ing  from Program  Budgeting  and Marginal  Analysis  exercises  appeared  to  be  more  widely
implemented  than those  coming  from  alternative  processes.  Identifying  if the  process  was
repeated  following  the initial process  was suggested  as  a means  to measure  success.1. Introduction
Demand for services in health systems around the world
will  inevitably exceed the resources available to provide
them.  As such, decisions need to be made on which ser-
vices  and programs to fund and at what level [1]. Priority
setting has been deﬁned as ‘decisions about the allocation
of  resources between the competing claims of different ser-
vices,  different patient groups or different elements of care’
[3].  Substantial work has been devoted to the development
∗ Corresponding author.
E-mail  address: bangell@georgeinstitute.org.au (B. Angell).
http://dx.doi.org/10.1016/j.healthpol.2016.10.005
0168-8510/© 2016 Elsevier Ireland Ltd. All rights reserved.
Health Economics and I©  2016  Elsevier  Ireland  Ltd.  All  rights  reserved.
of priority-setting frameworks to assist decision-makers
balance these competing demands as public agencies
are increasingly held accountable for the way  in which
resources are allocated [2,4–6,7]. A number of such frame-
works  exist, however, it has been highlighted that their
effectiveness is likely constrained in practice, not by a lack
of  understanding on the part of policy-makers but by a
lack  of consideration for broader institutional and polit-
ical  characteristics of health systems in the frameworks
[8]. As such an understanding of effective implementation
and use of priority-setting frameworks is vital for decision-
makers looking to implement such frameworks in health
systems. This paper endeavours to shed more light on this
issue  through a survey of prominent researchers in the ﬁeld
ndigenous Health 169
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o ascertain their views on facilitators and barriers to suc-
essful  implementation of priority-setting frameworks and
he  evaluation of the use of such frameworks.
.1. Existing evidence on the implementation of priority
etting  frameworks
A  number of studies have investigated applying
riority-setting frameworks in health systems around the
orld  [7,10,11–21] and a small literature has developed
nvestigating the facilitators and barriers to the imple-
entation process. These have focused on a number of
ifferent  priority-setting frameworks, though many have
ocused  on Program Budgeting and Marginal Analysis
PBMA) frameworks. PBMA frameworks are based on the
conomic  concepts of opportunity cost and the margin
nd  seek to maximise the effectiveness of healthcare bud-
ets  by focusing on the marginal impacts of resource
llocation decisions [22]. Mitton and Donaldson proposed
 number of facilitators and barriers to implementing
BMA frameworks [23]. They highlighted a number of
rganisational and system level factors that act as both
arriers  (stafﬁng issues, politics, too many administrative
emands) and facilitators (strong leadership, designated
esources to implement the framework, organisational cul-
ure,  incentives and integrated budgets). The importance
f  organisational factors to the success of implementation
as also highlighted by Cornelissen et al. in a commu-
ity  care context, who also emphasised the importance
f  adapting the priority setting framework (in this case
BMA)  to ensure aligned with the ongoing business of
he  healthcare provider rather than being seen as a dis-
inctly  separate process [27]. Others have suggested that
ealth  researchers could improve the feasibility of priority-
etting  processes by working with decision-makers and
embedding’  themselves within organisations and promot-
ng  economic principles of opportunity cost and marginal
nalysis  [24]. A number of other studies have looked at the
iews  of policy-makers of the priority setting process both
n  the potential of implementing explicit frameworks (and
esirable  features of these) [12,15,25] as well as feedback
n  attempts to implement existing frameworks [13,14]. As
 whole these studies have highlighted the importance of
aving  clear processes, committed teams to implement the
rameworks  and a transparent process.
There have been few attempts at evaluating the effec-
iveness  of implementation of these frameworks on either
ealth  or procedural outcomes. Tsourapas and Frew [26]
ttempted  to review the success of a Program Budgeting
nd  Marginal Analysis (PBMA) approach to priority-setting.
hey looked at all published PBMA studies and judged
uccess  in terms of ‘whether participants gained a better
nderstanding of the area under interest and therefore a
hange  in the decision-making culture was achieved’ [26].
n  the wake of their review, they listed the ways that they
ncountered  to evaluate PBMA:. To establish if a disinvestment list has been created.
. To assess if resources have been successfully moved
from the disinvestment list to the investment list.
ti
p
li
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 To evaluate if the PBMA exercise has led to the improve-
ment of participants’ knowledge regarding the area
under consideration.
 To assess if PBMA has improved patient outcomes.
 To observe if PBMA has inﬂuenced the organisational
culture  or way  of thinking.
 To assess if PBMA has been adopted for future use by the
organisation.
Notably,  improved efﬁciency and equity objectives,
ch as providing more health beneﬁts for the same
source input or changing the distribution of beneﬁts,
e  not listed here. The authors conclude that the success
 implementing a PBMA framework depends largely on
hether  participants have considered the existing struc-
res  and priority-setting processes used in the area [26].
is  paper investigates in closer detail the views of leading
searchers of the implementation of priority-setting pro-
sses  and what factors are identiﬁed as contributing the
ccess  or otherwise of this process.
 Methodology
A targeted survey of leading authors in the priority-
tting ﬁeld was conducted to elicit their views on the
plementation of priority-setting frameworks within
ealth  systems. The survey was  conducted alongside a
pid  review of the literature of the major priority-
tting frameworks in the literature: PBMA, QALY league
bles,  needs-assessment methodologies, target setting,
re  health care, generalised cost-effectiveness analy-
s,  accountability for reasonableness and the Swedish
riority-setting system. These categories of priority-setting
ameworks were selected by the authors as the most
portant to consider in the ﬁeld. From this review, authors
 key studies were selected and approached. This study
as  carried out to inform a health system within Australia
d  as such authors were purposively recruited based on
eir  priority-setting research in either Australian jurisdic-
ons  or others comparable to the Australian situation. In
tal  18 authors of key studies were approached. Authors
ere  approached via email in June 2012 by the senior
thor  of this paper (GM) and were asked to respond within
two-week period. Participants were asked if they would
dress  three questions related to their own  experiences
 researchers (either as a primary researcher in particular
stems  or based on their observations across the broader
eld):
 To what extent have recommendations from priority
setting exercises been implemented?
 Where recommendations were implemented, what dif-
ference was  made to efﬁciency and/or equity outcomes?
 Where recommendations were implemented, what
were the key reasons that allowed this or when recom-
mendations were not implemented, why  not?These three questions were selected due to their prac-
cal  importance for health systems looking to implement
riority-setting frameworks and because these issues are
ttle  addressed in the academic literature. All researchers
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approached to take part in this study are listed in Appendix
A  in the Supplementary material. Responses were provided
via  return email. Any clariﬁcation on the issues relating
to  either the questions or responses provided was  car-
ried  out over email. Responses were analysed by one of
the  authors (GM) who coded the data and identiﬁed key
themes  relating to the implementation of priority-setting
frameworks emerging from the responses to each ques-
tion  above. Themes were discussed between all authors
and  the interpretations reached were agreed to by consen-
sus  between the three authors. The analysis is presented
under the subheadings below, themes that emerged across
all  questions are emphasised in the narrative analysis
of  responses presented here. Quotes were selected and
included in the analysis to illustrate the themes discussed.
Some respondents did not wish to be identiﬁed with their
comments and this has been respected in what follows.
3.  Results
All respondents highlighted the need for such research
and pointed to a gap between what is happening in the
research literature and what was happening in practice.
With regards to whether priority-setting recommenda-
tions were implemented there was a three-way spilt across
respondents with approximately a third saying recommen-
dations of priority-setting processes were implemented; a
third  saying they were not; and a third saying they did not
know.
3.1.  Factors helping and hindering priority setting
implementation
There was a high degree of agreement across respon-
dents with regards to factors that they considered
important to facilitate the implementation process. Across
all  respondents, two common features were identiﬁed with
respect  to success in facilitating the implementation of pri-
ority  setting frameworks. The ﬁrst was the presence of good
leadership  (or ‘a champion’) through the implementation
process and, the second, having a health economist to guide
the  process. Interestingly, a number of respondents high-
lighted  problems implementing recommendations when
the  priority-setting process has sought to be transparent.
The importance of organisational-level factors to
priority-setting processes were highlighted by many
respondents. Donaldson, for example, argued that the
keys  to success were ‘leadership, organisational readi-
ness  and simply having good project management skills
and  support in place.’ Peacock emphasised the importance
of  strong leadership in getting recommendations imple-
mented, together with a culture open to change and buy-in
from  the bottom up. At a broader level, many respon-
dents highlighted the importance of garnering support
for  the priority-setting process across the system. Mitton
emphasised that ‘implementation is tied to political back-
ing,  which speaks to the need for up-front work on buy-in,
acceptance of criteria and lots of engagement activity’ a
point  that Mooney echoed when he stressed the need to
get  clinicians’ support during the priority-setting process.
Mooney reported on one study which he argues went very
t
c
c
t
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ell  until an attempt to implement it in oncology was
locked by the head oncologist and seemingly no one could
et  him to become involved. That, combined with the loss
f  the clinical champion to another city, resulted in the
ttempts to implement the priority-setting process coming
nstuck.
A  number of respondents noted that when a priority-
etting process has sought to take resources away from an
rea  and to do so explicitly and transparently, this ‘disin-
estment’ process often ﬂoundered. These decisions, as one
bserver  put it, ‘are much easier when they are obscured
nd shrouded rather than open and transparent.’ This inter-
sting  relationship between the importance of prominent
eadership and the transparency of the process was also
ighlighted by Mitton: ‘In one case, one CEO backed away
rom  implementation because despite there being support
rom  senior managers he wanted a less transparent pro-
ess  . . . because he didn’t want anything pinned on him.’
ooney reported on a similar situation which arose in an
rea  Health Service in New South Wales (Australia) where
he  CEO, having had the Area Health Service staff complete
 PBMA exercise and with solid recommendations, called
n  NSW Health who  then ignored the study recommenda-
ions and cut X% across the board. The CEO did not want
o  be seen in the local community to be responsible for the
uts.  Mooney adds that there may  be an optimal distance
etween cuts and making decisions about cuts—and it is
not  up close.’
Similarly, Ruta emphasised his experience that PBMA
ets  implemented more readily when there is extra money
nd  no need for disinvestment. Other factors leading to
ailed  implementation of priority-setting processes high-
ighted  by respondents tended to be the reverse of the
acilitators identiﬁed above. These included rapid changes
n  health organisation personnel and agendas; lack of a
hampion; the absence of a health economist or other key
ersonnel; and not having earmarked personnel, time or
oney  for the process.
.2.  Case studies of successful implementation efforts at
he  health system level
A  number of the respondents highlighted implementa-
ion attempts they had been a part of at the health system
evel  to highlight factors that they observed as contributing
o  the success or otherwise of priority-setting exercises.
The  most promising responses came from research
n Canada (Donaldson, Mitton and Peacock). As Mitton
eported: “Of the thirty odd PBMA applications I have been
nvolved  in primarily in Canada, I’ve seen recommenda-
ions implemented in about 90% of these.” In the Australian
ontext, Jan suggests from his experience two  areas where
ifferences have occurred in the priority-setting process,
ne  related to equity and the other efﬁciency. First, the
ew  South Wales vertical equity weighting for Aboriginal-
ty  that saw increased resources directed to the Indigenous
opulations of the jurisdiction and second, the Pharmaceu-
ical Beneﬁts Advisory Committee (PBAC) which advises on
ost-effectiveness of pharmaceutical budget bids. The suc-
ess  of implementing an equity weighting Jan attributes
o  a recognised gap on the part of policy makers, strong
ndigenous Health 171
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dvocacy from the researchers and an alignment of rec-
mmendations with the strategic thinking of the policy
akers.  In the case of PBAC, he highlighted the importance
f  the body’s legislative mandate as critical to the central
ole  of the body in the priority-setting process.
In Sweden, at a national level, Carlsson reported that
systematic and transparent priority setting’ is ‘ongoing’ at
wo  levels—for health services in general and more speciﬁ-
ally  for pharmaceuticals. Carlsson added, however, that it
s  difﬁcult to say to what extent recommendations on prior-
ties  are implemented as “explanations behind changes in
ractice  are more complex” but there are ‘lots of examples’
here  decisions and recommendations have been accepted
nd  implemented.
For  Denmark, Holm indicates that the priority-setting
ecommendations of the Danish Council of Ethics in the
ate  1990s were implemented but in only one of the Dan-
sh  counties (although others did consider doing so) and
nly  for a short time. The main reason why it was  unsuc-
essful,  argued Holm, was that ‘health care is one of the
ain  functions of the counties’ and ‘this made it very dif-
cult  for politicians to be explicit and transparent’ at a
ocal  level, especially about ‘de-prioritising’ echoing the
esponses  from a number of other researchers identiﬁed
bove.
Others  noted the importance of embedding the research
rocess  within the priority-setting framework. Baltussen
rgues  that there has been little impact of priority-setting
tudies on resource allocation in general but points to two
xamples  of success in Thailand and Tanzania. The explana-
ion  for success there he suggests was ‘a strong embedding
f  the research in the policy making context.’
.3. Measuring successful implementation
There was a large degree of agreement between respon-
ents  with regards to whether differences to efﬁciency or
quity  outcomes resulted from priority-setting processes
ith  almost none making claims for improved efﬁciency
r  equity. A measure of successful implementation com-
only  suggested by respondents was whether the process
as  repeated following initial implementation.
Daniels, commenting on his approach of ‘accountabil-
ty  for reasonableness’, reported that there is a body of
iterature  which examines whether decision procedures
n  various settings (mainly in Canada) conform to the
onditions  speciﬁed in accountability for reasonableness.
eyond that, Daniels points to the measurement issue of
rying  to judge, for example, if equity is improved saying:
I  know of no research that examines the outcome of the
rocess  to see if it makes decisions better in some rele-
ant  way.’ Similarly, Mitton responded that he is ‘yet to
ee  a study measure efﬁciency or equity in a robust way.’
nterestingly because of the problems of measuring and
ttributing  changes in efﬁciency and/or equity, he con-
ludes:  ‘I’d be sceptical if anyone claimed that their process
id  improve equity/efﬁciency.’ Along the same lines, Carls-
on  notes of Sweden that he knows of no evidence that
ould  show whether efﬁciency or equity outcomes were
ffected  as a result of priority-setting processes. However,
e  does identify that ‘there is less opposition nowadays
re
th
p
in
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hen county councils present lists of disinvestments as
mpared  with 2003 when it happened for the ﬁrst time.’
In  general, respondents suggested that proving that
anges  are a result of any priority setting exercise is dif-
cult  and measuring such changes even more difﬁcult. Yet
e  responders generally were keen to see this done in
e  future if at all possible. Much of the work of Don-
dson  was in conjunction with Mitton. He reports that
ith  Mitton they came up with ‘109 published papers on
MA  with it having been used almost 90 times in over
 organisations across 7 countries. Over half the organi-
tions  reported using the process again (after their initial
tempt)  but 60% reported a positive short or long term
pact  in that resources were realigned due to the use of
MA.’  The Calgary health service in Canada used PBMA
peatedly over several years. As Donaldson states: ‘They
reed  with the principles, and so, despite imperfections
 the process ﬁrst time around, they continued to work
ith  it to reﬁne it rather than abandon it after a one-off
ercise.’ Similarly, a different PBMA study highlighted by
e  respondent of mental health services did seemingly
elp  to move resources geographically to areas that were
entiﬁed  in the PBMA exercise to have been underfunded.
Ruta  suggested an alternate means to evaluating these
ameworks suggesting a focus on interim efﬁciency objec-
ves  (doing more for less) when he made the argument that
here  is so much inefﬁciency in our health care systems
d  services that there is a lot of scope for a kind of tech-
ical  efﬁciency application.’ That is encouraging especially
 it is less threatening than the full ‘allocative efﬁciency’
proach to PBMA.
Speciﬁcally, with respect to the burden of disease (BOD)
proach  to priority setting, Lopez argued that widespread
se  could be used as an indicator of successful implemen-
tion  noting that while he has not been involved greatly in
plementation, he reported that ‘there have been close to
 national applications of the methodology since we  ﬁrst
ublished  it 20 years ago.’ Vos also claimed some success in
me  of his applications of the BOD approach particularly
 an Australian context.
 Discussion
This paper highlights the views of approached
searchers with regards to issues of vital importance
 the implementation of priority-setting recommenda-
ons. A number of factors were highlighted as important
 the successful implementation of priority-setting
ameworks: having a climate that accepts that priority
tting  is needed is vital; the recommendations from
MA  studies seem to have been those most frequently
plemented; having good leadership, especially clinical
adership,  is crucial; having a health economist ‘on the
ot’  increases the prospects of implementation; and a
ggested  good measure of success is if, after an initial
riority-setting exercise in a particular health authority,
peated exercises follow.
The ﬁndings of this analysis complement efforts in
e  literature that have attempted to elicit the views of
olicy-makers on methods of priority-setting setting used
 practice and ways that they have proposed that such
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frameworks could be of use [25]. Ultimately, organisational
factors were judged to be hugely important to the success of
implementation of priority-setting frameworks by respon-
dents.  Having appropriate skills and staff within the system
and  ensuring broad system support for the process were
thought to be essential to the success of the priority-setting
process. The ﬁndings above also reinforce the importance
of  involving physicians in priority-setting processes, which
has  been described in the literature (as have the challenges
associated with doing so) [6].
One issue of particular interest was the impor-
tance attributed to having a transparent mechanism for
priority-setting. The qualitative literature outlined in the
introduction that has looked at the views of policy-makers
in a range of jurisdictions have emphasised the impor-
tance of having an explicit and transparent process to
make  resource allocation decisions. Similarly, many of the
priority  setting frameworks discussed above have been
developed with transparency as a central tenant. Yet many
of  the respondents in this study outlined highlighted the
drawbacks of transparency when policy makers shied away
from  recommended decisions due to political or other
pressures. This was particularly true for situations where
disinvestment was required. This again highlights the need
to  consider the political structures and powers at play in
any  given health system when considering priority-setting
frameworks. In particular, further work needs to examine
the  processes behind priority-setting decisions when dis-
investment is required and potentially, means to improve
the  use of priority-setting frameworks when such decisions
are  made.
Interestingly, the role of the incentives facing clinicians
in  health systems was not extensively highlighted as a
facilitator (or barrier) to implementing priority-setting rec-
ommendations. This is in contrast to previous ﬁndings in
the  literature which has identiﬁed appropriate incentives
as  a key facilitator to effective implementation [23]. Mit-
ton  noted his own evolution on the issue when responding
to  the survey: ‘I used to think incentives were critical but
less  so now.’ Apart from that, there was limited attention
paid to the issue of incentives by respondents again chal-
lenging  the emphasis placed on the issue in the theoretical
literature.
With regard to evaluating the implementation and use
of  priority-setting frameworks, respondents reinforced the
need  for further work to develop appropriate techniques
to  assess the impact of the implementation of such frame-
works.  The responses from the participants in this study
suggest that process and sustainability indicators such as
repeated  use of the framework may  be more suitable at this
stage  than attempting to derive impacts on expenditure
patterns or health outcomes.
While the study was able to gain unique insights into the
views  of researchers on these issues, there are a number of
limitations  to this analysis. First, an interview methodology
would have been better suited to our research questions
and the complexity of the subject matter than the survey
used.  This was not possible, however, due to budget and
time  constraints. The sample of researchers approached
was selected based on their work in the ﬁeld but was  by
no  means comprehensive. Further, asking researchers in
Health Economics and I20 (2016) 1389–1394 1393
he  ﬁeld to report on processes they were responsible for
ay  lead to a bias in that they have a signiﬁcant stake in
he  results of these activities. This study was also limited in
he  fact that it only elicited views of researchers, however,
t  was carried out to complement a growing area of liter-
ture  that has investigated the views of policy-makers on
his  topic. In spite of these limitations, the ﬁndings were
onsistent across many respondents and highlighted the
ap  between what happens in practice and what is reported
n  academic studies.
.  Conclusion
There are a number of key implications from this anal-
sis  for decision makers in health systems looking to
mplement formal priority-setting frameworks. In addition
o  the factors listed above as being important to successful
mplementation, the lack of clear methods to best evalu-
te  the implementation of these frameworks remains an
ssue.  Some options to assess success are highlighted in this
nalysis,  however, it is important to note again that none
f  these rely on health or efﬁciency outcome data. Thus,
hile the ultimate goal of priority-setting processes may
e  to improve the allocation of available resources so as to
mprove  or maximise the overall health of the target popu-
ation  or change the distribution of beneﬁts, it might be the
ase  that a lack of hard outcome variables will need to be
at  least in part) compensated by data on process indicators
f  implementation and sustainability. In this sense, health
r  efﬁciency outcomes may  be seen as only secondary to
he  implementation of priority-setting frameworks and the
nitial  objective to be measured will be a procedural one in
hich  to achieve transparency in resource allocation.
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APPENDIX 4: PATIENT CARE EXPERIENCE PRIORITIES 
 
APPENDIX OVERVIEW 
This appendix presents a commentary discussing measures of patient experience in the 
context of a new measure of patient safety. The appendix consists of a single manuscript 
titled: What are patients’ care experience priorities?. 
While outside the scope of this thesis, the work provides a discussion of the importance of 
incorporating patient views into the health care practices and highlights the importance of 
ensuring that culturally and linguistically diverse communities are adequately represented in 
the development of these measures.  
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We are investing considerable resources
in defining and measuring patients’ care
expectations. Such measurement will
yield insight into whether and how ser-
vices are meeting patients’ experience
expectations. But because measurement is
inherently distanced in time and space, it
does not resolve patients’ experience of
feeling ‘reluctant to directly challenge
healthcare professionals’1 about issues
that matter to them now and which may
make them feel unsafe.
Research has shown that when patients
and family members experience concerns
about their care, they want to be able to
discuss these experiences with their clini-
cians. They often want such discussions
to include explanations from profes-
sionals and dialogue about ‘what hap-
pened’ and about tensions, uncertainties
and contradictions.2
Patients and family members interviewed
for a large incident disclosure study
reported that they appreciated that care is
complex,3 and that there may be no simple
answers to explain care problems.4 But
being granted the time for dialogue with
their clinicians and service representatives
reassured patients and family members that
their concerns and questions were taken
seriously. This meant for them in turn that
similar events might be prevented from
happening again. They also felt that dia-
logue reassured them that their views on
and advice about how to improve care
were respected. When patients have con-
cerns about their care, the timing and
authenticity of such dialogue are seen as
paramount.
For its part, measuring patients’ experi-
ences presupposes abstracting ‘what hap-
pened to you’ into a general metric that
applies to ‘people like you’. Measurement
is, in the first instance, about the service
and the system. Dialogue is about the
patient and their family. Measurement
will never obviate patients’ providing
feedback about their concerns to their
own clinicians and their local services.
What started out as satisfaction survey-
ing in the 1970s5 has now morphed into a
major industry, with Picker,6 Press Ganey7
and HCAHPS8 (the US-based ‘health con-
sumer assessment of healthcare providers
and systems’) leading the way. A number
of landmark government reports has now
enshrined the role of patient feedback
measurement in healthcare governance
and practice improvement.9 10 In addition
to the hundreds of ‘patient reported
outcome measures’11 that have to date
been developed to measure whether care
meets patients’ care-outcome expecta-
tions, ‘patient reported experience mea-
sures’ (PREMs)12 invite feedback about
service features such as waiting times,
admission processes, staff responsiveness,
discharge processes and so forth. PREMs
also elicit feedback on matters ranging
from clinical team communication to
service responsiveness to patient needs,
accessibility of information, environmen-
tal factors (lighting, space design), equip-
ment availability and functionality, and
they have been shown to shed light on
clinical outcomes.13 14
It is this rapidly growing area of ‘patient
experience’ research that is the focus of
the article by Rebecca Lawton and collea-
gues.15 Following this team’s development
of an overview of factors contributing to
patient safety incidents (referred to as the
Yorkshire Contributory Factors
Framework (YCFF)16), patient measure of
safety (PMOS) was constructed from an
analysis of the priorities attributed by 33
patient interviews to YCFF.1 The team’s
most recent article reports on a compari-
son of PMOS against a range of other
safety rating instruments.
For the purpose of making such com-
parisons possible, data were collected
from 33 hospital wards across three
acute hospitals, including responses
from staff for the four outcome mea-
sures in the Hospital Survey of Patient
Safety Culture, patient responses to the
PMOS and the so-called Friends and
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Family Test (‘Would you recommend this service to
a friend or family member?’). The study also col-
lated publicly reported safety outcome data for
‘harm-free care’ on each ward. The article’s main
finding is that PMOS provides a perspective on
safety and improvement that both confirms and
complements information produced from other
safety measures.
What PMOS adds to our understanding of safety is
that it creates an intersection between patient safety
factors and patients’ observations of care going on
around them. Like PREMs and HCAHPS (measures
that were not included in the study’s comparison it
should be noted), PMOS asks patients’ judgements
about matters relating to their own care. Casting its
feedback net a little wider than PREMs and
HCAHPS, PMOS opens the door for patients to
evaluate care from a rather more general perspective.
For example, patient ratings of clinical team function-
ing and organisational culture are invited with survey
statements like: ‘staff did not work together as a team
here’, ‘staff seemed to struggle to help when they
needed it’ and ‘nurses were always able to get help
from other staff ’.
In eliciting patients’ views on what they see going
on around them, PMOS invests faith in patients’
ability to provide ‘eyewitness’ accounts. This is not
surprising. A number of studies have now reported
patients to be keen to provide their local service with
advice, particularly when care goes wrong: “What I
[patient] had started to do [during my care] was to
write down a journal and do an evaluation of what
was going on in the hospital and where the problems
were.”4 These studies also make clear that patients’
feedback may harbour critical implications for service
improvement.17
Of course, patients may get it wrong.18 It is striking,
though, that more and more healthcare service
improvement initiatives involve patients and draw on
their experiences to inspire and guide change.19 It is
patients’ lived experiences in particular that play an
increasingly important role at conferences and meet-
ings. For patients, the next best thing to here-and-now
dialogue is indeed post hoc story-telling. Stories can
recount what happened in all its complexity, including
tensions, uncertainties and contradictions. Stories are
good for enabling us to make sense of confusing
experiences and complex circumstances:20 something
can make sense even when we lack answers and
certainty.
We make these observations by way of background
to three questions we want to pose about Lawton and
colleagues’ study.15 Our first question concerns the
measurability of non-standard experiences, the second
relates to the translation of measurement into practice
change and the third asks about the governance
approach and service responses favoured by patients
when their care falls short.
PMOS was originally designed to accommodate
non-standard care experiences from data obtained
from 14 non-Caucasian/British interviewees and 19
white/British interviewees.1 The inclusion of patients
from culturally and linguistically diverse backgrounds
is significant as they are more likely to experience sub-
standard care, incidents and less than ideal treatment
trajectories.21 Lawton and colleagues’ present study
draws on the input from predominantly white British
patient respondents. The question that arises here
then is whether the inclusion of patients from less
well-integrated and more recent immigrant popula-
tions in the design of PMOS might have yielded dif-
ferent items, and whether their inclusion in the
comparison between PMOS and other safety measures
might have yielded different results.
The second question is about how we convert PMOS
measurement results and rating comparisons into prac-
tice. If results highlight persistent problems in a particu-
lar domain of care or a particular service—say, a lack of
respect for patient’s need of privacy—that domain or
service may be targeted with a tailored improvement
programme. Patients’ interview statements that were ori-
ginally used as the basis for PMOS domains are quite
revealing about how to design such a programme: “This
one lady she has had a line on her chest … and a few
times they have not put the curtain around … her.”13
Designing a programme without reference to specific
local problems will render it abstract and decontextua-
lised, and its purpose and focus may not be apparent to
those targeted. Learning is most effective when tied to
specific experiential circumstances, because behaviour is
not necessarily fully conscious,22 and the learner needs
to recognise herself and her behaviour in what is
learned. Abstract formal learning remains at too many
removes from actors' practical awareness for it to trans-
late into behaviour change. As pedagogical theory has
taught us, we need to create opportunities for learners
to connect learning to actual in situ behaviour and per-
sonally experienced situations for them to be able to
close the loop between information, knowledge, self-
identity and practice.23 24 Measurement may be pro-
moted as service improvement resource, but its distance
in time and space from in situ care and local behaviour
considerably limit its effectiveness for achieving change
for patients.
Our third question rests on the finding that patients
experience ‘reluctance to directly challenge healthcare
professionals’. In practice, studies have found that
patients’ feedback to their own care providers is not
systematically encouraged, welcomed or used for prac-
tice improvement.4 When care is not to patients’ satis-
faction, let alone when care goes wrong, discussions
with clinicians and service representatives about con-
cerns and problems are more challenging and less
rewarding than patients expect them to be.2 25 At the
same time, patients are exhorted to become proactive
about care safety.26 Yet, it is evident that patients
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already play a credible and important, albeit invisible,
role in keeping their own and others’ care safe.27
Let us not forget that patients are among the first to
experience the baffling complexity of contemporary
care. Just think of the times we have been a patient
and were told: “Ms Smith, you need to be across the
road for that test. And this afternoon you’re not
seeing Dr Jones because she is on leave, and instead
you’ll be seeing Dr Bloggs whose office is on level 9.”
What to insiders may appear to be everyday occur-
rences are for patients bafflingly complex scenarios.
No doubt, this is not unrelated to patients being
more and more likely to present with multiple pro-
blems. Patients also interact with increasingly specia-
lised practitioners and services experiencing high
levels of staff turnover. Practitioners often experience
uncertainty about treatments and resource
decisions, as well as having to accommodate ongoing
technological change, scientific development and
organisational reform. When asked about their care
experiences, patients often talk about complex care
journeys, variable impressions and persistent
questions.25
It is also clear that chronically ill patients, alongside
culturally and linguistically diverse background
patients, are particularly at risk in this regard.21 Their
journeys and experiences are complex, unique and
often fraught. While these ‘complex patients’ may be
increasingly targeted with trials, surveys and inter-
views, they do not always feel that such studies make
it possible for them to relate issues that matter to
them.3 When they feel unsafe, patients should be able
to provide direct feedback and see that feedback is
translated into action when and where they receive
their care. At the least, they should be able to expect
that their fellow patients be spared the problems that
they happened to witness or personally experience.4
These expectations raise the bar in two ways. First,
to ensure that—besides making possible interservice
ratings and comparisons—patients’ experiences
produce meaningful and timely impact on care as
practice, healthcare services need to adopt a proactive
stance towards patients’ in situ feedback. This is
because patients’ experiences—whether scientifically
measured or told as post hoc stories—continue to
have a tenuous link with service improvement.27
Second, to ensure that the generic and abstract aspects
of patients’ experiences and their richness and diver-
sity become integral to practice improvement, we
need to grant patients a greater say in how they
provide feedback, and how their feedback is converted
into practice. In spite of all the effort put into patient-
focused research, it is still the case that patients ‘are
rarely given the opportunity to represent themselves
in ways that enable them to highlight their own points
of view and issues of concern, or to provide creative
insights that they themselves hold dear’. (personal
communication, Collier A and Wyer M, 2015).
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APPENDIX 5: COMMUNITY-LED LEGAL INTERVENTIONS TO CONTROL ALCOHOL 
 
APPENDIX OVERVIEW 
This appendix presents the findings of a systematic review of evaluations of community-led 
legal interventions in Indigenous populations around the world referenced in the introduction 
to this thesis. The appendix consists of a single manuscript titled: Global systematic review of 
Indigenous community-led legal interventions to control alcohol. 
While outside the scope of this thesis, the work provides insight into the effectiveness of 
community-led legal interventions to control health. This represents an alternative means 
incorporating Indigenous preferences and values in the development of health interventions 
outside the techniques examined in this thesis.  
PUBLICATION DETAILS 
Muhunthan, J., B. Angell, et al., Global systematic review of Indigenous community-led legal 
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ABSTRACT
Objectives: The national and subnational
governments of most developed nations have adopted
cost-effective regulatory and legislative controls over
alcohol supply and consumption with great success.
However, there has been a lack of scrutiny of the
effectiveness and appropriateness of these laws in
shaping the health-related behaviours of Indigenous
communities, who disproportionately experience
alcohol-related harm. Further, such controls imposed
unilaterally without Indigenous consultation have often
been discriminatory and harmful in practice.
Setting, participants and outcome measures: In
this systematic review of quantitative evaluations of
Indigenous-led alcohol controls, we aim to investigate
how regulatory responses have been developed and
implemented by Indigenous communities worldwide,
and evaluate their effectiveness in improving health and
social outcomes. We included articles from electronic
databases MEDLINE, EMBASE, CINAHL, PsycINFO and
Web of Science from inception to December 2015.
Results: Our search yielded 1489 articles from which
18 met the inclusion criteria. Controls were
implemented in rural and remote populations of high-
income nations. Communities employed a range of
regulatory options including alcohol rationing,
prohibition of sale, importation or possession,
restrictions on liquor sold, times of sale or mode of
sale, Indigenous-controlled liquor licensing, sin tax and
traditional forms of control. 11 studies reported
interventions that were effective in reducing crime,
injury deaths, injury, hospitalisations or lowering per
capita consumption. In six studies interventions were
found to be ineffective or harmful. The results were
inconclusive in one.
Conclusions: Indigenous-led policies that are
developed or implemented by communities can be
effective in improving health and social outcomes.
INTRODUCTION
Governments in most developed nations
have adopted some form of regulatory and
legislative control over alcohol supply and
consumption through initiatives such as
licensing systems, taxation, a minimum age
of purchase and penalties for drink drivers.
These measures have proven beneﬁcial
to the health of populations worldwide,
however, Indigenous communities across the
world remain disproportionately affected by
harmful alcohol use, casting doubt over the
effectiveness of these measures in reducing
the burden of alcohol-related deaths,
chronic disease and disability in Indigenous
populations. There have been limited evalua-
tions of the effectiveness of such legal mea-
sures and their appropriateness in shaping
alcohol-related behaviours in Indigenous
communities.
In part, the disproportionate burden of
alcohol harm borne by Indigenous commu-
nities around the world has resulted from
the stressful experiences of discrimination,
colonialism, dispossession and economic
and social marginalisation of Indigenous
peoples in many countries.1 2 Public health
academics hypothesise that legal measures
may be ineffective in reducing this burden
in Indigenous populations because policy
models lack cultural acceptability, due to
Strengths and limitations of this study
▪ This systematic review is the first to explore the
effectiveness of legal responses to alcohol
misuse and alcohol-related harm that have been
designed and implemented by Indigenous
communities.
▪ Summarising the evidence on effective and inef-
fective community-led policy models could
provide valuable insights into local policy innov-
ation to promote the health of marginalised
populations.
▪ Effective controls could encourage nation-states
and subnational governments to facilitate,
through a menu of regulatory instruments, power-
ful and acceptable community-led approaches to
Indigenous alcohol policy worldwide.
▪ This review was limited to published literature
and did not include grey literature.
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inadequate investment in the social determinants of
health (eg, education, transport and employment) and
that these policies fail to achieve adequate levels of
enforcement and accountability in these communi-
ties.3 4 The United Nations (UN) Expert Mechanism
on the Rights of Indigenous Peoples has mandated
that Indigenous participation in decision-making on
the full spectrum of matters that affect their lives forms
the fundamental basis for the enjoyment of human
rights.5 Further, the UN has cautioned member states
that a failure to ensure these rights can lead to further
marginalisation and inequities among Indigenous
people.5 Yet peak Indigenous health bodies such as
Australia’s National Aboriginal Community Controlled
Health Organisation attribute the ongoing crisis in
Indigenous health to a lack of cohesive public policy
and the lack of power that Indigenous people have
had in inﬂuencing public policy decisions that affect
their social and emotional and well-being.6 In Australia,
public health academics have argued that compulsory
alcohol restrictions which have been imposed on
Indigenous communities by unilateral state action
(in some areas for decades), have constituted “an
affront to Indigenous self-determination” and that with-
out community support, these interventions are “an
overly simplistic solution to a complex problem” and
risk the revival of a protectionist past.7 In the USA,
following a move to nullify local alcohol laws estab-
lished by Alaska Native tribal councils by the Federal
Government, alcohol abuse and alcohol-related mortal-
ity escalated for the next two decades until this centra-
lised approach was reversed.8
Local Indigenous knowledge and systems of govern-
ance, which could provide insights into policy innov-
ation and a sustainable shift in social norms, remain
neglected areas of public health research to date.
There is potential for community-led legal initiatives to
be used as preventative health tools for communities
affected by the harmful use of alcohol and dispropor-
tionately affected by chronic conditions and their risk
factors. While community leadership is the ideal, it is
not always clear how this concept is applied, in particu-
lar how community involvement in the design and
enforcement of these programmes interacts with formal
government regulatory input. Such community input
could involve the engagement of local leaders in devel-
oping local solutions through innovative initiatives that
use tools such as community partnerships, local taxes,
restrictions or incentives. Lessons regarding the use
and effectiveness of such measures have not been
synthesised previously in the published literature. In
light of emerging interest in building countries’ legal
infrastructure to promote health, this study aimed to
investigate how Indigenous communities use public
health law mechanisms to control alcohol and prevent
its misuse and to what extent controls are effective in
achieving improvements in health and social
outcomes.9
METHODS
A systematic review of published literature was under-
taken. Databases MEDLINE, EMBASE, CINAHL,
PsycINFO and Web of Science, were searched from
inception to 18 December 2015 to identify published
quantitative evaluations of Indigenous-led alcohol con-
trols. The WHO deﬁnition was followed in identifying
Indigenous populations.10 Globally, there is a lack of
consensus regarding the terminology used to describe
Indigenous populations. In this review, we have mirrored
the study authors’ use of Indigenous terminology.
Inclusion criteria
Studies had to meet four criteria for inclusion in this
review. First, studies had to examine an Indigenous
population. The search strategy (see online
supplementary ﬁle 1) for this component was adapted
from previously published systematic reviews.11 12
Second, studies had to examine legal interventions
(including traditional forms of law) that were
community-led. The authors deﬁned community-led in
terms of development and/or implementation (either
in terms of development and/or implementation). In
order to be included on the basis of development, com-
munities needed to have developed (in isolation or in
collaboration with other stakeholders such as govern-
ments) the nature and scope of the alcohol control. To
be included on the basis of implementation, it was
necessary that alcohol controls were implemented or
governed by the community or community representa-
tives. Studies were included if controls were government-
facilitated with supporting regulatory controls. The
authors acknowledge that regulatory responses to
control alcohol often require the resources and regula-
tory power of governments and their agencies.
Therefore, it is open to conjecture whether these con-
trols can be genuinely community led. Third, studies
had to examine interventions designed to reduce the
harms of alcohol consumption. Finally, studies had to
quantitatively evaluate the effectiveness of legal interven-
tions to control alcohol in improving one or more
health or social outcomes. Qualitative articles, as they
lacked a quantitative measure of effectiveness, were
excluded from this review. Studies were not excluded on
the basis of language, the methods of the quantitative
studies or their outcome measures.
Data extraction
Study review and selection were independently under-
taken by two authors ( JM and BA). Abstracts, titles and
keywords of the studies returned from the search were
screened for compatibility with the inclusion criteria.
Once studies were identiﬁed for potential inclusion, full
texts were reviewed. Reference lists of included papers
were independently reviewed by two authors ( JM and
BA) for studies that may warrant inclusion. Data were
extracted from the studies using a form developed for
the review in consultation with the authorship team.
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Data extracted included country of origin, Indigenous
population and size, category of alcohol control, legal
instruments employed, communities’ use of research evi-
dence or population data to inform the control, data
collected and time horizon of the evaluation (table 1).
Any disagreements throughout this process were
resolved by arbitration with reviewers MLH and SJ.
RESULTS
The review found 18 studies spanning 1975 to 2014.
Populations studied
All studies came from high-income nations, the USA
(n=10), Australia (n=6), Canada (n=1) and Greenland
(n=1; see table 2). Except for the Greenlandic study
which was nationwide, populations studied were rural or
remote communities.
Study designs
All study designs were of before and after, cross-sectional
or time-series analyses using primarily secondary data
(table 2). Two of the included Australian studies are
linked before and after studies evaluating the impact of
alcohol controls in four communities following the
introduction of two state government-facilitated
supply-reduction strategies, one in 2002–2003 and the
other in 2008.13 14
Eight studies evaluated health or social outcomes
before and after alcohol controls were introduced.13–20
Two of those studies also evaluated health or social out-
comes after the controls were repealed in their study
populations.19 20
Six studies used one or more other populations as a
control group to compare ‘wet’ villages (those without a
restrictive alcohol law) with ‘damp’ villages (those with
some restrictions in place but where alcohol could still
be bought in speciﬁc containers, quantities and venues)
or ‘dry’ villages (those with laws prohibiting the availabil-
ity of alcohol).8 17 21–24
Two studies from the US compared health outcomes
between one or more communities with different forms
of governance of alcohol control.25 26 One compared
traditional forms of control with communities that had
implemented local option laws (government-facilitated
opt-in alcohol controls that could be voted in by resi-
dents via local referendum).25 The other compared
outcomes between communities that had alcohol pro-
hibited under federal law, state law and local option
laws.26 One study compared Native and non-Native
American populations.27
One study evaluated a package of Indigenous-led
interventions implemented at different points in time
and used a time-series analysis to evaluate health and
social outcomes.28 Three studies employed a comparison
of Indigenous communities and state or national
averages across health and social outcomes.17 28 29 In
their use of comparators, some studies fell into more
than one of the categories discussed above.
Time horizon of evaluation
The length of follow-up investigations ranged between 1
and 27 years (table 2).
Categories of alcohol control
A range of regulatory options were designed and imple-
mented by local communities (table 2). The majority of
controls involved prohibition of the sale, importation or
possession, restrictions on liquor sold, times of sale or
mode of sale, Indigenous-controlled liquor licensing
and enhanced law enforcement. Other forms of regula-
tory control included a local excise tax, alcohol ration-
ing and traditional forms of control. Under Greenland’s
alcohol rationing system, each individual was entitled to
a sheet of 72 points of rationing coupons per month.
Alcohol was priced according to strength or size of
alcohol purchase (eg, one point for one beer and 24
points for three-quarters of a litre of hard liquor).20
Traditional forms of control were observed in Alaskan
communities where the ‘Yupi’it Nation’ sovereignty
movement (in opposition to government-facilitated local
option laws) had gained popularity. Interventions
involved a range of group-oriented responses including
ignoring antisocial behaviour, presenting the transgres-
sion in a dramatised dance form in the men’s house
(kashgi), community leaders resolving the dispute
through consultation, banishment from the village and
ﬁnally, killing the offender.25
Indigenous representation in decision-making
Indigenous-led controls reviewed fell into four categor-
ies. First, controls that were conceived and implemented
by the community included the traditional forms of
control discussed previously.25 Second, government-
Table 1 Data extracted from evaluations meeting inclusion criteria
Population Characteristics of evaluation Mechanism of alcohol control Effectiveness of control
Indigenous population
Country of origin
Setting (urban or remote)
Size of study population
Study design
Time horizon of evaluation
Use of control population
Study limitations
Generalisability of findings
Policy implications
Type of alcohol control mechanism
Legal instruments employed
Use of research evidence and
population data to inform scope and
nature of control
Outcomes reported
Effectiveness of control in
achieving prevention
outcomes
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Table 2 Quantitative evaluations of alcohol controls meeting inclusion criteria
Author
(year)
Country of
origin
(Indigenous
population) Population size
Category of alcohol
control Legal instruments
Health and social
outcomes reported Data collected
Time Horizon of
evaluation
May (1975)19 United States
(Native American)
12 000 (Native American) Prohibition of sale,
importation or possession
Tribally imposed
prohibition laws
Arrests Tribal Police data 3 years ( June–July
1969, June–July
1970, June–July
1971)
Schechter
(1986)20
Greenland
(Greenlandic
Inuit)
50 000 (80% Indigenous) Alcohol rationing Rationing ordinance
passed by the
Greenland Council
following public
plebiscite
Alcohol sales; crime Alcohol sales or
consumption data
6 years (1978–1984)
Gallaher et al
(1992)27
USA (Native
American)
123 000 (all residents of
New Mexico)
Prohibition of sale,
importation or possession
Tribally imposed
prohibition laws
Unintentional injury Cause-specific mortality
data; Hospital records or
medical examiner
reports; Traffic accident
report files (containing
location of Indigenous
pedestrian deaths)
10 years ( January 1
1980 to December 31
1989)
Lee (1993)25 USA (Alaska
Native)
8 Indigenous villages (of
57 in the region)
Restrictions on liquor sold,
times of sale or mode of
sale; traditional forms of
control
Local option law Crime; Intentional
injury (self-harm,
attempted suicide or
suicide)
Crime data for serious or
minor offences
5 years (1983–1987)
Chiu et al
(1997)16
USA (Alaska
Native)
4000 (61% Indigenous) Prohibition of sale,
importation or possession
Local option law Social or health service
usage
Alcohol-related
outpatient visit records
33 months
(November 1993
through July 1996)
Landen et al
(1997)24
USA (Alaska
Native)
Dry villages: 63 419
person-years (93%
Indigenous)
Wet villages:
38 867 person-years
(55% Indigenous)*†
Prohibition of sale,
importation or possession
Local option law Unintentional injury Cause-specific mortality
data
3 years (1990-1993)
Landen
(1997)23
USA (American
Indian)
Wet reservations:
(1) <5000; (2) 5000–
10 000; (3) <5000 (4)
5000–10 000 (5) 5000–
10 000
Dry reservations:
(6/7) 10 000 –15 000
10 000–15 000 (8) 5000–
10 000
Prohibition of sale,
importation or possession
Tribally imposed
prohibition laws
Alcohol-related
mortality
American Indian
mortality data by county
11 years (1979–
1990)
Continued
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Table 2 Continued
Author
(year)
Country of
origin
(Indigenous
population) Population size
Category of alcohol
control Legal instruments
Health and social
outcomes reported Data collected
Time Horizon of
evaluation
Douglas
(1998)17
Australia
(Aboriginal and or
Torres Strait
Islander—
primarily Kija and
Djaru language
groups)
∼1200 with 3000 from
surrounding towns (63%
Indigenous)
Restrictions on liquor sold,
times of sale or mode of
sale
Regulation instituted
by state or territory
liquor licensing
authorities
Crime; Social or health
service usage
Alcohol sales or
consumption data
3 years (1991–1994)
d’Abbs
(1998)29
Australia
(Aboriginal and
Torres Strait
Islander)
7 Indigenous
communities (of total of 8
with licensed clubs)
Indigenous-controlled
liquor licensing
Not stated Alcohol consumption Alcohol sales or
consumption data
1 year (1994–1995)
Berman et al
(2000)22
USA (Alaska
Native)
29 000 (26 000 in control
group)
Indigenous-controlled
liquor licensing;
Prohibition of sale,
importation or possession
Local option law Injury Legal determinations
classifying injury deaths
(data not available to
determine whether
alcohol-related)
13 years (1980–
1993)
Gray et al
(2000)15
Australia
(Aboriginal and
Torres Strait
Islander)
∼2700 (all residents of
Tennant Creek)
Restrictions on liquor sold,
times of sale or mode of
sale
Regulation instituted
by state or territory
liquor licensing
authorities
Alcohol consumption;
hospital admissions;
admissions to local
women’s refuge and
sober up shelter;
crime;
Alcohol sales data,
health and social service
admissions data; local
police data
4 years (1994–1998)
Ellis (2003)28 USA (American
Indian)
McKinley County: 43 000
Indigenous
Fremont: 7000
Indigenous
Restrictions on liquor sold,
times of sale or mode of
sale; local excise tax;
enhanced law
enforcement
Local option law Crime; Mortality (motor
vehicle accident
mortality, homicide,
suicide and
alcohol-induced
causes); Motor vehicle
accidents
Alcohol sales or
consumption data;
adolescent substance
use data; Hospital
records or medical
examiner reports; Traffic
accident report files;
crime data for serious or
minor offences
21 years (1974–
1995) for annual
mortality rates for
selected substance
abuse-related
causes; 1 year
(1989–96) for traffic
crash rates.
Wood and
Gruenewald
(2006)8
USA (Alaska
Native)
Dry villages: 165 191
person-years (108 906
with and 56 285 without
local police presence)
Wet villages: 67 906
person-years (45 655
person-years with and
22 251 person-years
without local police
presence)*†
Prohibition of sale,
importation or possession
Local option law Motor vehicle
accidents; Intentional
injury (self-harm,
attempted suicide or
suicide); Intentional
injury (self-harm,
attempted suicide or
suicide)
Serious injury data
obtained from state
trauma registries; data
pertaining to police
presence (number of
months that a village had
a police service used as
an indicator of police
presence)
10 years (1991–
2000)
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Table 2 Continued
Author
(year)
Country of
origin
(Indigenous
population) Population size
Category of alcohol
control Legal instruments
Health and social
outcomes reported Data collected
Time Horizon of
evaluation
Hogan et al
(2006)18
Australia
(Aboriginal and
Torres Strait
Islander)
Not stated Restrictions on liquor sold,
times of sale or mode of
sale
Regulations
instituted by state or
territory liquor
licensing authorities
Alcohol sales; crime;
Social or health service
usage
Alcohol sales or
consumption data;
Hospital records or
medical examiner
reports; Admissions to
local Sobering Up
shelter; Crime data for
serious or minor
offences
1 year (April 2002—
June 2003)
Margolis et al
(2008)13
Australia
(Aboriginal and
Torres Strait
Islander)
4 Indigenous
communities
Restrictions on liquor sold,
times of sale or mode of
sale
Alcohol
Management Plan
(AMP)
Injury; Social or health
service usage
Royal Flying Doctor
Service trauma retrieval
data
8 years pre and
2 years post-AMP (1
January 1995–24
November 2005)
Wood
(2011)21
Canada (First
Nation)
23 Indigenous
communities
Prohibition of sale,
importation or possession
Local option law Crime data for serious or
minor offences
21 years (1986—
2006)
Margolis et al
(2011)14
Australia
(Aboriginal and
Torres Strait
Islander)
Community A 1129
(1059, 94% Indigenous),
community B 1101
(1028, 93% Indigenous),
community C 599 (541,
90% Indigenous),
community D 644 (580,
90% Indigenous).
Prohibition of sale,
importation or possession;
Restrictions on liquor sold,
times of sale or mode of
sale
Alcohol
Management Plan
(AMP)
Injury; Social or health
service usage
Royal Flying Doctor
Service trauma retrieval
data
14.5 years (1 January
1996—31 July 2010)
Berman
(2014)26
USA (Alaska
Native)
178 Indigenous
communities
Prohibition of sale,
importation or possession
Local option law Intentional injury
(self-harm, attempted
suicide or suicide)
Cause-specific mortality
data
27 years (1980-2007)
*Person-years: Some studies used person-years to quantify the populations of wet and dry villages where communities changed alcohol status one or more times during the period of the study.
For example, in Landen’s study, multiple wet and dry villages changed alcohol status. Thus, each month a village was dry, its population contributed one-twelfth of a person-year to the dry total.
A similar method was used for wet villages.
†.
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facilitated community-led controls included prohibition
and restriction controls that were facilitated by local
option laws that allowed communities to vote on their
desired form of alcohol control (eg, that alcohol could
be bought and sold, imported, sold and imported or
that possession was to be prohibited) through legally
held referendums.22 A third model involved ‘community
coalitions’ backed by government intervention. In an
Australian study in the Kimberley region, this involved
the Alcohol Action Advisory Committee consisting of
police, health, Aboriginal Legal Services and faith-based
organisations as well as individual members of the com-
munity who together lobbied the state Director of
Liquor Licensing to impose alcohol restrictions.17 A
fourth model of governance involved government
initiated community partnerships such as Queensland
Australia’s Meeting Challenges, Making Choices
Committee. The Committee involved community justice
groups and Indigenous Elders tasked with developing
alcohol management plans for their communities in
partnership with government agencies.13 14
Use of evidence in informing controls
The extent to which research evidence or population
data was used by communities to inform the develop-
ment and implementation of controls is unclear as most
studies (n=17) did not report this. One study reported
that research evidence pertaining to the severity of local
burden and conditions was available to tribal leaders and
the public.28 In that study, research evidence and popula-
tion health data, in combination with the local knowl-
edge of tribal leaders, helped to inform decision makers
about the various dimensions of the substance abuse
problem, provide indicators for the ongoing monitoring
of progress and safeguard against unintended impacts
on vulnerable sectors of the community through the
development of programmes (eg, an alcohol crisis
centre, alcohol server training and KICK-IT, an adoles-
cent programme targeting at-risk youth).
Enforcement of alcohol controls
One study investigated the impact of the brief legalisa-
tion of alcohol in a large American Indian tribe on the
Great Plains where the possession and use of alcohol
had never been legal. That study estimated that arrests
for intoxication declined immediately after legalisa-
tion.19 The ﬁndings suggested that the enforcement of
prohibition controls did not necessarily reduce inci-
dences of harmful alcohol use. For example, authors
hypothesised that drinkers were less likely to rapidly
consume alcohol in attempts to circumvent prohibition
controls when alcohol was legal. Another study from the
US, reported that despite prohibition on the sale and
importation of alcohol, 117 convictions for bootlegging
were enforced by the Alaska Alcoholic Beverage Control
Board over the 3-year evaluation.24
Sixteen studies did not report quantitative data regard-
ing the legal enforcement of the alcohol controls.
However, the authors noted several challenges, many
speciﬁc to particular categories of control.
Alcohol rationing
With regards to alcohol rationing, alcohol coupons were
legally non-transferable but the proper legal use of the
coupons was seldom enforced. Identiﬁcation was not
requested and the point sheets were not printed with a
marker of personal identiﬁcation.20
Prohibition and restriction controls
With regards to the prohibition category, ‘dry’ communi-
ties that bordered ‘wet’ communities often found a per-
sisting problem in the movement of heavy drinkers in
‘dry’ communities to other towns where alcohol was
legally available.19 27 In New Mexico, this resulted in
limited options for intoxicated persons to travel home
safely and deaths due to hypothermia or pedestrian acci-
dents resulting from travelling the large distances
between towns.27
In studies that evaluated interventions in the prohib-
ition or restriction categories, providing adequate police
services in rural areas was problematic.8 Challenges
included difﬁculties imposed by extreme weather and an
absence of roads connecting communities to major
towns. In one study, this precluded the deployment of
trained state-certiﬁed police ofﬁcers to the most isolated
Alaska Native villages. Only a few communities had their
own local departments that employed fully certiﬁed
police ofﬁcers. Other villages were served by non-
certiﬁed para-professional Village Public Safety Ofﬁcers.
However, many villages went months without the pres-
ence of an ofﬁcer due to extremely high rates of attri-
tion of ofﬁcers. Some villages had no local police
presence and were instead served by state troopers on
an as-needed basis by air or river.8
The presence of illegal smuggling of alcohol into com-
munities, and then unlicensed sales to drinkers pre-
sented a challenge to enforcement for other
communities. In one study, authors cited anecdotal
reports and unpublished consultation data pointing to
rising rates of sly grogging in some communities in
Cape York, Queensland.14 However, one study reported
that stronger enforcement measures had brought about
increased efﬁciency. Code enforcement had become
increasingly diligent and in combination with the
enforcement of other liquor laws, had the effect of redu-
cing the frequency of inappropriate alcohol sales. The
measures also led to increased community cohesion and
engagement with alcohol sellers. When hours for
drive-up alcohol sales were restricted, some alcohol
sellers voluntarily closed their drive-up windows.28
Traditional forms of control
With regard to traditional forms of control, a signiﬁcant
issue was that the village social structure did not support
a village member assuming a formal, external, authori-
tarian role. Having to interfere with personal
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relationships or arrest one’s friends and relatives was not
compatible with village life.25
Effectiveness of interventions
In 11 of the 18 studies reviewed, the Indigenous-led
alcohol controls employed were effective in achieving
improvements in one or more health outcomes
(eg, reductions in disease, injury or crime)
(table 3).8 13–17 20–22 24 28 Interventions were classiﬁed
as effective if the controls were associated with improve-
ments within the same population or in comparison
with other populations, except where authors deemed
the results inconclusive due to methodological or
reporting biases.
Seven of these studies involved the evaluation of one
category of alcohol control.8 13 16 17 20 21 24 The remain-
ing four studies involved evaluations of multiple categor-
ies of alcohol control.14 15 22 28 Prohibition of alcohol
possession, sale or importation was the most frequently
implemented form of alcohol control among those that
were effective (n=6).8 14 16 21 22 24
Five studies reported less crime in the communities
studied (either in comparison to before the controls
were implemented, or in comparison to other popula-
tions without similar controls).8 17 20 21 28 Three studies
reported fewer injury deaths.22 24 28 Four studies
reported fewer injuries in the communities
studied.8 13 14 17 One reported that annual per capita
consumption of pure alcohol declined, as well as hos-
pital admissions for acute alcohol-related conditions.15
Some alcohol controls were effective in achieving only
some of the health outcome measures included in the
evaluations.17 22 In a US study of communities that went
‘dry’, by prohibiting the sale, importation and possession
of alcohol, they achieved reductions in homicides but
there was no effect on rates of suicide. Communities
that became ‘damp’ achieved reductions in suicides, but
there was no effect on homicides.22 In an Australian
study, a package of interventions implemented in a
single community including reduced trading hours for
take-away outlets and restrictions on the type of alcohol
sold at speciﬁc times of the day, achieved reductions in
criminal charges imposed by the Halls Creek Police
Station. Reductions were also achieved in aeromedical
retrieval evacuations resulting from serious injury requir-
ing hospital treatment and as such, could not be
managed within the study communities. However,
despite ﬂuctuations in the data for domestic violence
presentations to Halls Creek District Hospital, there was
no discernible or statistically signiﬁcant evidence of an
increasing or decreasing trend in hospitalisations over a
2-year evaluation period.17 Controls also had unintended
consequences. In Tennant Creek in Australia, despite
overall reductions in per capita consumption, restric-
tions were circumvented with a shift to fortiﬁed wine
purchases which remained accessible when sold in con-
tainers less than or equal to 1125 mL. In addition,
unlawful entries to dwellings signiﬁcantly increased fol-
lowing the imposition of alcohol restrictions.15
In six studies, alcohol controls were ineffective
(table 3).18 19 23 26 27 29 In one study in New Mexico,
US, there had been an increase in hypothermia and
pedestrian deaths in response to restrictions that
deemed alcohol possession and sale to be illegal.27 In
another US study involving 178 Alaska Native communi-
ties, the prohibition on importation was shown to be
ineffective in preventing suicide, the primary outcome
of the study. This ﬁnding raised questions about
whether alcohol was the causal factor in risk of suicide
or a comorbid response to depression or other mental
health problems.26 One US study found no signiﬁcant
differences in alcohol-related mortality between reserva-
tions where alcohol possession and use was prohibited
and those where it was legal.23 In another US study, the
short-lived (2-month) legalisation of alcohol possession
and consumption saw a decline in arrests for driving
while intoxicated.19 Arrests signiﬁcantly increased fol-
lowing a return to prohibition.19
In the Northern Territory in Australia, Aboriginal-
controlled licensed clubs failed to lower persistently
high consumption levels. Aboriginal-controlled licensed
clubs, a term often used interchangeably with Aboriginal
Social Clubs and wet canteens are speciﬁc community
venues that encourage responsible drinking patterns
(eg, through day caps, restrictions on hours of sale or
bans on problem-drinkers) and reinforce community
standards. In communities with these clubs, per capita
consumption remained 183% higher than the territory
average in males and 76% higher in females.29 Another
Australian study within the same territory found that
implementation of a suite of measures including restric-
tions on time of sale in take-away outlets, the removal of
liquor in containers >2 L and the provision of only light
beer in bars before noon was not associated with a sig-
niﬁcant reduction in quarterly wholesale sales of pure
alcohol over the 12-month trial period. Rather, drinkers
shifted from one product to another product of equal
price and purchased the same amount of pure alcohol.
There was a shift in consumption from cask wine to 2 L
cask port which was priced at 28 cents (AUD) per
10 mL, the same price as alcohol in the 4 and 5 L casks
that became unavailable under the trial restrictions.18
In a study of Alaska Natives, the results were inconclu-
sive.25 The data showed that villages that had maintained
traditional forms of social control had less crime
(including felonies and misdemeanours, with the excep-
tion of liquor violations as well as drunk in public and
protective custody incidents). However, the authors rea-
soned that this may be linked to reporting mechanisms
—the abolition of VPSO positions, avoiding contact with
state troopers, relying on traditional mechanisms with
no formal records of crime or choosing to ignore
certain behaviours. Another possibility that was high-
lighted is that such communities are more culturally
cohesive as they have retained traditional (Yup’ik) values
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Table 3 Effect of legal interventions to control alcohol on health and social outcomes
Author (year) Main results
May (1975)19 ▸ Arrests declined for the 2-month period of alcohol legalisation by 30% (182 in June-July of 1969 to
126 in June-July of 1970).
▸ Following the repeal, arrests rose by over 30% to 189 in June-July of 197.1
▸ Data pertaining to individual arrests was unavailable. However, at an aggregate level in 1969 and
1970, 88.7% of Native American arrests within and bordering the reservations were for alcohol
intoxication and driving while intoxicated.
Schechter (1986)20 ▸ Overall importation and consumption declined significantly.
▸ Number of drinks imported fell from 47 million in 1978 to 35.2 million in 1979, 30.5 million in 1980
and 36 million in 1981.
▸ Litres of pure alcohol consumed dropped from 513 627 in 1978 to 406 856 in 1979, 346 384 in 1980
and 436 066 in 1981.
▸ National crime rate dropped markedly particularly violent crimes (murder, attempted murder and
assault).
▸ After the repeal of alcohol rationing, consumption and importation rose by 60% and incidences of
crime increased significantly.
Gallaher et al
(1992)27
▸ Over 50% excess mortality from all unintentional injuries among Native Americans resulted from
hypothermia and pedestrian-motor vehicle crashes.
▸ New Mexico Native Americans nearly eight times more likely to die of hypothermia compared with
other New Mexico residents.
▸ At death, 90% of those Native Americans tested were highly intoxicated (median blood alcohol
concentrations of 0.24 and 0.18 mg/dL for pedestrian and hypothermia deaths, respectively).
▸ Most deaths occurred at off-reservation sites in border towns and on roads leading back to the
reservation.
Lee (1993)25 ▸ Of 9882 reported incidents of crime overall, Nation villages (employing traditional forms of control)
reported 34.5% of the total, non-Nation villages (employing local option controls) reported 65.5% of
the total.
▸ Rates for felonies and misdemeanors were lower in Nation villages, with the exception of liquor
violations and drunk in public and protective custody incidents.
▸ In non-Nation villages, incidence of strongarm rape were 6.9 times higher, non-aggravated assault
were 3.8 times higher, burglary 2.9 times higher and sexual assault 5 times higher.
▸ Nation villages reported more protective custody and drunk-in-public incidents than non-Nation
villages, yet serious reported crime were lower.
Chiu et al (1997)16 ▸ Substantial decrease in the number of alcohol-related outpatient visits when the ban on possession
and importation was imposed compared with baseline.
▸ When the ban was lifted, outpatient visits increased; when the ban was reimposed, the number of
outpatient visits again decreased.
▸ Interrupted time-series analysis confirmed that the alcohol ban, its lifting and its reimposition had a
statistically significant and negative effect on the number of alcohol-related outpatient visits (p<0.05).
▸ A significantly higher number of visits were made during the two non-ban periods (November
1993-October 1994) and November 1995-February 1996) compared with the two ban periods (p<0.05).
Landen et al
(1997)24
▸ Of 302 injury deaths, blood alcohol concentrations (BACs) were available for 200 deaths (66.2%). Of
these, 130 (65.0%) had a BAC greater than or equal to 17 mmol/L (greater than or equal to 80 mg/
dL) and were therefore considered alcohol-related.
▸ Total injury mortality rate was greater among Alaska Natives from wet villages (rate ratio (RR), 1.6;
95% CI 1.3 to 1.2). This difference was not present for non-natives (RR, 1.1; 95% CI 0.3 to 3.8).
▸ For Alaska Natives, the alcohol-related injury mortality was greater among residents of wet villages
(RR, 2.7; 95% CI 1.9 to 3.8) than among residents of dry villages. The strength of this association
was greatest for deaths due to motor vehicle injury, homicide and hypothermia.
Landen (1997)23 ▸ No significant differences across reservations with prohibition controls and those where alcohol was
legal. The average age-adjusted mortality rate found that the mortality rate was higher (n=158) than
prohibition (n=138) reservations.
Douglas (1998)17 ▸ Decrease in alcohol consumption observed for each of the 2 years following the intervention.
▸ Overall, incidence of crime declined.
▸ Alcohol-related presentations to the hospital and presentations resulting from domestic violence
decreased relative to the equivalent quarterly period prior to the intervention. Short-term fluctuations
were observed, particularly with domestic violence, where presentations (of lesser severity) became
more request during several quarters.
▸ Emergency evacuations as a result of injury showed a marked decrease.
Continued
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Table 3 Continued
Author (year) Main results
D’Abbs (1998)29 ▸ Mean consumption levels in standard drink terms, the corresponding equivalents were 5.8 standard
drinks per day for female drinkers and 9.3 for male drinkers.
▸ Among both male and female drinkers, the overall mean consumption levels were ∼50% above the
level designated as harmful.
▸ In one community, mean consumption lay in the responsible range and the other in the hazardous
range. In all others, male and females were above the harmful level.
▸ Total beer sales in the seven clubs (1994-1995) amounted to 882 259 L. Assuming a retail price of
$3.50 per 375 mL can of full-strength beer and $3.00 per can of light beer, the total retail turnover
would amounted to ∼$8.1 million.
Berman et al
(2000)22
▸ Injury deaths generally lower during periods when alcohol sales, importation or possession were
restricted than when no restrictions were in place (wet).
▸ More restrictive controls (dry) significantly reduced homicides but had no effect on suicide rates; less
restrictive control options (damp) reduced suicides but had no effect on homicide rates.
▸ Accident and homicide death rates fell, on average, by 74 and 66 per 100 000, respectively, for the
89 communities that banned sale and importation or possession. Sixty-one small communities that
did not change control status under the law showed no significant changes over time in accident or
homicide death rates.
▸ The decline in overall injury death rates was much greater in communities with less restrictive
options (127 compared to 48 per 100 000). However, death rates were higher in these communities
while they were wet, with the discrepancy statistically significant for suicides.
Gray et al (2000)15 ▸ Annual per capita consumption declined by 19.4% in the 2 years following the introduction of alcohol
restrictions.
▸ Hospital admissions for acute alcohol-related conditions declined.
▸ Restrictions were circumvented by a shift to fortified wine purchases. Fortified wine purchases
increased by 570% (573 L) offsetting 14% of the mean quarterly decline of 4173 L of cask wine
immediately following the restrictions.
▸ Purchases at Aboriginal-controlled licensed clubs (also not covered by the restrictions) increased by
55.7% from 2801 L to 1799 L of pure alcohol and offsetting 20% of the mean quarterly decline of
3002 L.
Ellis (2003)28 ▸ Following the introduction of restrictions on liquor sold, times of sale or mode of sale, a local excise
tax and enhanced law enforcement measures, from 1974 to 1995, McKinley County’s (MC) motor
vehicle accident mortality rate declined by 60% and was matched by similar declines in mortality
from homicide (58%), suicide (59%), alcohol-induced causes (30%) and drug-induced causes (50%).
▸ From 1989 to 1995, alcohol-related arrests declined 42% in Gallup, and protective custody
detentions were cut in half. Between 1982 and 1995, traffic crashes had declined 32% in MC. All
declines experienced in MC exceeded similar trends for New Mexico and the nation.
Wood (2006)8 ▸ Villages prohibiting alcohol had lower age-adjusted rates of serious injury resulting from assault,
motor vehicle collisions. Dry villages with a local police presence had a lower age-adjusted rate of
serious injury caused by assault.
▸ Local prohibition was associated with lower rates of assault injuries.
▸ Local police presence was associated with lower rates of assault injuries. Contrary to expectations,
there was no difference in the age-adjusted rate of injury attributed to self-harm for wet vs dry
isolated Alaska Native villages. Rates of serious injury caused by assault were 36% higher in
villages during periods of police absence than when police were present.
Hogan et al
(2006)18
▸ Over 12 months the reduction in trading hours was accompanied by decreased levels of
alcohol-related harm. However, the regulation of container size was undermined by a shift to cheap
cask port with sales of this product increasing by 1000%.
▸ A one-third reduction was observed in instances of drunkenness and breaches of the 2 km law, as
were Protective Custodies.
▸ Ambulance services received 25% less alcohol-related call-outs and selected presentation to the
emergency department of Alice Springs were reduced by 19%.
▸ Alcohol-related assaults were 13% lower. There was a nearly 20% increase in alcohol-related
offences, especially criminal damage and disturbances and indications of more acute conditions
being admitted to Alice Springs Hospital. However, the author’s reanalysis of these findings found
that the evaluators did not provide sufficient data to ascertain whether these were significant
reductions of chance phenomena.
Margolis et al
(2008)13
▸ Overall reduction (2 years vs 2 years before the AMP was implemented) was on average 51.9%
(Community (A) 44.8% (B) 54.6% (C) 66% (D) 42.2%).
Continued
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to a greater extent than communities with ‘Western
mechanisms’ of social control developed by state and
federal governments and operationalised by authorities
(eg, ‘judges, magistrates, district courts and marshals’)
external to Indigenous social and cultural systems.28
DISCUSSION
This review found 18 quantitative evaluations of
Indigenous-led alcohol controls. The controls were
implemented in rural and remote populations in high-
income countries. Prohibition on the sale, importation
or possession of alcohol was the predominant category
of control. Eleven of the 18 studies found one or more
alcohol controls (predominantly prohibition) to be
effective in improving a broad range of health and social
outcomes including reduced rates of hospitalisations,
injury and crime.
The ﬁndings of this review add to qualitative research
that has explored the widespread and under-recognised
agency of Indigenous communities to engage in effect-
ive health governance.30 31 The studies reveal a wide-
spread preference for strong, legal responses to public
health problems such as harmful alcohol use which
conﬁrm ﬁndings of qualitative work exploring commu-
nity views regarding Indigenous-led alcohol controls.15 32
In addition, they suggest that many such policy models
characterised by community representation and leader-
ship in the development and implementation of alcohol
controls are effective in improving health outcomes and
deserve serious consideration by governments who can
facilitate opportunities for Indigenous populations glo-
bally to actively participate in the advocacy, design and
implementation of public health law.
Nevertheless, the results reveal the complexity involved
in implementing Indigenous-led alcohol controls such
Table 3 Continued
Author (year) Main results
▸ Retrieval rates for all other causes did not reveal any statistically significant change. Serious injury
resulted in 798 retrievals during the observation period. There was a significant (p=0.021) decrease
in injury after the introduction of AMP.
Wood (2011)21 ▸ Wet communities in Nunavut recorded rates of violent crime that were higher than dry communities.
▸ Relative to dry communities, wet communities’ overall sexual assault rate was 1.48 (95% CI 1.38 to
1.60) times higher, the serious assault rate was 2.10 (95% CI 1.88 to 2.35) times higher and the
homicide rate was 2.88 (95% CI 1.18 to 8.84) times higher.
▸ Dry communities were safer than wet communities but still reported rates of violence that were
higher than national rates, including a serious assault rate that was double the national rate (3.25 per
1000 vs 1.44 per 1000) and a sexual assault rate that was at least seven times as high as the
national rate (7.58 per 1000 vs 0.88 per 1000).
▸ Homicide, the rarest violent offence, was relatively more frequent in wet communities than in dry
communities (RR=2.88; 95% CI 1.18 to 8.84).
Margolis et al
(2011)14
▸ After alcohol restrictions were introduced in 2002-2003, retrievals for serious injury dropped initially,
then increased in the 2 years before further restrictions in 2008 (average increase, 2.34 per 1000 per
year). This trend reversed in the 2 years after the 2008 restrictions (average decrease 7.97 per 1000
per year).
▸ There was a statistically significant decreasing time trend in serious-injury retrieval rates in each of
the four communities for the period 2 years before the 2002-2003 restrictions, 2 years before the
2008 restrictions and the final 2 years of observations (2009-2010) (p <0.001 for all four communities
combined).
▸ Overall, serious injury retrieval rates dropped from 30 per 1000 in 2008 to 14 per 1000 in 2010, and
the proportions of serious-injury retrievals decreased significantly for all four communities.
Berman (2014)26 ▸ Suicide rates were higher in communities prohibiting alcohol importation under state law, but the
effect was not significant after controlling for other community characteristics.
▸ More remote communities, those with fewer non-Natives and those with evidence of cultural divides
had higher suicide risks.
▸ Communities with higher incomes, more married couples and traditional elders had lower risks.
There was a strong association of community characteristics with the choice of alcohol status,
consistent with the hypothesis that it is endogenous.
▸ Communities choosing alcohol control by referendum were generally larger, with a higher percentage
of Alaska Native residents and more remote.
▸ Communities with lower median incomes were more likely to choose prohibition.
▸ Young men’s suicide risks were significantly higher (p<0.01) when alcohol was prohibited under the
state local option law.
▸ The association between adoption of any local alcohol control option and suicide was even stronger
(p=0.01). However, communities using federal Indian law to ban alcohol had significantly lower
suicide risks (p<0.5).
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that populations beneﬁt (in terms of health and social
outcomes and other social goods including community
engagement and capacity building) and vulnerable
members of the community are not further disadvan-
taged. Many of the studies reviewed reported unintended
impacts on vulnerable members of communities includ-
ing those experiencing substance addiction, unemploy-
ment, poverty, women and children and other at-risk
populations. This was particularly signiﬁcant for commu-
nities that were not geographically isolated from commu-
nities where alcohol was legally available. The availability
of alcohol in other regions carried the potential to under-
mine controls in neighbouring ‘dry’ or ‘damp’ communi-
ties by facilitating heavy drinking in neighbouring areas
without alcohol restrictions or the illegal importation of
alcohol into ‘dry’ areas. For example, the introduction of
prohibition, the strongest form of alcohol control carried
health risks to individuals experiencing substance abuse
and travelling long distances to neighbouring areas to
obtain alcohol. Health risks included hypothermia due
to excessively cold weather conditions, hunger and thirst
and pedestrian deaths due to being struck by a vehicle
driven by an intoxicated driver or exposure to risk as an
intoxicated pedestrian.27 This information problem is
pervasive in under-resourced and marginalised commu-
nities.33 However, the experience of McKinley County in
the US, where sizable declines (60%) in the rate of
motor vehicle accident mortality and (40%) in alcohol-
related arrests were achieved, may suggest that communi-
ties could beneﬁt from being able to access and use
research evidence and public health surveillance systems
to inform local alcohol policy.28
Another signiﬁcant challenge faced by communities
was maintaining the sustainability of the controls, which
in many cases were repealed and reinstated on multiple
occasions. This occurred due to demographic change
(eg, a higher proportion of non-Indigenous voters, who
were less likely to support alcohol restrictions), local
business and economic interests, unpopularity of the
control and inadequate resourcing to combat unlicensed
alcohol supply (bootlegging), unsafe home brewing and
crime (eg, theft) committed with the intent of obtaining
possession of alcohol.17 20 22 24 27 Prohibition controls
that were implemented through local elections in the
US and Canada could be repealed easily by local refer-
endum and as such, many communities changed their
alcohol status from year to year, highlighting the chal-
lenges of sustainability.16 21 An additional challenge to
the sustainability of controls is their enforcement. Few
studies reported data (eg, arrests, imposition of penal-
ties) on the extent to which controls were enforced.
Such measures often do not reveal the true extent of
compliance. However, to the extent that it is accessible,
the reporting of these data could work to better inform
and prepare communities as alcohol control models
evolve and adapt to community need.
The responsibility of governments to protect the health
of populations, particularly that of marginalised
populations is almost universally recognised.34 35 Further,
national and subnational governments are considerably
better resourced than Indigenous communities to meet
this aim and as such, hold a unique position to contribute
in the key areas highlighted in this review.34 35 The ﬁnd-
ings suggest that a ﬁrst step could be taken in remedying
the information problem by providing access to public
health evidence and population data at the outset of the
consultation and design process. This could enable a
more targeted, informed and effective approach, help to
identify potential unintended impacts on vulnerable indi-
viduals who may be disproportionately affected and iden-
tify measurable indicators for the monitoring and
evaluation of the control. In addition, governments could
provide support to ensure local decision makers have
access to a context-speciﬁc menu of available legal avenues
that communities can consider for potential effectiveness,
acceptability and equity. Speciﬁcally, this could involve
legal information pertaining to the availability of alcohol
within the communities and in surrounding populations,
legal status of the control, enforcement measures, the
scope of the control, models for immediate and stepwise
implementation and consideration of time horizons (eg,
trial periods or sunset provisions). In addition, this could
include the provision of case studies and evaluations of
controls in other communities.
A key strength of this study is its comprehensiveness.
No limitations were placed on the basis of language,
study type, type of health or social outcome, measure of
effectiveness or Indigenous population. Further, we
included traditional forms of control that did not
involve government intervention. One limitation is that
we focused exclusively on the peer reviewed literature as
it there are no comprehensive global holdings of the
grey literature in this area.
CONCLUSIONS
Public health law can be a powerful prevention tool
capable of alleviating the devastating effects of alcohol and
alcohol-related harms, particularly where strengthened by
community based and culturally sensitive enforcement
mechanisms. Advocates and Indigenous health scholars
have underscored the importance of Indigenous peoples
retaining a place at the forefront of decision-making in a
manner that is reﬂective of Indigenous rights including,
but not exclusive to those enshrined in the UN
Declaration on the Rights of Indigenous Peoples and dis-
tinct from the almost universal history of paternalistic
alcohol control.5 36 The ﬁndings of this review indicate
that community-led alcohol controls characterised by their
development and/or implementation by Indigenous com-
munities globally have been shown to be effective in
improving health and social outcomes.
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APPENDIX 6: DISCRETE CHOICE EXPERIMENT QUESTIONNAIRE 
 
This appendix presents the questionnaire used in the study presented in Chapter 7. The questionnaire 
was administered by trained Aboriginal research assistants.
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 Thank you for agreeing to participate in this Survey Evaluation of the Ironbark Falls Prevention 
Program 
As part of evaluating the Ironbark project, we would like to ask you a few questions about what the 
most important features of the program are to you. For the next 6 questions we would like to ask 
you which of two hypothetical classes you would choose if you had the choice. If you would prefer to 
not attend either class then please select neither. If this is the case we would still like to know which 
class you would prefer. 
Please remember that the classes are not real and your answers will not affect the Ironbark program 
that you are currently attending. Your responses will be used to help identify what is important 
about the program and how it can be made better in the future. 
 
WHAT DO YOU NEED TO DO IN EACH QUESTION? 
• Imagine that your doctor has recommended you attend an exercise class to improve your 
functioning and reduce your risk of falling. 
• You are given a choice between Class A and Class B. Both classes are one hour long and are 
held once per week. Both classes are equally effective in improving your functionality and 
reducing your chance of having a fall. 
For each question please choose which class you would prefer: Class A, Class B or neither. 
• There are 6 questions 
• Each question has a different version of Class A and Class B 
• The classes are not real, you will not have to attend. We are asking you to choose the Class 
you would prefer if you had a choice between attending Class A, Class B or neither. 
 
 
There are no right or wrong answers! 
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Question 1 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: $10     0     
Transport to class is provided Yes     No     
The class is for  Mainstream group     Aboriginal-specific group     
 
What does this mean? 
• Class A is $10 more expensive than Class B per class 
• Transport is provided for Class A but not for Class B (you have to make your own 
way). 
• Class A is for a mainstream community group while Class B is for an Aboriginal-
specific group. 
 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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Question 2 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: $10     $5     
Transport to class is provided Yes     No     
The class is for  Mainstream group     Aboriginal-specific group     
 
What does this mean? 
• Class A is $5 more expensive than Class B per class 
• Transport is provided for Class A but not for Class B (you have to make your own 
way). 
• Class A is for a mainstream community group while Class B is for an Aboriginal-
specific group. 
 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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Question 3 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: $10     $5     
Transport to class is provided No     Yes     
The class is for  Aboriginal-specific group     Mainstream group     
 
What does this mean? 
• Class A is $5 more expensive than Class B per class 
• Transport is not provided for Class A (you have to make your own way) but is 
provided for Class B. 
• Class A is for an Aboriginal-specific group while Class B is for a mainstream 
community group. 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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Question 4 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: 0     $10     
Transport to class is provided No     Yes     
The class is for  Aboriginal-specific group     Mainstream group     
 
What does this mean? 
• Class A is $10 cheaper than Class B per class 
• Transport is not provided for Class A (you have to make your own way) but is 
provided for Class B. 
• Class A is for an Aboriginal-specific group while Class B is for a mainstream 
community group. 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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Question 5 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: 0     $5     
Transport to class is provided No     Yes     
The class is for  Aboriginal-specific group     Mainstream group     
 
What does this mean? 
• Class A is $5 cheaper than Class B per class 
• Transport is not provided for Class A (you have to make your own way) but is 
provided for Class B. 
• Class A is for an Aboriginal-specific group while Class B is for a mainstream 
community group. 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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Question 6 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: 0     $5     
Transport to class is provided Yes     No     
The class is for  Mainstream group     Aboriginal-specific group     
 
What does this mean? 
• Class A is $5 cheaper than Class B per class 
• Transport is provided for Class A but is not provided for Class B (you have to make 
your own way). 
• Class A is for a mainstream community group while Class B is for an Aboriginal-
specific group. 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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 Thank you for agreeing to participate in this Survey Evaluation of the Ironbark Falls Prevention 
Program 
As part of evaluating the Ironbark project, we would like to ask you a few questions about what the 
most important features of the program are to you. For the next 6 questions we would like to ask 
you which of two hypothetical classes you would choose if you had the choice. If you would prefer to 
not attend either class then please select neither. If this is the case we would still like to know which 
class you would prefer. 
Please remember that the classes are not real and your answers will not affect the Ironbark program 
that you are currently attending. Your responses will be used to help identify what is important 
about the program and how it can be made better in the future. 
 
WHAT DO YOU NEED TO DO IN EACH QUESTION? 
• Imagine that your doctor has recommended you attend an exercise class to improve your 
functioning and reduce your risk of falling. 
• You are given a choice between Class A and Class B. Both classes are one hour long and are 
held once per week. Both classes are equally effective in improving your functionality and 
reducing your chance of having a fall. 
For each question please choose which class you would prefer: Class A, Class B or neither. 
• There are 6 questions 
• Each question has a different version of Class A and Class B 
• The classes are not real, you will not have to attend. We are asking you to choose the Class 
you would prefer if you had a choice between attending Class A, Class B or neither. 
 
 
There are no right or wrong answers! 
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Question 1 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: $10     0     
Transport to class is provided No     Yes     
The class is for  Mainstream group     Aboriginal-specific group     
 
What does this mean? 
• Class A is $10 more expensive than Class B per class 
• Transport is not provided for Class A (you have to make your own way) but is 
provided for Class B. 
• Class A is for a mainstream community group while Class B is for an Aboriginal-
specific group. 
 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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Question 2 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: $5     $0     
Transport to class is provided No     Yes     
The class is for  Aboriginal-specific group     Mainstream group     
 
What does this mean? 
• Class A is $5 more expensive than Class B per class 
• Transport is not provided for Class A (you have to make your own way) but is 
provided for Class B. 
• Class A is for an Aboriginal-specific group while Class B is for a mainstream 
community group. 
 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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Question 3 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: $5     $10     
Transport to class is provided Yes     No     
The class is for  Mainstream group     Aboriginal-specific group     
 
What does this mean? 
• Class A is $5 cheaper than Class B per class 
• Transport is provided for Class A but is not provided for Class B (you have to make 
your own way). 
• Class A is for a mainstream community group while Class B is for an Aboriginal-
specific group. 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
 
  
Health Economics and Indigenous Health 207
Question 4 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: $5     $10     
Transport to class is provided Yes     No     
The class is for  Aboriginal-specific group     Mainstream group     
 
What does this mean? 
• Class A is $5 cheaper than Class B per class 
• Transport is provided for Class A but is not provided for Class B (you have to make 
your own way). 
• Class A is for an Aboriginal-specific group while Class B is for a mainstream 
community group. 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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Question 5 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: 5     0     
Transport to class is provided No     Yes     
The class is for  Mainstream group     Aboriginal-specific group     
 
What does this mean? 
• Class A is $5 more expensive than Class B per class 
• Transport is not provided for Class A (you have to make your own way) but is 
provided for Class B. 
• Class A is for a mainstream community group while Class B is for an Aboriginal-
specific group. 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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Question 6 
 
Please choose whether you would prefer Class A, Class B or Neither. Both classes are equally 
effective in preventing falls and improving functionality. 
 
 Class A Class B 
This will cost you: 0     10     
Transport to class is provided Yes     No     
The class is for  Aboriginal-specific group     Mainstream group     
 
What does this mean? 
• Class A is $10 cheaper than Class B per class 
• Transport is not provided for Class A but is not provided for Class B (you have to 
make your own way). 
• Class A is for a mainstream community group while Class B is for an Aboriginal-
specific group only. 
Please select the BEST option between Class A, Class B or, if neither of these classes appeals to you, 
neither. 
Class chosen (please tick) 
A  
B  
Neither  
 
• If you did select ‘neither’, we would still like to know (for the second part of this question) 
which you prefer out of Class A or Class B. 
A  
B  
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 APPENDIX 7: CONTINGENT VALUATION QUESTIONNAIRE 
 
This appendix presents the questionnaire used in the study presented in Chapter 8. The questionnaire 
was administered via an online interface. 
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Thank you for taking part in this project.  
We would like to ask you some questions about yourself. 
How old are you? __ 
What is your gender?  
• Male 
• Female 
What is the annual income of your household before tax (please include all forms of income received 
such as salaries, rent collected and government benefits)? 
• <$40,000 
• $40,001 - $60,000 
• $60,001 - $80,000 
• $80,001 - $100,000 
• $100,001 - $120,000 
• >$120,000 
What is your highest educational qualification attained? 
• Left school before year 12 
• Year 12 
• Trade Certificate or diploma 
• Bachelor degree 
• Postgraduate degree 
Are you currently employed? 
• Yes - fulltime  
• Yes – Part-time or casual  
• Yes – self-employed 
• Retired 
• No 
Which of the following best describes your occupation?  
• Manufacturing 
• Trades 
• Retailing or hospitality 
• Professional services 
• Health Service 
• Education 
• Community care service 
• 'Other - please specify'.  
Where do you usually live (please provide suburb or postcode)? _______ 
Are you of Aboriginal or Torres Strait Islander origin? 
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• Yes – Aboriginal 
• Yes – Torres Strait Islander 
• Yes – both Aboriginal and Torres Strait  
• No 
Are you attending a school, university, TAFE or any other educational institution? 
• Yes - fulltime student 
• Yes – Part-time student 
• No 
Who do you live with? 
• Spouse or partner 
• Spouse or partner and children or other family members  
• Unrelated housemates 
• On your own 
How many dependent children live with you in your household? ____ 
How many people usually live in your household? ____ 
Now we would like to ask you some questions about your driving licence and transport options 
more generally 
How long have you held a driver’s licence? __ years  
Do you require a driver’s licence to work? 
• Yes 
• No 
Have you had your licence suspended or disqualified in the past five years?  
• Yes 
• No 
• Prefer not to say 
If yes, for what reason?  
• Driving-related offences 
• Non-road related fines or other offences 
• Other reasons 
• Prefer not to say 
Have you been fined for a traffic offence in the past 5 years? 
• Yes 
• No 
• Prefer not to say 
If yes (to question above) did you pay the fine? 
• Yes  
• No 
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Do you have your own car to drive?  
• Yes 
• No 
Apart from your own car, what transport options do you have when you need to travel somewhere 
(please select all that apply)?  
• Train 
• Bus 
• Ferry 
• Share car 
• Borrow car from a family member or friend 
• Someone else drives me 
• Motorcycle 
• Bicycle 
• Walking 
• Other - please specify _______ 
Thinking about your driving in the past year for what purpose do you drive a car?  
• Work 
• Grocery shopping 
• Social reasons 
• Study 
• Doctor 
• For fun 
• Other - please specify ______  
Then for each selected option –  
How often do you drive for X reason.  
• Less than once per week 
• Once a week 
• 2-3 times a week 
• Almost every day 
• 7 days a week 
 
Please read the following and then answer the questions that follow 
Holding a valid driver’s licence is necessary to legally drive on Australian roads. It is estimated that 
approximately 7 in 10 Australians aged 18 years and over travel to work or full-time study primarily 
in private cars.1  
Given the importance that holding a licence and driving more generally holds for many people in 
Australian society, it is important that the value of holding a licence is fully recognised. The aim of 
1 http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4102.0Main+Features40July+2013 
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this survey is to obtain from members of the general public a dollar value of having a licence. This 
will help us guide policies and programs that will help people attain and ultimately keep their 
licences.    
For the following questions, please consider yourself in a hypothetical situation where you face 
suspension of your licence for a period of 12 months. Over this time you will not be able to legally 
drive on Australian roads using any vehicle. 
1. Would you be willing to pay a fine of $700 to avoid losing your licence for 12 months? 
(yes/no/not sure) 
2. Would you be willing to pay a fine of $1,400 to avoid losing your licence for this period? 
(yes/no/not sure) 
3. Would you be willing to pay a fine of $2,100 to avoid losing your licence for this period? 
(yes/no/not sure) 
4. Would you be willing to pay a fine of $2,800 to avoid losing your licence for this period? 
(yes/no/not sure) 
5. Would you be willing to pay a fine of $3,500 to avoid losing your licence for this period? 
(yes/no/not sure) 
6. Would you be willing to pay a fine of $4,200 to avoid losing your licence for this period? 
(yes/no/not sure) 
7. Would you be willing to pay a fine of $4,900 to avoid losing your licence for this period? 
(yes/no/not sure) 
8. Would you be willing to pay a fine of $5,400 to avoid losing your licence for this period? 
(yes/no/not sure) 
9. Would you be willing to pay a fine of $6,300 to avoid losing your licence for this period? 
(yes/no/not sure) 
10. Would you be willing to pay a fine of $7000 to avoid losing your licence for this period? 
(yes/no/not sure) 
Participants to be randomised so half see the options from lowest to highest and half see highest to 
lowest.  
For participants who see the values from lowest to highest, continue until they respond no, and then: 
Why did you answer no for this value? _______ 
For all participants (even if they do not answer no to any values given): 
What is the maximum fine you would be willing to pay to avoid losing your licence? _____ 
For participants who see the values from highest to lowest, continue until they respond Yes to a value 
and then: 
Why did you answer yes for this value? _______ 
For all participants (even if they do not answer yes to any values given): 
What is the maximum fine you would be willing to pay to avoid losing your licence? _____ 
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